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ABSTRACT 
The aim of this study was to investigate the early ( ~48 h) changes 
in lipid metabolism occuring in the liver after 17~-oestradiol 
treatment (0.75 mg/100 g body wt.) of the male chick in vivo. 
An increase in liver weight was observed from 13 - 61 h after 
oestrogen treatment while an oestrogen-induced increase in the total 
hepatic DNA content was observed from 37 - 61 h suggesting that the 
early ( <37 h) liver growth response involved cell hypertrophy where-
as cell hyperplasia was involved in the later ( ~37 h) phase of the 
response. Oestrogen-induced increases in total liver triacylglycerol 
and phospholipid were observed from 7 h post-injection while an 
oestrogen-induced increase in total liver free fatty acid was not 
observed until after 26 hours. 
Similarly, total triacylglycerol and phospholipid concentrations in 
the plasma increased progressively from 7 - 44 h after hormone 
treatment. Plasma levels of VLDL-triacylglycerol and VLDL-phospho-
lipid in similarly-treated birds increased from 13 h and 6 h post-
injection, respectively, involving an oestrogen-induced increase in 
the number of VLDL particles specifically enriched with phospholipid. 
An oestrogen-induced increase in total free fatty acids in the 
plasma was not observed at any time post-injection. 
Analysis of the fatty acid compositions of liver triacylglycerol, 
VLDL-triacylglycerol and VLDL-phopsholipid, accumulating in oestrogen-
treated chicks, revealed that the major oestrogen-induced change was 
an increase in the level of oleic acid, from 13 hours post-injection. 
An oestrogen-induced increase in the hepatic activity of the key 
lipogenic enzyme acetyl-CoA carboxylase (E.C.6.4.1.2) was observed 
from 24 - 48 h post-injection, involving increased specific activity 
( i i ) 
both with respect to protein and DNA, and total organ activity. 
The results from the study were correlated in an attempt to 
determine the early sequence (~ 48 h) of oestrogen-induced changes 
in lipid metabolism. 
( i i i ) 
GLOSSARY 
The abbreviations suggested by the Biochemical Journal (Policy of 
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( i v) 
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( v) 
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CHAPTER 1 
GENERAL INTRODUCTION 
-1-
1. Egg formation 
The production of eggs by female oviparous vertebrates involves 
dramatic changes in the composition of the blood and in the 
metabolism of the liver and oviduct. The onset of egg-laying in the 
domestic fowl and other oviparous vertebrates is associated with 
alterations, both quantitative and qualitative, in blood lipids and 
proteins (Laskowski, 1936; Vanstone et al., 1955; Dessauer & Fox, 
1959; Schjeide et al .• 1963; Follett & Redshaws 1968). It is 
generally agreed that proteins and lipids destined for the egg yolk 
are synthesised in the liver, secreted into the blood and 
transported to the ovary for incorporation into the developing 
oocyte, whereas egg white components such as ovalbumin, conalbumin, 
ovomucoid and lysozyme are synthesised by the oviduct (Oka & 
Schimke, 1969; Palmiter & Wrenn, 1971; Griffin et al., 1984). 
(a) Changes associated with the liver 
(i) Proteins 
The changes in protein metabolism that take place during the 
process of vitellogenesis have been studied in the domestic fowl 
and the African clawed toad, Xenopus laevis. At sexual maturity, 
the liver of females synthesises large amounts of a glycolipo-
phosphoprotein which is secreted into the blood (Wallace & Jared, 
1968; Ansari et al., 1971; Redshaw & Follett, 1971; Clemens, 1974; 
Tata, 1978). This protein known as vitellogenin, is the plasma 
precursor of the egg yolk proteins phosvitin and o(- and B-lipo-
vitellin (Mok et al., 1961; Bergink & Wallace, 1974; Gruber et al., 
1976; Tata, 1978). Like many proteins destined for secretion, 
vitellogenin is synthesised on membrane-bound polysomes, passes 
into the cisternae of the endoplasmic reticulum, and is transported 
to the Golgi apparatus before being secreted from the cell. During 
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the passage to the Golgi apparatus, the newly-synthesised protein 
molecule is extensively chemically modified, the major post-
translational modification being extensive phosphorylation, 
glycosylation and lipidation (Clemens, 1974; Follett & Redshaw, 
1974; Tata, 1976, 1979; Shore & Tata, 1977; Wang & Williams, 1982). 
Chicken vitellogenin has a molecular weight of about 450,000 and 
is composed of 2 subunits, each having a molecular weight of 
210,000 - 230,000, and it is suggested that each subunit consists 
of 2 phvsvitin residues and 1 lipovitellin residue (Deeley et al., 
1975; Gordon et al., 1977). 
In the laying hen, vitellogenin present in the blood is taken up 
into developing oocytes by endocytosis (Griffin et al., 1984) and 
then split into its phosvitin and lipovitellin components within 
the oocyte (Redshaw & Follett, 1972). Phosvitins are glycosylated 
phosphoproteins, and 56% of their amino acids are serine (Clemens, 
1974). Most of the serine residues are phosphorylated, which means 
that about 10% by weight of the phosvitins is phosphorus (Allerton 
& Perlmann, 1965; Christmann et al., 1977). The lipovitellins are 
also phosphoproteins but contain about 20% by weight of lipid (Tata, 
1979). In addition, the lipovitellins are rich in methionine 
residues and about 4% of the amino acid residues are serine. The 
o(- and ~-lipovitellins differ from each other in their phosphate 
content and in their ability to be dissociated into 2 subunits at 
alkaline pH (Wallace, 1965). It is not altogether clear whether 
the presence of multiple forms of phosvitins and lipovitellins is 
the result of polypeptide heterogeneity or of different degrees of 
lipidation, glycoslyation and phosphorylation. The lipovitellins 
contribute about 30% and phosvitin about 7% - 8% to the yolk protein 
(Gruber, 1972). 
In addition to the changes in vitellogenin production, some of the 
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proteins that are deposited in the developing egg yolk are normally 
occurring plasma proteins which are made in the liver. During 
vitellogenesis the concentrations of these proteins in the plasma 
are altered. For example, in the domestic fowl, the concentrations 
of LDL and VLDL (Schjeide et al., 1963; Christie & Moore, 1972) and 
of various vitamin-binding proteins (~landella ~·· 1978) are 
increased, whilst the level of albumin appears to decrease (Schjeide 
et al., 1963), indicating that the stimulation of protein synthesis 
is specific rather than general in nature. 
(ii) Lipids 
In the rat and many other mammals, the adipose tissue and the liver 
are the major sites of lipogenesis, and the adipose tissue has been 
shown to be quantitatively more important than the liver in de novo 
fatty acid biosynthesis (Romsos & Leveille, 1974; Vernon, 1980; 
Pearce, 1983). In contrast, the liver has been shown to be the 
principal site of lipogenesis in avian species, including the 
domestic fowl (Leveille et al., 1968; 0 1 Hea & Leveille, 1969; Brady 
et al., 1976). Although the adipose tissue of the chicken is 
capable of fatty acid synthesis (0 1 Hea & Leveille, 1968), the 
chicken liver has a far greater capacity for de novo fatty acid 
synthesis (Leveille et al., 1968; Goodridge, 1968d; Aprahamian 
et al., 1979). On the assumption that the liver and adipose tissue 
are the only lipogenic sites, chicken liver has been shown to 
contribute 90% - 95% to total de novo fatty acid synthesis (0 1 Hea 
&Leveille, 1969). 
All plasma lipids, other than free fatty acids, are transported as 
part of macromolecular complexes called lipoproteins. The 
classification and nomenclature of these lipoproteins is based 
primarily on their electrophoretic mobility or on their rate of 
ultracentrifugal flotation in salt solutions (Jackson et al., 1976; 
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Chaoman. 1980). Based on these criteria, the major vertebrate 
' ' ' 
plasma lipoprotein fractions are (i) chy1omicra, in which the lipid 
is of dietary origin, and 3 fractions in which most of the lipid 
is produced endogenously, namely, (ii) very low density lipoproteins 
(VLDL), (iii) low density lipoproteins (LDL) and (iv) high density 
lipoproteins (HDL). Plasma lipoproteins are similar in that their 
basic structure consists of a hydrophobic core, comprising mainly 
triacylglycerol and cholesteryl ester, surrounded by an amphipathic 
surface 'coat' of phospholipid, cholesterol and specific apoproteins. 
A major difference in the lipid metabolism of birds and mammals 
exists, however, in the absorption of exogenous lipid. In avian 
species, dietary lipid is absorbed via the portal system as large 
VLDL or 'portomicra' (Bensadoun & Rothfeld, 1972) rather than as 
chylomicra via the lymphatic system as typically occurs in mammals. 
At the approach of lay in the female domestic fowl, the liver 
synthesises and secretes large amounts of lipoproteins, mainly VLDL, 
for transport to the yolk of the developing egg (Schjeide et al., 
1963; Christie & Moore, 1972). Consequently, egg-laying domestic 
fowl exhibit hyperlipaemia, primarily due to increased plasma 
triacylglycerol levels associated predominantly with VLDL (Lorenz, 
1954; Christie & Moore, 1972; Bergink et aJ., 1974). The liver has 
been shown to be the major site of VLDL synthesis (Haft et al., 
1962; Jones et al., 1967) indicating, therefore, that most of the 
triacylglycerol is of hepatic origin. 
As well as lipid being secreted into the blood in the form of 
lipoproteins for transport to the developing egg, much of the newly-
synthesised hepatic lipid, at least initially, is used for the 
proliferation of the endoplasmic reticulum and Go1gi apparatus in 
order to support the biosynthesis and export of large amounts of 
vitellogenin and other egg yolk proteins (Schjeide et al., 1963, 
1974; Schjeide, 1967). Large amounts of hepatic lipid are also 
-5-
incorporated into the newly-synthesised vitellogenin molecule 
during the process of post-translational modification. 
In contrast to the situation in laying domestic fowl, Xenopus 
laevis does not develop highly lipaemic plasma during the process 
of vitellogenesis (Follett & Redshaw, 1968; Wallace & Jared, 1968; 
Bergink et al., 1974). Xenopus laevis also differs from the 
domestic fowl in that the large amount of calcium observed in the 
blood of laying birds (Follett & Redshaw, 1968; Munday et al., 1968; 
Wallace, 1970; Clemens,1974) is not observed in the amphibian 
(Wallace & Jared, 1968), presumably since there is no egg shell 
production in this species. 
That increased hepatic lipogenesis is a major and specific feature 
of vitellogenesis in the domestic fowl, and not simply part of a 
general increase in metabolic rate, has been indicated by the work 
of Pearce (1971) and Pearce & Balnave (1976). These studies showed 
that with the onset of laying, the specific activities of certain 
lipogenic enzymes were increased while the specific activities of 
a variety of gluconeogenic, glycolytic and amino acid metabolising 
enzymes were unchanged. Interestingly, in the same studies, a 
similar pattern of altered enzyme activities were observed in 
sexually immature pullets treated with exogenous oestrogen. 
The physiological changes that occur at the approach of lay in 
female oviparous vertebrates are considered to arise as a result of 
the action of steroid hormones, notably oestrogen (Follett & 
Redshaw, 1968; Clemens, 1974), although a number of hormonal 
activities are almost certainly involved in the fine control. The 
importance of oestrogen in the induction of these changes in 
sexually mature domestic fowl has been emphasised by the fact that 
oestrogen treatment of male and immature females leads to hyper-
lipaemia, a situation which mimics that observed in laying hens 
-6-
(Lorenz, 1954; Schjeide et a1., 1963; Heald & McLachlan, 1964; 
Clark, 1967; Bergink et al., 1974). 
(b) Changes associated with the oviduct 
While the liver has been shown to synthesise and secrete protein 
and lipid for incorporation into the egg yolk, egg white components 
are synthesised and secreted by the oviduct (Oka & Schimke, 1969; 
Palmiter & Wrenn, 1971). The egg white contains over 40 individual 
proteins but the principal egg white proteins are, in order of 
decreasing percentage contribution, ovalbumin, conalbumin, 
ovomucoid and lysozyme (Aitken, 1971). 
During the development of the female domestic fowl there is a 
substantial increase in the weight of the oviduct such that, at 
16 weeks of age, the organ weighs, on average, 0.2 g whereas in the 
mature hen the organ weight is 40- 60 g (Amin & Gilbert, 1970). 
It has been estimated that this weight increase represents a 
20,000-fold increase in oviduct cell number after hatching (Palmiter, 
1975). In the sexually active bird, the oviduct is a tortuous tube, 
approximately 80 em in length, extending from the ovary to the 
cloaca. However, in sexually inactive birds, the oviduct is a 
fairly inconspicuous and narrow tube, approximately 14 - 19 em in 
length (Aitken, 1971). 
The oviduct of the egg-laying bird exhibits distinctive structural 
variations which allows its subdivision into 5 principal parts; 
infundibulum, magnum, isthmus, uterus (shell gland) and vagina. 
The magnum is responsible for the production and secretion of the 
egg-white proteins, and consists of a thick-walled tube with up to 
90% of the cells being protein-secreting tubular gland cells (Aitken, 
1971; Palmiter, 1975). Immediately prior to ovulation, the gland 
cells are distended with secretion droplets which are destined for 
incorporation into the developing egg (Aitken, 1971). 
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The increase in oviduct weight and the synthesis and secretion of 
egg-white proteins observed when the female domestic fowl reaches 
sexual maturity has been shown to be caused principally by oestrogen, 
since similar changes in oviduct structure and function have been 
mimicked in sexually immature birds following the administration of 
exogenous oestrogen. Substantial increases in oviduct weight have 
been observed in immature chicks after treatment with large doses 
of oestrogen (Hawkins & Heald, 1966; Aprahamian et al., 1979) and 
the oestrogen-induced increase in weight has been shown to involve 
both hypertrophy and hyperplasia (Pearce & Brown, 1971; Balnave & 
Pearce, 1974; Pearce & Balnave, 1975) and a massive proliferation 
of tubular gland cells (Kohler et al., 1969; Palmiter & Wrenn, 1971; 
Palmiter, 1972, 1975). Similarly, the administration of oestrogen 
to immature pullets results in a rapid induction of synthesis of 
the egg-white protein, ovalbumin by the tubular gland cells (Oka & 
Schimke, 1969; Palmiter et al., 1971; Palmiter, 1972). 
While the studies using oestrogen-treated immature birds clear1y 
implicate oestrogen as a major causative factor in the changes in 
oviduct structure and function in the female domestic fowl during 
sexual maturation, it is believed, however, that other sex steroids 
are also involved, to a lesser extent. This view is supported by 
evidence that the effect of exogenous oestrogen on the synthesis of 
egg-white proteins, by immature pullets, is modulated by exogenous 
progesterone and testosterone (Palmiter, 1973, 1975). 
(c) Mechanism of action of oestrogen 
In mature females of oviparous vertebrate species, the changes in 
hepatic lipid and protein production, and in oviduct physiology, 
occur constitutively in response to endogenous oestrogens secreted 
by the ovary. All steroid hormones are thought to act by combining 
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with specific receptor proteins in target cells to form a complex 
that binds to chromatin in the nuclei, thereby switching on mRNA 
synthesis from specific genes (King, 1984). A 'two-step' model of 
steroid hormone intracellular action was put forward independently 
by Gorski et al. ( 1968) and Jensen et al. ( 1968). This model is 
based on studies of the uptake and binding of radioactive oestrogens 
to receptors in reproductive tissues and according to the model, 
oestradiol enters the target cell, binds to a specific cytoplasmic 
receptor and then is translocated to the nucleus by a temperature-
dependent 'activation' process. This 'activation' of the steroid-
receptor complex was reflected both by a change in its sedimentation 
coefficient from 4S to 5S and by its ability to bind to isolated 
target cell nuclei. Therefore, in this 'two-step' model, cyto-
plasmic receptors can exist either steroid-filled or unfilled, 
whereas nuclear receptors can exist only when steroid-filled. 
A number of studies, however, have shown that unfilled receptors do 
in fact exist in the nuclei of oestrogen target tissues 
(Sonnenschein et al., 1976; Jungblut et al., 1978; Carlson & Gorki, 
1980; Edwards et al., 1980; Clark et al., 1982) and thereby casting 
some doubt upon the previously accepted 'two-step' model of 
steroid action. In these studies careful attention was paid to 
the purity of the nuclei, thereby ensuring no contamination of the 
preparation with cytoplasmic receptors. Such observations led to 
the hypothesis that in intact cells, unfilled receptors may exist 
in a state of equilibrium between the cytoplasm and nucleus 
(Sheridan et al., 1979). However, recent evidence suggests that 
unfilled oestrogen receptors reside exclusively within the target 
cell nucleus. Welshans et al. (1984) obtained cytoplast and 
nucleoplast fractions from oestrogen receptor-rich cells, derived 
from rat pituitary tumours, by a process of cytochalasin B-induced 
enucleation. The cytoplasts were found to contain little oestrogen-
binding activity, with most of the unfilled receptor residing within 
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the nuclear fraction. The study of King & Greene (1984) also 
provides convincing evidence that oestrogen receptors may reside 
exclusively in target cell nuclei. These workers used immunocyto-
chemical staining of a monoclonal antibody generated against the 
oestrogen receptor protein. Specific staining was found to be 
confined to the nucleus of a variety of oestrogen-sensitive 
tissues including human breast tumours and uterus, rabbit uterus, 
oviduct corpus luteum, mammary gland, pituitary and liver. There-
fore, the distribution of oestrogen receptors as predicted by the 
studies of Welshans et al. (1984) and King & Greene (1984) has led 
to a 'one-step' model of oestrogen intracellular action (Clark, 
1984). This latest model of steroid hormone action involves the 
entry of the hormone, in an unbound state, directly into the 
nucleus via the cytoplasm. Once inside the nucleus, the steroid 
hormone binds to specific receptor protein and forms a steroid-
receptor complex which in turn can affect the transcription of 
specific genes. 
Whilst the 'one-step' model of oestrogen intracellular action is 
the model most easily reconciled with the available evidence, a 
number of details still need to be sorted out, including the 
question of the location of filled and unfilled oestrogen receptors 
within the target cell nuclei (Clark, 1984). 
2. Oestrogen treatment of male and female oviparous vertebrates 
Studies on male and immature female domestic fowl have shown that, 
after oestrogen administration, hepatic lipid and protein synthesis 
increase and certain lipids and proteins, including vitellogenin, 
VLDL and vitamin-binding proteins, accumulate in the blood in a 
manner which is qualitatively similar to the situation in females 
during the approach to lay (Lorenz, 1954; Bergink et al., 1973, 
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1974; Kudzma et a 1., 1973; Luskey et a 1., 1974; Chan et a 1., 1976, 
1978). Furthermor·e, there does not appear to be a limit to the age 
at which the chicken liver will respond to oestrogen, since even 
the administration of oestrogen to chick embryos results in the 
production of plasma lipid and egg yolk proteins (Schjeide et al., 
1960, 1980; Lazier, 1978; Elbrecht et al., 1981). Similar studies 
on male and immature female Xenopus laevis have produced similar 
observations (Follett & Redshaw, 1968; Follett et al., 1968; Munday 
et al., 1968; Smith et al., 1978b; Philipp & Shapiro, 1981). In 
consequence, male animals have been useful in the study of 
oestrogen-induced physiological changes which normally occur with 
the onset of egg-laying in the female, since no significant levels 
of endogenous oestrogen exist in such individuals and any changes 
observed can be assumed to be caused by exogenous oestrogen, after 
comparison with suitable controls. Immature females, however, are 
not as useful in this respect since the levels of endogenous 
oestrogen, and oestrogen receptors may increase during their 
development. 
The induction of hepatic vitellogenin synthesis by exogenous 
oestrogen, in the domestic fowl and Xenopus laevis. is characterised 
by a lag period before vitellogenin is detectable. Steroid hormone 
action is normally preceded by a lag period, the length of which is 
dependent upon the hormone used, the target tissue and whether the 
target tissue has been previously exposed to the hormone. This 
effect has been observed in the livers of male oviparous vertebrates 
after oestrogen treatment, since secondary stimulation results in 
a shorter lag phase before vitellogenin is detectable, as compared 
with that obtained with primary stimulation (Bergink et al., 1973, 
1974; Tata, 1976). In vivo studies in the cockerel have shown that, 
after a single oestrogen injection, vitellogenin first becomes 
evident in the blood from about 3 - 4 hours to about 20 hours later, 
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depending on the sens -j t i vi ty of the detection assay ( Greengard et 
~·, 1964; Beuving & Gruber, 1971; Bergink et a l., 1973) and 
increases in concentration to reach a peak after 3 - 4 days 
(Bergink et al., 1973, 1974). The dose level of oestrogen used has 
also been shown to affect both the magnitude and the time-course 
of the response (Wallace & Jared, 1968; Beuving & Gruber, 1971; 
Shapiro, 1982). A difference has been shown to exist between the 
time-courses of the responses of male Xenopus laevis and male 
domestic fowl. After a single injection of oestrogen, a peak in 
blood vitellogenin levels is observed more rapidly in cockerels 
than in the amphibia~s although, in both species, peak hepatic lipid 
production occurs earlier than the observed peak in blood 
vitellogenin content (Bergink et al., 1974; Tata, 1976). 
Several workers have shown that oestrogen treatment of domestic fowl 
results in a dramatic increase in the plasma concentration of VLDL, 
with a lesser increase in LDL and a marked decrease in HDL 
(Annison, 1971; Luskey et al., 1974; Kudzma et al., 1979). All the 
lipoprotein fractions are enriched in triacylglycerol, whilst the 
proportion of cholesterol is decreased in all the fractions. 
Therefore, whilst the bulk of the plasma lipids constituting the 
lipaemia associated with oestrogen treatment of the domestic fowl 
are triacylglycerols (Kudzma et al., 1973, 1975, 1979; Luskey et 
al., 1974; Chan et al., 1976, 1977), the remaining hyperlipaemia 
is attributable to phospholipids and to a lesser increase in 
cholesterol. Chan et al. (1977) reported increases in plasma 
VLDL-protein, -phospholipid, -cholesterol and -triacylglycerol 
within 5 hours of administering 178-oestradiol (1 mg) to young male 
chicks, reaching peak levels at 48 hours after injection before 
returning to control levels, 68 hours after treatment. 
Xenopus laevis responds to oestrogen treatment in a similar way to 
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the domestic fowl, but this species differs from the domestic fowl 
in thnt the plasma remains transparent after oestrogen treatment. 
giving no indication of enhanced VLDL synthesis (Follett & Redshaw, 
1968; Bergink et al., 1974). However, an increase in hepatic lipid 
synthesis, primarily of cholesterol and fatty acids, has been 
detected in the oestrogen-treated male and female Xenopus laevis, 
the bulk of the lipid being incorporated into intracellular 
membranes, although some of it is associated with the egg yolk 
proteins (Merry et al., 1973; Smith et al., l978b; Philipp & 
Shapiro, 1981). The peak production of lipid in the oestrogen 
treated female Xenopus laevis occurs about 6 days after a single 
dose of 17~-oestradiol (1 mg.). 
Vitellogenesis has also been induced by oestrogen in vitro, in cell 
and organ cultures of male Xenopus laevis liver (Wangh & Knowland, 
1975; Wangh et al., 1979; Searle & Tata, 1981; Wangh & Schneider, 
1982; Tenniswood et al., 1983) and embryonic and young chick liver 
(Carinci et al., 1976; Chan et al., 1977b). These studies have 
established that oestrogen is the sole inducer required for the 
synthesis of egg yolk proteins, that DNA synthesis does not appear 
to be essential for the initial stages of induction and that the 
action of the hormone upon the liver is direct. 
As described above, liver cells of oviparous vertebrates respond to 
oestrogen with an increase in lipid production and the synthesis of 
specific proteins, including vitellogenin and apoprotein moieties 
of lipoproteins. In contrast, the oviduct of female oviparous 
vertebrates responds to oestrogen with an increase in growth and 
cell differentiation and the production of egg white proteins (Oka 
& Schimke, 1969; Palmiter & Wrenn, 1971) indicating that oestrogen 
stimulates the transcription of different genes in the two organs. 
Consequently, oestrogen-treated male domestic fowl and Xenopus 
laevis have proved to be valuable in the study of the early 
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cellular events in hormone action, particularly the role of 
steroid receptors and the control of transcription and translation 
(lata, 1978). The induction of vitel1ogen synthesis in the 
oestrogen-treated male animal is a very interesting phenomenon, 
since it involves the activation of genes which are not normally 
expressed significantly (Deeley et al., 1977; Blue & Williams, 
1981). Following oestrogen treatment of male oviparous vertebrates, 
a substantial increase in the hepatic synthesis of mRNA coding for 
vitellogenin has been observed (Greengard et al., 1964; Beuving & 
Gruber, 1971; Bos et a1., 1972; Deeley et a1., 1977). 
The oestrogen-induced increase in hepatic VLDL production in male 
domestic fowl has also been shown to be accompanied by increased 
hepatic concentrations of mRNA coding for apo-VLDL-II, a specific 
apoprotein moiety of oestrogen-induced plasma VLDL, indicating an 
increased rate of transcription of the gene coding for apo-VLDL-II 
(Chan et a1., 1978, 1980; Codina-Salada et a1., 1983). The 
induction of apo-VLDL-II synthesis in the oestrogen-treated male 
animal is similar to the induction of vitellogenin synthesis in 
that the apo-VLDL-II gene is also not normally expressed to a 
significant extent (~viskocil et al., 1980). 
A great deal of work has been done using birds and amphibians to 
examine the transcriptional events and protein synthesis resulting 
from oestrogen treatment. Similarly, a number of workers have 
carried out investigations in order to increase our understanding 
of the changes in lipid metabolism which underly the increased 
lipid synthesis during oestrogen-induced vitellogenesis. Kudzma 
et al. (1973) administered oestrogen to young chicks (sex 
undetermined), in vivo, and observed an increased rate of de novo 
fatty acid synthesis in liver slices, monitored by the incorporation of 
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[1- lil~ acetate into lipid. Similarly, Courtney (1984) measured 
increased de novo fatty acid synthesis 1n liver slices from 
oestrogen-treated immature male chicks as determined by the 
incorporation of [1 - 14tj acetate and 3H20 into lipids. Further-
more, oestrogen treatment increased the rate of incorporation of 
preformed fatty acids into hepatic glycerolipids, in vivo (Kudzma 
et al., 1975), and in liver slices, in vitro (Courtney, 1984). 
Increases in the rate of de novo lipogenesis, monitored by the 
incorporation of 3H2o into hepatic glycerolipid in vivo, have also 
been observed in oestrogen-treated immature male turkeys (Dashti 
et al., 1983). A number of attempts have also been made to monitor 
any oestrogen-induced changes in hepatic lipogenic enzyme activities 
in male and immature female avian species. Oestrogen treatment of 
immature female domestic fowl has been shown to cause increased 
specific activity of hepatic ATP citrate lyase (E.C.4. 1.3.8) 
(Balnave & Pearce, 1974; Pearce & Balnave, 1975). Similarly, an 
oestrogen-induced increase in the hepatic specific activity of 
•malic• enzyme (malate dehydrogenase (decarboxylating; NADP+), 
E.C. 1. 1. 1.40) has been observed in immature female domestic fowl 
(Balnave & Pearce, 1974; Pearce & Balnave, 1975) and roosters 
(de Vellis & Schjeide, 1967). An increase in hepatic fatty acid 
synthetase activity has been reported in oestrogen-treated immature 
female (Aprahamian et al., 1979) and immature male (Courtney & 
Manning, 1984) domestic fowl. A rapid increase in the specific 
activity of hepatic acetyl-CoA carboxylase (E.C.6.4. 1.2), within 
3 hours after oestrogen treatment, has been reported in immature 
female Japanese quail (Pageaux et al., 1981). 
A number of studies have also reported increases in the activities 
of enzymes involved in phospholipid and triacylglycerol biosynthesis 
in the liver of oestrogen-treated male and immature female domestic 
fowl. For instance, Vigo et al. (1981) reported increases in the 
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in oestrogen-treated male chicks. Coleman et al. (1977) detected 
increases in the total hepatic activities of fatty acid:CoA ligase 
(AMP-forming) (E.C.6.2. 1.3), ~-glycerol 3-phosphate:acyl-CoA 
transferase (E.C.2.3. 1. 15) and diacylglycerol acyltransferase 
(E.C.2.3. 1.20) in oestrogen-treated immature male and female birds. 
The above reports of changes in hepatic lipogenic activity in 
oestrogen-treated birds are somewhat difficult to compare with each 
other since differences in the age and the sex of the birds used, 
and in the dose of oestrogen used exist between the studies. There-
fore, at the moment, our understanding of the changes in lipid 
metabolism, which underly the oestrogen-induced increase in lipid 
production, is fragmentary and there is scope for a more coherent 
study in this field. 
Although the administration of oestrogen to immature pullets and 
male domestic fowl cause qualitative changes in blood and hepatic 
lipids similar to those in laying hens, quantitative differences 
exist, suggesting that oestrogen administration does not entirely 
mimic the situation in the laying hen. Balnave (1971) has reported 
an over-reaction of immature pullets to oestrogen in that the 
resultant liver weights were greater than those in the laying hens. 
A substantial increase was also observed in the percentage of 
palmitic acid in the liver and blood lipids of the same oestrogen-
treated birds, an increase not detected in laying hens. However, the 
mature hen was sho~ to have an increased capacity to retain 
dietary linoleic acid and this increase was not observed in the 
oestrogen-treated birds. Such differences could be explained by the 
fact that the physiological changes associated with sexual maturity 
in hens are not controlled solely by oestrogen, and other endocrine 
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secretions may exert an effect (Balnave, 1969; Balnave & Pearce, 
1974). Furthermore, the egg-laying process itself may exert a 
significant effect since lipid is removed from the body when eggs 
are laid, an effect obviously not evident in oestrogen-treated 
immature birds. 
3. Medical implications of oestrogen-treated birds. 
Severe hyperlipaemia is evident in a number of clinical conditions 
in man including uncontrolled diabetes (Bagdade et al., 1967), 
myxoedema (Fredrickson et al., 1963) and genetically determined 
hyperlipoproteinaemia (Porte et al., 1966). The incidence of 
cardiovascular disease has been shown to be linked with the levels 
of blood lipids (Barboriak et al., 1974). The domestic fowl has 
been a very useful experimental animal in the study of such medical 
conditions since oestrogen treatment leads to hyperlipaemia {Kudzma 
et al., 1973; Chan et al., 1976, 1978) and arteriosclerosis develops 
after prolonged oestrogen treatment or cholesterol feeding 
(Hillyard et al., 1956). In addition, the normal plasma levels of 
triacylglycerol, cholesterol and free fatty acid (Kudzma et al., 
1973) and the lipid composition of the plasma lipoproteins (Kudzma 
et al., 1973; Chapman, 1980) of domestic fowl are similar to those 
of man. 
Epidemiological studies have linked low plasma HDL and high VLDL 
and LDL levels with premature coronary arteriosclerosis (Miller & 
Miller, 1975; Blue et al., 1982). Women have been shown to have 
significantly higher levels of plasma HDL than men, at all ages 
after puberty, and lower levels of plasma VLDL and LDL than men in 
middle age (Heiss et al., 1980). It is interesting to note, there-
fore, that women have a reduced chance of suffering from arterio-
sclerotic disease (Kissebah et al., 1973). These higher HDL levels 
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have been attributed to endogenous oestrogen since treatment of men 
and women with exogenous oestrogen has resulted in elevated HDL 
levels (Barr, 1955; Schaefer et al., 1983). The slightly lower 
VLDL and LDL levels in women compared to men have been attributed 
to the higher progesterone levels in women (Schaefer et al., 1983). 
Premenopausal women taking exogenous oestrogen, in the form of 
contraceptive treatment, have been shown to have elevated fasting 
plasma levels of lipids, mainly triacylglycerols, associated 
principally with an increase in VLDL levels and, to a lesser extent, 
increases in HDL and LDL levels (Sachs et al., 1969; Wynn et al., 
--
1969; Schaefer et al., 1983). The hyperlipaemia in such women is 
qualitatively similar to the hyperlipaemia which develops in the 
oestrogen-treated fowl and, therefore, the oestrogen-treated fowl 
represents a model for use in studies of the hyperlipaemia evoked 
by oestrogen-containing oral contraceptives. Evidence has been 
presented which suggests that the altered plasma lipoprotein 
profiles of oestrogen-treated women increase their susceptibility 
to cardiovascular disease, such as myocardial infarction (Oliver, 
1970) and cerebral vascular accidents (Vessey & Doll, 1969). 
Although the oestrogen present in oral contraceptives is believed 
to be responsible for the hyperlipaemia, the progestagen component, 
whichis a feature of most preparations, appears to be inert or 
antagonistic in this respect (Glueck et al., 1969; Kim & Kalkhoff, 
1975; Chan et al., 1977). 
The hyperlipaemia observed in both humans and domestic fowl treated 
with exogenous oestrogen could be caused by an increased rate of 
production of triacylglycerol-rich lipoproteins, especially VLDL, 
or a reduced removal of triacylglycerol from the plasma or a 
combination of the two. Studies on the oestrogen-treated fowl 
have shown that the increase in plasma VLDL levels is accompanied by 
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increased hepatic VLDL synthesis (Kudzma et al., 1975, 1979; Chan 
et a1., 1976, 1978, 1980). Similarly, clinical investigations have 
indicated that the rise in plasma VLDL levels in women using 
oestrogen-containing contraceptives is accompanied by increases in 
the hepatic synthesis of apoprotein moieties of lipoproteins and 
triacy1glycerol (l~ynn et al., 1969; Kekki & NikkilM, 1971; Kissebah 
et al., 1973; Schaefer et al., 1983; Gevers Leuven et a1., 1984). 
The clearance of triacy1glycero1 from the plasma occurs mainly 
through the action of lipoprotein lipase situated at the luminal 
surface of the endothelial cells of capillaries (Scow et al., 1976; 
Kompiang et al., 1976; Quinn et al.~ 1982). The intravenous 
injection of heparin causes the release of some or all of the 
enzyme in the blood. Several investigators have observed reduced 
post-heparin lipolytic activity (PHLA) in women receiving exogenous 
oestrogen in the form of contraceptives (Fabian et al., 1967; Ham 
& Rose, 1969; Hazzard et a 1., 1969; R~ssner et a 1., 1971) 
suggesting that the hyperlipaemia may, in part, be due to reduced 
plasma triacylglycerol clearance. It has been suggested, however, 
that oestrogen treatment might lead to lipoprotein lipase becoming 
more resistant to release by heparin (Hazzard et al., 1972) and, 
therefore, any observed depression of PHLA need not necessarily 
reflect a reduction in triacylglycerol clearance capacity. 
In comparison to the effect of oestrogen on PHLA in women, 
progesterone has been demonstrated to cause a decrease in plasma 
triacylglycerol levels with increased triacylglycerol clearance and 
increased PHLA (Glueck et al., 1969; Kissebah et al., 1973). 
A number of studies have examined the ability of hyperlipaemic 
oestrogen-treated birds and laying birds to clear triacylglycerol 
from the plasma. Kelley et al. (1976) reported that the PHLA in 
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the plasma of laying turkeys was decreased in relation to non-laying 
birds, and oestrogen treatment of male turkeys caused a similar 
decrease. However, Dasht i et a l, ( 1983) suggested that the oestrogen 
treatment of male turkeys resulted in hyperlipaemia principally 
through an increased hepatic production of triacylglycerol-
containing lipoproteins and that the observed decreased fractional 
turnover of triacylglycerol in the circulation was a secondary 
factor, resulting from the saturation of the removal mechanisms. 
Kudzma et al. (1975) arrived at similar conclusions from observations 
made on oestrogen-treated domestic fowl. 
In this discussion of the relative roles of lipid synthesis and 
lipid plasma clearance in the development of hyperlipaemia it is of 
interest to note the findings of Griffin (1981). This worker 
performed studies on isolated lipoproteins and found that, aithough 
VLDL from immature hens were readily hydrolysed by lipoprotein 
lipase, those from laying hens were hydrolysed only to a limited 
extent. These results suggest that the hyperlipaemia of laying hens 
may be, in part, associated with impaired catabolism of 
triacylglycerol-rich VLDL by lipoprotein lipase. Furthermore, 
Griffin (1981, 1984) suggested that the limited susceptibility of 
laying hen VLDL to hydrolysis was almost certainly due to their low 
content of an unspecified lipoprotein lipase 'activator' apoprotein, 
the VLDL from male and immature female birds possessing a higher 
content of this 'activator' apoprotein. 
4. The purpose of the present study 
Oestrogen-induced hyperlipaemia is well-documented in domestic fowl 
and it is generally accepted that increased hepatic synthesis and 
release of triacylglycerol-rich lipoproteins is a major causative 
factor (Luskey et al., 1974; Kudzma et al., 1975, 1979; Chan et al., 
1976, 1978, 1980). However, the mechanism(s) responsible for the 
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oestrogen-dependent increase in triacylglycerol synthesis is 
unciear. Severai studies have indicated that oestrogen 
treatment of birds causes an increase in the activity of a number 
of hepatic lipogenic enzymes (de Vellis & Schjeide, 1967; Balnave 
& Pearce, 1974; Pearce & Ba1nave, 1975; Coleman et al., 1977; 
Aprahamian et al., 1979; Vigo et al., 1981; Pageaux et al., 1981; 
Courtney & Manning, 1984), together with an increase in plasma 
triacylglycerol levels. However, many of these studies employed 
relatively high levels of oestrogen, sometimes administered in 
multiple doses, so the results may reflect a pharmacological 
response, rather than a physiological response, to the treatment. 
Furthermore, most investigators have examined the effects at 
relatively long periods ( >24h) after oestrogen administration, and 
so little is known about the events during the initial period of 
the response. 
Consequently, the aim of the present study was to study the early 
changes in various parameters of lipid metabolism, in both the 
liver and the blood of male birds which had received single intra-
muscular injections of oestrogen, in the hope of obtaining a greater 
and more coherent understanding of the mechanism(s) involved in the 
oestrogen-dependent stimulation of hepatic lipogenesis in birds. 
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CHAPTER 2 
CHANGES IN THE WEIGHT, SOLUBLE PROTEIN 
CONTENT AND DNA CONTENT OF THE LIVER 
OF THE MALE CHICK AFTER OESTROGEN 
TREAnlENT. 
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INTRODUCTION 
1. Factors affecting avian liver morphology 
(a) Effects of oestrogen 
As the female domestic fowl approaches lay, the liver becomes 
enlarged involving cellular hypertrophy and hyperplasia (Schjeide 
et al.,1963; Pearce, 1971; Balnave, 1971). Laying hen liver, as 
well as continuing with normal hepatic function, must synthesise 
components of egg yolk and the hepatic parenchymal cells of such 
birds are characterised by an extensive proliferation of the endo-
plasmic reticulum and Golgi apparatus (Schjeide et al., 1963; 
Sche ide, 196 7) . The 1 i ver ce 11 s produce 1 arge amounts of 1 i po-
proteins and yolk proteins which are secreted and then transported, 
via the blood, to their site of deposition in the developing 
oocyte (Schjeide et al., 1963; Heald & Mclachlan, 1965). These 
changes that occur in the sexually mature hen have also been reported 
in chicks, non-laying hens and cockerels after the administration 
of exogenous oestrogen (Lorenz, 1954; Schjeide et al, 1963; Bergink 
et al., 1974; Chan et al., 1976). The results of these studies, 
therefore, implicate endogenous oestrogen as the likely cause of the 
changes in liver morphology as female domestic fowl approach lay. 
Oestrogen treatment of male and immature female birds has been shown 
to cause substantial increases in liver size and weight (Schjeide et 
al., 1963, 1974; Hawkins & Heald, 1966; Balnave & Pearce, 1974; 
Pearce & Balnave, 1976; Pearson & Butler, 1978). Balnave (1969) 
treated 6 week-old male chicks with testosterone, progesterone or 
oestrogen and found that oestrogen was the only hormone to cause an 
increase in liver weight. An interesting observation was later 
reported by Balnave (1971) involving an apparent 'over-reaction' of 
the liver to exogenous oestrogen in immature female domestic fowl. 
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In this study 16-week old female chickens were treated with 5 mg 
oestradiol dipropionate on alternate days, over a 7-day period 
and the liver weights of these hormone-treated birds were similar 
to those of heavier mature laying hens. 
Other avian species have been shown to respond to oestrogen treatment 
in a similar fashion 
have been observed. 
Japanese quail (4.36 
to domestic fowl, in that increased liver wei'ghts 
Oestrogen treatment o~ 3 to 6 months old 
mg 17~-oestradiol/100 g body wt.) resulted in a 
near doubling of liver weight 4 days after hormone administration 
while after longer periods of time, the increase in liver weight 
diminished until gradually the liver weight returned to values similar 
to those of control birds (Gibbins & Robinson, 1982). Similarly, 
treatment of 19 day-old male turkeys with a single dose of 
diethylstilboestrol (40 mg/kg body wt.) resulted in increased liver 
weight, both in absolute terms and in relation to the body weight, 
at 24 hours, 48 hours and 72 hours after hormone injection maximum 
stimulation of liver weight being observed 48 hours post-injection. 
At this time, oestrogen-treated birds compared to control birds 
exhibited a 1.28-fold increase in absolute liver weight and a 
1.32-fold increase in 1·iver weight as a proportion of body weight 
(Dashti et al., 1983). It should be noted that this study on male 
turkeys and the study on Japanese quail both used massive doses of 
oestrogen. 
It is interesting to note that, although oestrogen treatment of the 
domestic fowl leads to an increase in liver weight, similar treatment 
of chick embryos leads to a decrease in liver weight. Schjeide et al, 
(1961) treated 15-day old chick embryos with large doses of oestrogen 
(5 mg/bird) and observed an approximately 15% reduction in liver 
weight after 3 days, compared with controls, whereas chicks oestrogen-
treated at hatching and sacrificed 3 days later had livers that 
weighed 28% more than those from untreated chicks. 
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The dose level and the duration of the oestrogen treatment has been 
shown by a number of investigators to affect the extent of the liver 
weight response in domestic fowL Balnave & Pearce (1974) treated 
immature female domestic fowl with 2 mg oestradiol dipropionate on 
alternate days over a 9-day period and showed that liver weight, 
expressed as a proportion of body weight, increased 1.6-fold over 
the first 4 days of hormone treatment, but the extent of the liver 
weight increase was depressed after 9 days of treatment. Similarly, 
Pearce & Balnave (1975) treated 4-week old pullets with single 
injections of oestradiol dipropionate and, 2 days later, they 
observed dose-dependent increases in liver weights up to 2 mg 
hormone/bird. With a dose of 4 mg hormone/bird, however, the extent 
of the observed increase in liver weight was depressed. Dose-
related increases in liver weights of oestrogen-treated 6 to 7-week 
old pullets have been reported by Pearson & Butler (1978) who 
administered 5 doses of 0.25, 0.5 or 1 mg oestradiol dipropionate/ 
100 g body weight at 3-day intervals, the birds being sacrificed 2 
days after the last dose. Similar dose-related increases have been 
observed by Akiba et al. (1982) after implanting silastic tubes 
filled with oestradiol dipropionate subcutaneously in the necks of 
2 to 3-week old male chicks. Different lengths of tube were used 
with release rates of 1 - 15.2 ~g oestradiol/day and the birds were 
sacrificed 2 - 3 weeks after implantation. 
Enlargement of the liver of oestrogen-treated domestic fowl and 
laying hens is considered to be predominantly due to hypertrophy as 
a result of water uptake and the accumulation of lipid (Scheide et 
al., 1963; Schjeide & Lai, 1970). There is an increase in the total 
hepatic lipid content, predominantly triacylglycerol, of both 
oestrogen-treated birds and hens at the onset of lay, which 
contributes to the increase in liver weight (Pearce, 1971, Pearce & 
Brown, 1972; Balnave & Pearce, 1974; Kuszma et al., 1975; Pearce & 
Balnave, 1975). Observations of the hepatocytes of such livers have 
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revealed a proliferation of the endoplasmic reticulum and Go1gi 
apparatus together with an increase in the number of associated 
ribosomes and mitochondria (Schjeide et al., 1963; Skipper & 
Hamilton, 1977; Tarlow et al., 1977; Tata, 1979). The cisternae of 
the endoplasmic reticulum have also been shown to be dilated in 
appearance as they become increasingly active in the production of 
secretory proteins and become engorged with lipid droplets and 
nascent lipoproteins (Schjeide et al., 1963; Tarlow et al., 1977; 
Garber & Brasch, 1982). 
As the liver enlarges it becomes paler in colour and fatty in 
appearance developing a softer, more fragile structure (Schjeide & 
Lai, 1970) and the increase in liver size and weight usually becomes 
obvious within 24 hours of oestrogen treatment (Schjeide & Lai, 1970; 
Balnave & Pearce, 1974). Hawkins and Heald (1966) measured the 
hepatic DNA content of 11-week old pullets, treated with 2 mg 
oestradiol benzoate on alternate days for 7 days and sacrificed on 
the 8th day, and showed that the DNA content per gram wet weight 
of liver,was decreased compared with control birds. In the same 
study it was also reported that the DNA content of a unit wet weight 
of liver from immature pullets was approximately 1.4-fold greater 
than the corresponding value for the laying hen. This suggests that 
the increase in liver weight observed in hens approaching lay may 
occur by a similar mechanism to the increase observed in oestrogen-
treated birds, in that cell expansion is a major causative factor 
of the weight gain. However, it has been estimated that, as well as 
an increase in cell volume, a proportion (~20%) of the liver 
parenchymal cells divide in response to oestrogen (Schjeide & Lai, 
1970; van den Berget al., 1974), and in addition, increased DNA 
synthesis, which is indicative of cell division, does occur (Jost et 
al., 1973). It is interesting to note that oestrogen-treatment of 
immature female birds has been shown to lead to an increase in 
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oviduct weight involving both hypertrophy and hyperplasia (Pearce 
& Brown, 1971; Balnave & Pearce, 1974; Pearce & Balnave, 1975) and 
in this respect, the responses of both the liver and oviduct to 
oestrogen are similar. 
Changes in liver morphology and cytology in response to oestrogens, 
have been reported in other oviparous vertebrates, the changes being 
similar to those of the domestic fowl. Xenopus laevis has been 
shown to respond with an increase in liver size (Follett & Redshaw, 
1968) and with a proliferation of the endoplasmic reticulum and Golgi 
apparatus (Follett et al., 1968; Lewis et al., 1976; Shapiro, 1982). 
Hepatocytes of the lizard, Uta stansburiana, have been shown to 
respond to oestrogen in a similar way and fat vacuoles become 
prominent in the cytoplasm (Schjeide & Lai, 1970). The adipose 
tissues of this species normally become enlarged before egg-laying 
and it is suggested that, in response to endogenous oestrogen, free 
fatty acids are released from adipocytes into the blood, and are 
carried to the liver where they are eventually utilised. 
It is interesting to note that a slight increase in the liver weight 
of an oestrogen-treated viviparous vertebrate, the female rat, has 
also been reported, the response being somewhat similar to that in 
the domestic fowl in that cell expansion was primarily involved with 
hypertrophy of the endoplasmic reticulum (Song et al., 1969; 
Weinstein et al., 1979). However, it should be recognised that the 
oestrogen doses used in these mammalian studies were much lower than 
those used in studies involving domestic fowl. 
(b) Effects of Prolactin 
Certain other circumstances, apart from oestrogen treatment, have 
been found in which the avian liver responds with a change in weight 
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Of these, one of the best-documented is the liver enlargement and 
stimulation of hepatic 1ipogenesis associated ~.,.;+h -4--ht""!' ":tor+..;,......., ,...,. ffll.,ll Yll~ U.\..\..IVII VI 
prolactin. This pituitary hormone appears to be involved in 
bringing about the metabolic changes necessary for the deposition 
of fat reserves in migratory birds (Maier et al., 1969; Wheeland 
et al., 1976). Goodridge & Ball (1967b, 1967c) studied the response 
of the pigeon liver to prolactin, and observed that after a daily 
dose of 1 mg of hormone for 5 days the liver had nearly doubled in 
weight, although the increase in liver weight was apparent after 
only 1 day of prolactin treatment. These workers suggested that an 
uptake of water was involved in this increase in liver size, at 
least in the early stages of the response. Prolactin also causes 
the enlargement of the crop sac of the pigeon and the formation of 
crop milk. Goodridge & Ball (1967c) observed that starvation 
eliminated the increase in liver size caused by prolactin, but that 
the crop sac still responded. These investigators concluded that 
prolactin causes hyperphagia, which leads to an increase in body 
weights of specific organs including the liver, pancreas and 
intestine. Hyperphagia has been shown to cause an increase in liver 
weight in avian species, mainly as a result of the deposition of 
lipid (Shapira et al., 1978). It is of interest to note that 
increased food consumption has been observed in oestrogen-treated 
immature male and female domestic fowl (Pearce & Brown, 1971; 
Pearson & Butler, 1971). 
(c) Effects of the diet and the pattern of food intake. 
The liver weight of the domestic fowl has been shown to fluctuate 
according to the pattern of food intake and the composition of 
diet. Leveille (l969a) reported fluctuations in the liver weights 
of chicks which had been subjected to a 3-day fast followed by a 
period of re-feeding. During the fast the liver weight of the chick, 
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expressed as a percentage of body weight, decreased by approximately 
30% whereas upon re-feeding for 2 days, the liver weight increased 
to a value greater than the control value. After 3 days of 
re-feeding, however, the liver weight returned to the control value. 
During the 3-day fasting period the hepatic total lipid content (mg 
lipid/g liver) did not change significantly although the value was 
10% lower than the corresponding value from fed birds. The increase 
in liver weight after re-feeding correlated with an increase in 
hepatic total lipid content. 
Meal-feeding of chicks has been shown to result in increased liver 
weights when compared to birds fed ad libitum (Muiruri et al., 1975). 
Moreover, 1 hour after allowing meal-fed chicks access to food, 
there was a significant increase in liver weight and it was 
suggested that this was primarily the result of increases in water 
and glycogen content and, to a lesser extent, in lipid content. 
A diet rich in fructose caused a marked increase in liver weight and 
liver lipid content in 7 to 8-week old pullets (Pearce, 1970) and, 
presumably, this is related to the well-documented stimulation of 
hepatic 1 i pogenes is by fructose (Hawkins & He a 1 d,, 1966; Goodridge, 
1973c). 
In some species, including the domestic fowl, embryonic and newborn 
individuals have fatty livers, the lipid being derived from the 
lipid-rich yolk on which the embryo is nourished. This phenomenon, 
however, is short-lived and the livers become normal a few days 
after hatching (Entenman et al., 1940; Lucas & Ridout, 1970). 
(d) Fatty liver and kidney syndrome (FLKS) and fatty liver-
haemorrhagic syndrome (FLHS) 
FLKS and FLHS are two non-infectious diseases afflicting young chicks 
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and laying hens, respective1y; and both cause enlargement of the 
liver (Butler, 1976). Chicks suffering from FLKS have widespread 
fatty infi1tration of the tissues, particularly of the liver and 
kidneys which become pale and enlarged (Wight & Siller, 1975). 
Chicks suffering from FLKS are also hyperlipaemic, the plasma levels 
of free fatty acids and triacylglycerol being high despite a 
reduction in hepatic lipogenesis (Evans et al., 1975). 
It is believed that the development of the symptoms of FLKS is 
caused by a decreased uptake of lipid by adipose tissue as a result 
of inhibition of lipoprotein lipase (Evans et al., 1975). This 
enzyme is located on the luminal surface of endothelial cells of 
capillaries in body tissues (Scow et al., 1976; Kompiang et al., 
1976) and is responsible for the hydrolysis of plasma triacylglycerol 
leading to the release of free fatty acids which may be taken up by 
adipocytes. Therefore, if this enzyme were to exhibit diminished 
activity an increase in plasma lipid levels may ensue together with 
an accumulation of fat in certain organs. 
It has been demonstrated that FLKS can be caused by a combination of 
nutritional factors, including low biotin, protein and fat levels in 
the diet, leading to an impairment of hepatic gluconeogenesis 
(Bannister, 1976; Whitehead et al., 1978). Susceptibility to the 
disease seems to be caused by adverse environmental factors such as 
stress or fasting, and death occurs as a result of hypoglycaemia 
(Bannister et al., 1979). 
Laying domestic fowl are affected by FLHS which manifests itself in 
the accumulation of fat, of which most is triacylglycerol, in the 
liver, kidneys and abdominal cavity. High plasma levels of free 
fatty acids and triacylglycerol and reduced egg production are also 
symptomatic of the disease (Butler, 1976). The internal structure 
of the liver of a victim of FLHS is disrupted greatly by the increased 
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incidence of fat vacuoles in the cytoplasm of hepatocytes which 
often leads to rupture of the cells, and by lysis of the reticulin 
bands around the cells which results in structural weakness in the 
liver. Furthermore, there are diffuse capillary haemorrhages, 
blood clots, vascular breakdown, and regions of fibrosis and necrosis 
(Butler, 1976; Jensen, 1979). In cases of FLHS, small haemorrhages 
are found in the periphery of the liver and death is usually caused 
by haemorrhage from the liver which ruptures the liver capsule. 
Evidence suggests that the steatosis associated with FLHS is the 
result of increased hepatic lipogenesis, and it seems probable that 
the syndrome is caused by an excessive intake of carbohydrate, 
leading to a positive energy balance, and results from an interplay 
of dietary and environmental factors. Therefore, hens kept at high 
environmental temperatures and which are unable to reduce their food 
consumption have a greater susceptibility to FLHS. Another factor 
implicated in the development of the disease is an abnormally high 
level of endogenous oestrogen (Butler, 1976; Jensen, 1979). The 
possible involvement of oestrogen in FLHS is supported by 
observations that oestrogen treatment of domestic fowl results in 
fatty liver and an increased incidence of hepatic haemorrhage 
(Wolford & Polin, 1973; Pearson & Butler, 1978; Stake et al., 1981). 
2. Effects of oestrogens on extra-hepatic organs 
Oestrogens have been shown to exert significant effects on the 
morphology and metabolic activity of organs other than the liver, 
notably the oviduct of avian species (Hawkins & Heald, 1966; Pearce 
& Brown, 1971; Balnave & Pearce, 1974; Pearce & Balnave, 1975; 
Aprahamian et al., 1979; Laugier et al., 1980), and the uterus 
(Aizawa & Mueller, 1961; Martin, 1980; Thompson et al., 1983), 
vagina (Martin, 1980\ and mammary gland (Topper & Freeman, 1980) of 
mammals. 
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Hawkins & Heald (1966) observed an approximately 25-fold increase 
in the oviduct weight of 11-week old chickens treated with 2 mg 
oestradiol benzoate on alternate days for 7 days. Similarly, 
Aprahamian et al. (1979) observed a 23-fold increase in oviduct 
weight in 1-month old chickens after treating each bird with 4 mg 
oestradiol benzoate/day for 6 days. Other investigators have 
observed similar increases in oviduct weight after treating 
immature pullets with oestrogen (Pearce & Brown, 1971; Balnave & 
Pearce, 1974; Pearce & Balnave, 1975). This increase in oviduct 
size is associated with both cell expansion and cell division, is 
accompanied by an increase in metabolic activity and stimulation 
of ovalbumin synthesis, and is a pre-requisite for the oviduct to 
respond to progesterone. 
The uterus of mammals also responds to oestrogen treatment with an 
increase in size and metabolic activity (Thomson et al., 1983), the 
response involving a substantial increase in the number and size of 
cells and the water content of the uterus (Aizawa & Mueller, 1961). 
The mammalian vagina responds to oestrogen with an increase in the 
thickness of the epithelium resulting from an increase in the rate 
of cell division in the basal layers (Martin, 1980). Changes 
occurring in the structure and function of mammary gland during 
puberty and pregnancy appear to occur in response to several 
hormonal stimuli. Oestrogen, together with other hormones, is 
involved in the ductal growth which occurs during puberty, and 
lobuloalveolar growth which occurs during pregnancy. Hormone-induced 
ductal growth involves cell division giving rise to undifferentiated 
cells. Subsequently, during pregnancy, the inter-ductal spaces are 
filled with lobuloalveolar structures as a result of cell division 
and differentiation (Topper & Freeman, 1980). 
In summary, oestrogen treatment of many species has been shown to 
cause substantial changes in the morphology of certain organs. 
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Therefore, in the context of a study of the effect of oestrogen on 
hepatic lipid metabolism of male domestic fowl, it was decided to 
carry out a preliminary investigation of the effects of oestrogen 
on liver morphology in similar birds. In the following account, 
details are presented of changes in liver weight, hepatic soluble 
protein content and hepatic DNA content at various times after 
17~-oestradiol treatment. By a detailed analysis of the time-
courses of changes in these parameters, it was hoped that an 
assessment could be made of the roles of cell expansion and cell 
division in any observed oestrogen-dependent liver growth. It was 
believed that information derived from this preliminary study might 
prove valuable in the interpretation of the results of subsequent 
investigations designed to follow the effect of oestrogen on various 
parameters of hepatic lipid metabolism. 
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METHODS 
1. Animals 
Day-old male Hi-Sex (strain-cross, White Leghorn) chicks were 
obtained from a commercial hatchery and housed in a communal pen, 
the environmental temperature being 19° - 2l°C. During the first 
10 days of life the birds were subjected to constant illumination 
provided by a lamp in the pen which served to provide localised 
heat. Subsequently, a fixed 9 hours/day photoperiod of artificial 
dimmed red iight was maintained (08.00 hours to 17.00 hours). 
From 19 days of age the birds were housed in groups of 3 - 5 in 
cages with raised wire floors. Throughout their lives, the chicks 
were fed on Dalgety Spillers, 404 Gold-Start Crumbs/ACS. 
In all experiments control chicks were injected intramuscularly 
(pectoral muscle) with 0.1 ml propane-1,2-diol/100 g body weight. In· 
one set of experiments, oestrogen-treated birds received injections 
of 17~-oestradiol in propane-1,2-diol (0. 1 ml/100 g body wt.) 
equivalent to one of the following doses; 0.25, 0.5, 0.75, 1.0, 
1.25 mg hormone/lOG g body weight. In a second set of experiments, 
all oestrogen-treated birds were injected with 17~-oestradiol in 
propane-1,2-diol (0. 1 ml/100 g body wt.) equivalent to a dose of 
0.75 mg hormone/100 g body weight. 
2. Preparation of particle-free supernatant from chick liver 
Birds were weighed and then killed by decapitation between 11.00 and 
13.00 hours in order to minimise differences caused by diurnal 
effects and to ensure, as far as possible, similar prandial states. 
Immediately after death, livers were rapidly excised and weighed. A 
portion of each liver was weighed rapidly, then plunged into liquid 
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nitrogen and stored at -zooc for future DNA estimation. Another 
portion of liver (5 g) was homogen1sed using a teflon-glass 
homogeniser with 2 volumes of ice-cold homogenisation buffer 
consisting of 94 mM-potassium phosphate, 0.5 mM-EDTA, 0.2 mM-
dithiothreitol, 65 mM-potassium chloride and 5 mM-potassium 
carbonate, at pH7.0. The tissue was disrupted with 8 'up and down' 
strokes of the rotating pestle. Volumes of homogenates were 
measured and they were then centrifuged at 100,000 1 (rav. 6.4 em) 
for 1 hour at 4°C in a M.S.E. Prepsin 50 centrifuge. The super-
natantswere diluted with an ice-cold dilution buffer, consisting 
of 50 mM-potassium phosphate, 0.1 mM-EDTA and 0.5 mM-dithiothreitol, 
at pH7.0. Aliquots of the diluted liver extracts were stored at 
-20°C for future determination of soluble protein whilst the activity 
of acetyl-CoA carboxylase (see Chapter 4) was determined in fresh 
extracts. 
3. Determination of DNA 
After storage for up to 14 days at -20°C, liver samples (0.8- 1.0 g) 
were thawed and then homogenised in 10 volumes (v/w) of 0.9% (w/v) 
NaCl. From duplicate samples (2 ml) of the homogenates, the DNA 
was precipitated, washed and extracted using a slight modification 
of the procedure of Prashad & Cutler (1976). An equal volume of 
cold IM-perchloric acid was added to an aliquot of homogenate and 
stored on ice for 1 hour. Following centrifugation at 6000 1 for 
20 min. at 4°C, the supernatant was discarded and the pellet washed 
2 times with aliquots (2 ml) of cold 0.5 M-perchloric acid. DNA 
was extracted from the washed pellet by resuspension in 0.5 M-
perchloric acid (2 ml), followed by heating at 70°C for 20 mins. 
After centrifugation at 6000 1 for 20 mins. at 4°C, the supernatant 
was collected and further DNA extracted from the pellets another 2 
times. The supernatants were combined and extracted DNA determined 
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by the method of Burton (1956) with slight modification. A 2 ml 
aliquot of the DNA extract was mixed with 4 ml diphenylamine reagent, 
prepared by dissolving 1.5 g diphenylamine in 100 ml glacial acetic 
acid and 1.5 ml of cone. H2so4, and 0.2 ml aqueous acetaldehyde 
(1.6 mg/ml). Following incubation for 18 hours at 30°C, the 
absorbance at 600 nm was measured in a Pye Unicam SPS-100 spectro-
photometer. Duplicate blank assays and assays using a standard DNA 
solution were included. A stock standard DNA solution was prepared 
by dissolving calf thymus DNA in 0.5 M-perchloric acid to give a 
concentration of 0.2 mg/ml. The DNA was solubilised by heating at 
70°C for 20 minutes and standards of a variety of concentrations 
(0.025- 0.2 mg/ml) were prepared by dilution with 0.5 M-perchloric 
acid. The resultant DNA calibration curves indicated that the 
assay was linear up to a total amount of 0.30 mg DNA. 
4. Determination of Protein. 
After storage for up to 7 days at -20°C, the soluble protein 
concentration of each liver extract was determined by the biuret 
method described by HUbscher et al. (1965), with some modification. 
iDle biuret reagent of Weichselbaum (1946) was modified as follows: 
biuret reagent (200 ml) and 1 M-NaOH (160 ml) were mixed, potassium 
iodide (4 g) was added and dissolved, and the solution was made up 
to 1 litre with distilled water and stored at 4°C. Duplicate 
protein samples were precipated with an equal volume of ice-cold 
10% (w/v) trichloroacetic acid. The precipitate was pelleted by 
centrifugation at 4°C and the pellet was dissolved in 1 ml of 
0.1 M-NaOH after removal of the supernatant. The modified biuret 
reagent (2 ml) was added and colour developed by incubation at 37°C 
for 15 minutes. After cooling, w~ter-saturated diethyl ether (3 ml) 
was added to remove any lipids which often cause cloudiness. The 
tubes were mixed, using a vortex mixer, and the phases separated by 
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subsequent low-speed centrifugation. The upper (ether) phase was 
removed and the absorbance of the lower layer measured at 555 nm 
using a Pye-Unicam SP8-100 spectrophotometer. Duplicate blank 
assays and assays using a standard aqueous solution of BSA (fatty 
acid poor) were included in each set of assays. Calibration curves 
indicated that the assay was linear up to 9 mg protein (BSA). 
5. Statistica1 analysis 
Data were ana1ysed statistica1ly by Student's 't' test. Probability 
values (p) of 0.05 or less were taken to be significant. Standard 
errors are provided to show the degree of variance and levels of 
statistical significance are indicated. 
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RESULTS 
1. The effect of varying doses of 17~-oestradiol on the weight and 
soluble protein content of male chick liver 
Variations in the weight and soluble protein content of livers from 
male chicks killed 48 hours after receiving a single intramuscular 
injection of 17~-oestradiol (0- 1.25 mg hormone/100 g body wt.) in 
propane-1,2-diol are presented in Table 2. 1. 
At all dose levels the mean liver weight (as% of body wt.) for 
oestrogen-treated birds was greater than the values for control and 
untreated birds. Significant increases were observed over controls 
at all doses except 0.25 mg 17~-oestradiol/100 g body weight. 
Maximum liver weight (as% of body wt.) was observed with the 
maximum dose levels of 1.25 mg hormone/100 g body weight, the value 
for oestrogen-treated chicks being 1.84-fold greater than the value 
for control chicks. 
A dose-related decrease in the soluble protein content of unit wet 
weight of liver was observed in oestrogen-treated birds when 
compared to controls. Significant differences were observed between 
the value for control birds and those for oestrogen-treated birds at 
all dose levels except 0.25 mg hormone/100 g body weight and the 
minimum soluble protein content/g liver was observed with the highest 
dose of 1.25 mg hormone/100 g body weight, the value for oestrogen-
treated birds being 82% of the value for control birds. 
Although the soluble protein content/g liver decreased upon oestrogen-
treatment, a dose-related increase in the total hepatic soluble 
protein content was observed in the same birds. At all hormone levels 
except 0.25 mg 17~-oestradiol/100 g body weight, significant 
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Table 2.1 
The effect of varying doses of 17p-oestradiol on liver weight and the hepatic soluble protein content of 
birds killed 48 hours after injection. 
Each oestrogen-treated bird received an intramuscular injection of 17~-oestradiol in propane-1,2-diol, 
equivalent to one of the following doses:-
0.25, 0.5, 0.75, 1.0, 1.25 mg 17~-oestradiol/100 g body weight 
Control birds received an equivalent volume of propane-1,2-diol, alone. Birds were sacrificed 48 hours 
after injection and liver extracts were obtained and assayed for soluble protein as described in the 
Methods section. 
Values are the means (± S.E.M.) of 5 - 8 birds. 
Data were analysed statistically by Student's 't' test. Levels of significance presented with oestrogen-
treated values are with respect to control values. 
Birds were aged 28 - 34 days. 
* significant at p <0.05 
# significant at p <0.01 
¥ significant at p <0.001 
17~-oestradiol (mg/100 g body wt.) 
0 0 0.25 0.50 0.75 1.00 l. 25 
UNT. CONT. 
Number of birds 8 8 6 6 5 6 6 
Body weight (g) 324 ±17 303 ±20 294 ± 6 343 !18 345 !27 387 + 25 I 4?5 ±10 
Liver weight ¥ ¥ ¥ 
(as % body wt. ) 2.88 ±0. 18 2.75 ±0.09 3.06 ±0. 12 3.91 ±0.22 4.50 ±0.29 4.69 ± 
¥ 
0.141 5.05 ±0.24 
Hepatic soluble 
protein (mg/g # * # 
liver) 81.0 ±1.3 81.9 ±1.7 79.9 ±1.0 70.2 ±2.6 72.9 ±3.0 70.4 + 
¥ 
2. 2 I 66.8 ±2. 1 
Total hepatic 
soluble protein # ¥ ¥ 
(mg/l iver) 747 ±47 677 ±48 720 ±43 936 ±73 1113 ±87 1270 + 
:{ 
69 I 1433 ±83 
-----
increases in total hepatic soluble protein content were observed 
with respect to the value for control birds Milxim11m tntill henntic .... ·-··--·· -.-- ., .. 
soluble protein was observed in birds injected with the highest 
dose of 1.25 mg hormone/100 g body weight, the value for oestrogen 
treated birds being 2. 12-fold greater than the value for control 
birds. 
2. The effect of a single intramuscular injection of 17~-oestradiol on 
the weight, DNA content and soluble protein content of male chick 
1 iver 
Variations in the weight, DNA content and soluble protein content 
of livers from male chicks killed during the 61-hour period 
immediately following a single intramuscular injection of 17~­
oestradiol (0.75 mg/100 g body wt.) are presented in Table 2.2 and 
Figures 2. l, 2.2 and 2.3. A dose of 0.75 mg hormone/100 g body 
weight was adopted because measurements of the hepatic activity of 
acetyl-CoA carboxylase (E.C. 6.4. 1.2), a key lipogenic enzyme, in 
birds treated with different doses of oestrogen, indicated that 
optimal stimulation of activity occurred with this dose (see 
Chapter 4). 
The mean liver weight of oestrogen-treated chicks was not significantly 
different from that of control chicks during the first 6 hours after 
injection (Table 2.2 and Fig. 2. 1). At later times, however, the 
mean liver weight of oestrogen-treated birds increased significantly, 
compared to control values, reaching a maximum at 37 hours after 
injection, when the value in oestrogen-treated birds was 1.61-fold 
greater than the corresponding control value. After this time, the 
mean liver weight of oestrogen-treated birds decreased 
progressively until, at 61 hours after hormone treatment the value 
was 1.54-fold greater than the corresponding control value (Table 
2.2 and Figure 2. 1). 
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Table 2.2 
The effect of a single intramuscular injection of 17~-oestradiol on the weight, DNA content and soluble 
protein content of male chick liver 
Each oestrogen-treated bird received an intramuscular injection of 17~-oestradiol (0.75 mg/100 g body wt.} 
in propane-1,2-diol. Control birds received an equivalent volume of propane-1,2-diol alone. At the indicated 
times after injection birds were sacrificed, liver extracts prepared and assayed for DNA and soluble protein 
as described in the Methods section. 
OE = values for oestrogen-treated birds 
C = values for control birds 
Values are the means(± S.E.M.} of 8- 19 birds. 
Data were analysed statistically by Student's 't' test. Levels of statistical significance presented with 
values for oestrogen treated birds are with respect to the corresponding control value. 
* significant at p <0.05 
# significant at p <0.01 
¥ significant at p <0.001 
The liver weight data, the hepatic DNA content data and the hepatic soluble protein content data are 
presented graphically in Fig. 2. 1, Fig. 2.2 and Fig. 2.3, respectively. 
Birds were aged 25 - 32 days. 
Tiwe after injection (h) 
0 3 6 13 19 24 37 48 61 
OE c OE c OE c OE c OE c OE c OE IJE c 
-----
Number of birds 19 6 6 12 12 9 9 9 9 9 9 8 8 9 9 9 9 
Body weight (g) 313 332 318 336 303 311 310 356 323 3tJ3 280 361 318 3313 312 318 338 
~II ~21 ~II :!:23 :!:21 :!: 7 :!: 9 ~18 :!:21 :!:15 !18 :!:10 :!:12 :!:20 :!:13 !12 :!:13 
* ¥ ¥ ¥ ¥ ¥ 
Liver weight (as% 3.33 3.52 3.41 3.42 3.51 3.59 3.29 4.11 3. 20 4.78 3.23 5.53 3.44 5. 11 3. 2ti ~.94 3.21 
body wt.) :!:0.04 :!:0. 10 :!:0.07 :!:0.06 :!:0.08 :!:0.08 :!:0.08 :!:0.09 :!:0. 10 :!:0. 18 :!:0.06 ~0. 10 :!:0. 15 :!:0.23 :!:0.06 :!:0. 16 :!:0.07 
* # # 
Total hepatic DNA 32.0 32.1 30.7 31.4 30.6 30. 1 31.0 33.4 30.5 30.8 29.0 42.3 30.6 40.3 29. 5 37.4 31.4 
(mg/liver) 
:!:1.3 :!:1.3 :!:0.8 :!:2.0 :!:1.9 :!:0.9 :!:1.5 :!:2. 1 :!:1.3 :!:2.2 :!:1.9 :!:2.4 :!:2.6 :!:1.7 :!:2. 2 :!:1.6 :!: 1. 1 
¥ ¥ ¥ # # 
Hepatic DNA (tng/g 2.99 2.78 2.84 2.76 2.89 2.70 3.03 2.35 3.00 2.12 3.10 2. 12 2.83 2.37 2.90 2.60 2.91 
1 iver) ~0.07 :!:0.08 ~0.08 ~0.05 :!:0.05 :!:0.06 :!:0.06 :!:0.07 :!:0.06 :!:0.04 :!:0.09 :!:0.08 !D. 12 :!:0.08 !O. 12 :!:0. 13 :!:0.08 
* * ¥ ¥ ¥ 
Total hepatic 787 837 810 795 743 760 791 943 776 919 706 1244 811 1186 751 1139 802 
soluble protein !28 :!:56 :!:33 :!:47 :!:44 :!:34 :!:32 :!:57 :!:34 !65 !52 :!:45 :!:35 !51 (mg/ 1 i ver) :!:38 :!:70 :!:36 
¥ # ¥ ¥ 
Hepatic soluble 75.8 71.9 75.0 70.0 70.5 67.8 77.5 65.4 76.4 63.2 78.2 62.4 74.7 68.6 73.7 72. 1 74. 
protein (mg/g 
:!:1. 1 :!:2.0 :!:1.9 ~0.9 :!:1.5 :!: 1. I :!:1.1 :!:2.6 !2.3 :!:1.2 :!:2.3 :!: 1.5 :!:1.5 :!:2. 1 I i ver) :!:1.4 :!:2.0 :!: 1 . 2 
¥ # 
Hepatic soluble 25.6 26. 1 26.4 25.4 24.4 25.3 25.6 28.6 25.6 29.9 25.3 30.4 27.4 29.5 25.8 29.9 25 6 
protein ( mg/mg DNA) :!:0.7 :!:1.3 !O. 7 :!:0. 5 :!:0.6 :!:0.8 :!:0.6 :!:1.5 !.1.2 :!:0.5 :!:0.7 :!:1.4 ~I. 4 :!:0.8 :!:1.1 :!:2.3 :!:0.9 
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Figure 2.1 
The effect of a single intramuscular injection of oestrogen on 
the liver weight of male chicks 
Consult the legend of Table 2.2 for details of experimental 
procedure. 
• value for untreated chicks 
o values for oestrogen-treated chicks 
• values for control chicks, injected with 
propane-1,2-diol, alone 
The results are expressed as means (~ S.E.M.) of 8- 19 birds. 
6 
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The mean tota1 amount of DNA in the liver of oestrogen-treated 
chicks was not significantly different from that of control chicks 
during the first 24 hours after hormone administration (Table 2.2 
and Fig. 2.2a). At later times (37- 61 hours) however, the mean 
total hepatic DNA content was significantly greater than the 
corresponding control value such that, at 37 hours after injection, 
the value in oestrogen-treated birds was maximal, being 1.38-fold 
greater than the control value. After this time, the mean total 
hepatic DNA content of oestrogen-treated birds decreased 
progressively until at 61 hours after hormone treatment the value 
was 1. 19-fold greater than the corresponding control value (Table 2.2 
and Fig. 2.2a). 
Expressions of the hepatic DNA content in terms of the amount of 
DNA/g liver revealed that during the first 6 hours after injection, 
the value in oestrogen-treated birds was not significantly 
different from that of control birds (Table 2.2 and Fig. 2.2b). At 
later times, however, the mean amount of DNA/g liver of oestrogen-
treated birds decreased significantly, compared to control values, 
reaching lowest values at 24 hours and 37 hours after hormone 
administration, when the values in oestrogen-treated birds were 68% 
and 75% of the corresponding control values, respectively. 
Subsequent to 37 hours post-injection, the mean amount of DNA/ g 
liver in oestrogen-treated birds increased progressively until at 
61 hours after hormone administration, the value was 89% of the 
corresponding control value and the two va1ues were not significantly 
different (Table 2.2 and Fig. 2.2b). 
Following oestrogen-treatment, the soluble protein content of liver 
from male chicks was determined (Table 2.2 and Fig. 2.3) and 
expressed as total soluble protein/liver (Fig. 2.3a), soluble protein/ 
g liver (Fig. 2.3b) and soluble protein/mg DNA (Fig. 2.3c), the 
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Figure 2.2 
The effect of a single intramuscular injection of oestrogen 
on the hepatic DNA content of male chicks. 
Consult the legend of Table 2.2 for details of experimental 
procedure. 
... values for untreated chicks. 
0 values for oestrogen-treated chicks. 
• values for control chicks, injected with 
propane 1 ,2-diol, alone. 
The results are expressed as means(~ S.E.M.) of 8- 19 birds. 
(a) Total hepatic DNA content (mg/liver). 
(b) Hepatic DNA content (mg/g liver). 
a. 
b. 
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latter expression being used as an indication of the cellular 
content of so1ub1e protein. 
The mean total hepatic soluble protein content of oestrogen-treated 
chicks was not significantly different from that of control chicks 
during the first 13 hours after injection (Table 2.2 and Fig. 2.3a). 
At later times (24- 61 hours), however, the mean total hepatic 
soluble protein content of oestrogen-treated birds increased 
significantly, compared to control values. A maximum value for 
oestrogen-treated birds was observed at 37 hours after injection, 
being 1.53-fold greater than the corresponding control value. After 
this time, the mean total hepatic soluble protein content of 
oestrogen-treated birds decreased slightly such that at 61 hours 
after hormone treatment, the value was 1.42-fold greater than the 
corresponding control value (Table 2.2 and Fig. 2.3a). 
The mean soluble protein content/g liver of oestrogen-treated chicks 
was not significantly different from that of control chicks during 
the first 6 hours after injection (Table 2.2 and Fig. 2.3b). 
However, at later times the mean soluble protein content/g liver of 
oestrogen-treated birds decreased significantly, compared to control 
values reaching a minimum at 37 hours after hormone administration, 
when the value in oestrogen-treated birds was 83% of the corresponding 
control value. After this time, the mean soluble protein/g liver of 
oestrogen-treated birds increased progressively such that at 48 hours 
and 61 hours after hormone treatment the value was not significantly 
different from the corresponding control value (Table 2.2 and 
Fig. 2.3b). 
During the first 13 hours after injection the mean hepatic soluble 
protein content/mg DNA of oestrogen-treated chicks was not 
significantly different from that of control chicks (Table 2.2 and 
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Figure 2.3 
The effect of a single intramuscular injection of oestrogen 
on the hepatic soluble protein content of male chicks. 
Consult the legend of Table 2.2 for details of experimental 
procedure. 
• values for untreated chicks. 
0 values for oestrogen-treated chicks. 
• values for control chicks, injected with 
propane-1,2-diol, alone. 
The results are expressed as means (~ S.E.M.) of 8- 19 birds. 
(a) Total hepatic soluble protein content (mg/liver). 
(b) Hepatic soluble protein content (mg/g liver). 
(c) Hepatic soluble protein content (mg/mg DNA). 
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Fig. 2.3c). At later times (19- 61 hours), however, the mean 
hepatic soluble pruteir1 content/mg DNA of oestrogen-treated birds 
increased, reaching a maximum at 37 hours after hormone 
administration and only slightly decreasing subsequently. During 
the same 19 - 61 hour post-injection period, the mean hepatic 
soluble protein content/mg DNA of control birds remained at a level 
similar to the value for untreated birds. Although the mean 
hepatic soluble protein content/mg DNA of oestrogen-treated birds 
was greater than the value for corresponding control birds during 
the 19 - 61 hour post-injection period, only at the 24 hours and 
48 hours time-points were the increases significant (Table 2.2 and 
Fig. 2.3c). 
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DISCUSSION 
l. The effect of varying doses of oestrogen on the weight and soluble 
protein content of male chick liver 
The data presented in Table 2.1 illustrates a dose-related increase 
in the liver weight of oestrogen-treated male chicks over the dose 
range 0.5 - 1.25 mg 17~-oestradiol/100 g body weight when the birds 
were injected with a single dose of hormone and sacrificed 48 hours 
later. Similar dose-related trends in liver and oviduct weight were 
observed by Pearce & Balnave (1975) who injected 4-week old pullets 
with varying doses of oestradiol dipropionate (0.5 - 4 mg/bird) and 
sacrificed the birds 48 hours after a single injection or 8 days 
after the start of hormone treatment,during which the birds received 
a hormone injection on alternate days. After 2 days of oestrogen 
treatment, oviduct weight (as% of body wt.) increased up to a dose 
of 1 mg oestradiol dipropionate, and with the higher doses the 
increase in weight was less. After 8 days of oestrogen treatment, 
oviduct weight increased progressively with increasing dose level. 
Liver weight (as% of body wt.) after 2 days of oestrogen treatment 
increased up to a dose of 2 mg oestradiol dipropionate and the 
response was depressed with a dose of 4 mg. A similar response 
pattern was observed after 8 days of hormone treatment. Balnave 
{1971) observed an 'over-reaction' of immature female chickens to 
exogenous oestrogen such that the liver weights were greater than 
those of mature laying hens. These observations suggest that large 
oestrogen doses and extended times of oestrogen treatment may lead 
to pharmacological effects rather than to a simulation of the 
physiological situation existing in the laying hen. A decrease in 
liver weight after treatment with high oestradiol doses was not 
observed in the present study, even though a similar range of 
oestradiol dose levels was administered. Taking into account the 
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different form of oestradiol used by these workers and the 
approximate body weights (250 g) of the birds used, Pearce & 
Balnave (1975) used a maximum dose of 1.13 mg oestradiol/100 g body 
weight which evoked a depressed liver weight increase when compared 
to that observed with a dose of 0.57 mg oestradiol/100 g body weight. 
In the present study, however, the maximum dose level was 1.25 mg 
oestradiol/100 body weight and the increase in liver weight 
observed at this level was greater than at all lower doses. This 
difference in dose levels in the two studies may be the result of 
sex differences, since male chicks were used throughout the present 
study, whilst Pearce & Balnave (1975) used immature females. 
The suggestion that sex differences may be important in determining 
the nature of the liver growth response to varying doses of 
oestrogen is supported by the results of Courtney (1984), who treated 
3 - 5-week old male chicks with varying doses of 17~-oestradiol 
(0.25- 1.25 mg/100 g body wt.) and observed a dose-dependent 
increase in liver weight, the greatest response being observed with 
administration of the greatest dose. However, the results of 
Pearson & Butler (1978) clearly demonstrate the importance of 
considering the age and sex of the birds used, together with the dose 
and duration of hormone administration, when attempting to make 
comparisons between individual studies. Pearson & Butler (1978) 
admi~tered 5 doses of 0.25, 0.5 or 1 mg oestradiol dipropionate/ 
100 g body weight at 3-day intervals to 6- to 7-week old pullets and 
sacrificed the birds 48 hours after the last dose. A dose-dependent 
increase in liver weight was observed with the greatest increase 
being obtained with the greatest dose of hormone. 
Table 2.1 shows that, as the liver weight increased with increasing 
hormone dose level, the soluble protein content of unit wet weight 
of liver decreased, suggesting that the increase in liver weight may 
be accompanied by cellular hypertrophy. 
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The dose-dependent increase in liver weight was accompanied by a 
dose-dependent increase in the total soluble protein in the liver 
such that at the maximum dose level (1.25 mg hormone/100 g body wt.) 
both liver weight and total hepatic soluble protein content were 
maximal. This suggests that the hormone-induced stimulation of 
liver weight involves a stimulation of the rate of synthesis of 
hepatic soluble protein and/or a decrease in the rate of degradation 
of soluble protein. 
That the oestrogen-induced increase in liver weight may be 
accompanied by cellular hypertrophy is supported by the following, 
more detailed analysis of changes in liver morphology occurring 
during the 61-hour period immediately after injecting birds with a 
dose of 0.75 mg 17~-oestradiol/100 g body weight. 
2. The effect of a single injection of 17~-oestradiol on the weight, 
DNA content and soluble protein content of male chick liver. 
The administration of a single intramuscular injection of 17~­
oestradiol to male chicks was found to result in an increase in 
liver weight, expressed as a percentage of body weight, compared to 
control birds (Fig. 2. 1). Initially, there was no significant 
difference between the liver weight of hormone-treated and control 
birds for the first 6 hours after injection. This was followed by 
a progressive and substantial increase in the liver weight of 
hormone-treated birds up to 37 hours after injection, followed by a 
gradual decline in the liver weight of these birds. A number of 
workers have obtained similar trends in liver weight, comb weight 
and oviduct weight of immature female chickens after treatment with 
gonadal hormones. For example, Balnave & Pearce (1974) injected 
4-week old pullets with 2 mg oestradiol dipropionate on alternate 
days for 9 days. No difference in liver weight, expressed as a 
proportion of body weight, was observed between control and oestrogen-
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treoted birds during the first 12 hours after hormone administration. 
After 24 hours, however, and up to 4 days after the start of hormone 
treatment, the liver weight was found to progressively increase, 
although by the 9th day of treatment the liver growth response was 
considerably reduced, compared to controls. Treatment of 4-week old 
pullets with 2 mg testosterone propionate on alternate days over a 
period of 9 days caused a time-related increase in comb weight, 
expressed as a proportion of body weight, from the 2nd day until the 
9th day. Both treatment with oestradiol dipropionate, as described 
above, and similar treatment of 4-week old pullets with 2 mg 
oestradiol dipropionate and 1 mg testosterone propionate together, 
caused a time-related increase in oviduct weight from 24 hours after 
hormone treatment until the 9th day of hormone treatment. On the 
4th and 9th days of hormone treatment, the oviduct weights (as 
proportions of body weights) of the birds treated with oestradiol 
and testosterone were significantly greater than those of birds 
treated with oestradiol alone, representing an enhancement of 
oestrogen-induced oviduct growth by testosterone. 
Pearce & Balnave (1975) also noted time-related increases in oviduct 
weight and liver weight of 4-week old pullets treated with varying 
doses of oestradiol dipropionate, in the range 0.5 - 4 mg hormone/ 
bird. The weights of individual organs were measured 2 days after 
a single injection of oestrogen, and 8 days after the start of 
hormone treatment, during which oestrogen was administered on 
alternate days. At all dose levels, the liver weight and the oviduct 
weight were greater after 8 days than after 2 days of hormone 
treatment. 
Similar time-related increases in liver weight have been observed in 
oestrogen-treated birds of other species. Gibbins & Robinson (1982) 
treated 3- to 5-month old male Japanese quail with a single 
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injection of 4.36 mg oestradiol/100 g body weight, and observed a 
day after treatment. 
Subsequently, however, the extent of the response decreased. 
Dashti et al. (1983) treated 19-day old male turkeys with a single 
--
injection of diethylstilboestrol (4 mg/100 g body wt.) and observed 
a time-related increase in liver weight expressed as a percentage 
of body weight, up to 48 hours after injection, followed by a 
diminished response at 72 hours after injection. 
The DNA content of liver in the present study was used as an 
indicator of cell number. Although somatic polyploidy has been 
shown to be a common developmental feature of endocrine target tissue, 
including vertebrate liver (Brasch, 1980), the assumption was made 
that the DNA content of individual liver cells was constant. There-
fore, DNA content of liver expressed as mgDNA/whole liver (Fig. 2.2a) 
was used as an indication of the number of cells/liver, whereas 
expression of the hepatic DNA content as mgDNA/g liver (Fig. 2.2b) 
was assumed to be indicative of individual liver cell mass. 
Significant decreases in the DNA content of unit wet weight of liver, 
with respect to control birds, were observed from 13 hours after 
oestrogen treatment, reaching a minimum value at 24 - 37 hours after 
injection. Subsequently, this value returned to the control value 
61 hours post-injection (Table 2.2 and Fig. 2.2b). These results 
indicate an increase in the mass of individual liver cells during 
this period, reaching a maximum of 24 - 37 hours after hormone 
treatment. Significant increases in the total hepatic DNA content 
were observed in oestrogen-treated chicks, with respect to control 
birds, at 37 - 61 hours after injection, the maximum value being 
observed at 37 hours post-injection. After this time, the total DNA 
content of oestrogen-treated male chick liver decreased somewhat. 
(Table 2.2 and Fig. 2.2a). These results indicate an increase in 
the number of cells per liver, with respect to controls from 37 - 61 
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hours after oestrogen treatment with a maximum number of cells 
hours after hormone ""\,..lrn.;.,.....;,..-J-""..,+-..;....,.,... U.UIIIIIII.J\..1 Ol, lVII, TL.-.,......,..,.,.;: ..... ""',..., IIIC:I C:l VIc:, 
changes in DNA content of unit wet weight of 1iver, and in the DNA 
content of whole liver suggest that both cellular hypertrophy, 
resulting in increased cell mass, and cellular hyperplasia are 
involved in the increase in liver weight in response to oestrogen 
treatment, although increased cell division does not appear to play 
a part during the early stages (0 - 24 hour post-injection) of the 
response. In addition, the decrease in the total DNA content of 
livers, and the increase in DNA content of unit wet weight of liver 
observed in oestrogen-treated birds from 37 - 61 hours after 
injection suggests that the decrease in liver weight observed during 
this period is accompanied by a decrease in the total number and the 
mass of individual liver cells. 
A number of investigators have observed changes in the livers of 
oestrogen-treated domestic fowl which suggest that the response of 
-
the liver to the hormone involves both cellular hypertrophy and 
increased cell division. For example, van den Berget al. (1974) 
treated 8- to 12-week old male birds with subcutaneous injections 
of oestradiol (2.5 mg/100 g body wt.) and observed that the total 
hepatic DNA content did not change significantly during the first 
24 hours after injection. Subsequently, however, a sharp increase 
in the hepatic DNA content of oestrogen-treated birds was obtained 
such that 45 hours after hormone treatment the value was 1.37-fold 
greater than that for control birds. These results suggest that cell 
division may have played a part in the later stages (24 - 45 hours 
post-injection) of the liver 1 S response to exogenous oestrogen. 
Schjeide & Lai (1970) administered large doses of oestrone (1 mg/ 
100 g body wt./day) to approximately 8-week old male birds. From 
2 - 4 days after the start of the treatment, electronmicrographic 
analysis of liver from these birds revealed an increase in cell 
volume, involving a proliferation of total and rough endoplasmic 
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reticulum, and evidence that approximately 20% of cells were dividing. 
Similarly, Schjeide et a1. (1963) treated male domestic fowl with 
--
pharmacodynamic doses of oestrogen and observed that, 7 days after 
hormone treatment, the liver had increased 50% in total weight. 
Electronmicrographic analysis of the liver tissue from oestrogen-
treated birds revealed increased cell division, many of the cells 
exhibiting highly developed and engorged endoplasmic reticulum. 
In the present study the mean hepatic DNA content of untreated birds 
was 2.99 mg DNA/g liver and a minimum value of 2.12 mg DNA/g liver 
was observed 24 - 37 hours after oestrogen treatment. Similar 
changes in the levels of hepatic DNA in the liver of oestrogen-
treated birds have been reported by other investigators. For 
example, Hawkins & Heald (1966) reported decreases in the DNA content 
of unit wet weight of liver from both oestrogen-treated female birds 
and hens as they came into lay. Treatment of 11-week old pullets 
with 2 mg oestradiol monobenzoate on alternate days for 7 days 
resulted in a reduction of approximately 33% in the DNA content of 
a unit weight of liver, from a value of 4.0 mg DNA/g liver to 2.7 mg 
DNA/g liver. In the same study, the hepatic DNA content of 9- to 
16-week old immature hens was found to be 3.46 mg DNA/g liver 
whereas the mean value for 23- to 32-week old laying hens was 
2.50 mg DNA/g liver. Courtney (1984), using 3- to 5-week old male 
chicks~ determined a value of 3.16 mg DNA/g liver for control and 
untreated birds. Treatment of similar birds with a single 
injection of 17~-oestradiol (1 mg/100 g body wt.) resulted in a 
marked decrease in the DNA content of unit weight of liver during 
the 50-hour period immediately after injection, the lowest individual 
level of 1.79 mg DNA/g liver being recorded 27 hours post injection. 
The possibility that cellular hypertrophy plays an important part in 
the liver growth response to oestrogen in the present study, is 
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supported by the following observations:-
(a) the increase in liver weight was accompanied by a decrease in the 
soluble protein content of unit wet weight of liver, the liver 
weight reaching a maximum when the soluble protein/g liver value 
was at a minimurn37 hours post-injection, and 
{b) the total hepatic DNA content of oestrogen-treated chicks was not 
significantly different from that of control chicks during the first 
24 hours after injection. As mentioned earlier, the cellu1ar hyper-
trophy observed by Schjeide et al. (1963) and Schjeide & Lai (1970) 
in liver from 8-week old roosters treated for up to 7 days with 
oestrone (1 mg/100 g body wt./day) was shown to be caused, in part 
by a proliferation of endoplasmic reticulum. However, these workers 
also showed that the oestrogen treatment led to the livers of the 
birds becoming more fragile and fatty in appearance and, therefore, 
concluded that the cellular hypertrophy also involved an uptake of 
water and lipid by the cells. In the present study, a close analysis 
of the hepatic soluble protein data also suggests that enhanced 
water and lipid uptake may be involved, in part, in the liver 
response to oestrogen. Expression of the hepatic soluble protein 
content as soluble protein/mg DNA was taken to be an indication of 
the cellular soluble protein levels. This parameter did not 
significantly increase over controls until 24 hours after oestrogen 
treatment, suggesting that the increase in cell mass observed, at 
least at 13 hours and 19 hours after hormone administration, may 
have principally involved an increase in the water and lipid content. 
Such a possibility is further supported by the observation that, in 
the present study, the enlarged livers of oestrogen-treated birds 
were almost invariably pale in colour, and fragile. 
Taken as a whole, the observations made during the 61-hour period 
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inmediately following oestrogen treatment, in the present study, 
indicate that a time-related increase in liver s1ze occurred, 
reaching a maximum 37 hours post-injection and that this involved 
an initial increase in liver cell mass, probably as a result of 
accumulating water and lipid, with a later increase in cell number. 
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CHAPTER 3 
QUALITATIVE AND QUANTITATIVE CHANGES 
IN LIPIDS OF THE LIVER AND PLASMA 
OF MALE CHICKS AFTER OESTROGEN TREATMENT 
-57-
INTRODUCTION 
1. Lipid transport in the blood 
Plasma lipids, other than free fatty acids, are transported as 
macromolecular lipoproteins which consist. ofa hydrophobic core, 
comprising mainly triacylglycerol and cholesteryl ester, surrounded 
by an amphipathic surface 'coat' of phospholipid, cholesterol and 
specific apoproteins. The apoproteins are important in maintaining 
lipoprotein structure and some have specific regulatory functions 
in lipid and lipoprotein metabolism. In mammals, for example, 
apo-C-II activates lipoprotein lipase (E.C. 3. 1. 1.34) (La Rosa et al., 
1970; Havel et al., 1970) and apo-A-I activates lecithin:cholesterol 
acyltransferase (E.C. 2.3. 1.43) (Fielding et al., 1972). 
Plasma lipoproteins represent a continuum of lipid-protein complexes 
in which the ratio of lipid to protein, and hence their density, 
varies (Gurr & James, 1980). In mammals, they can be divided into 
groups, according to their density, which include chylomicra, very 
low density lipoprotein (VLOL), low density lipoprotein (LDL) and 
high density lipoprotein (HDL). Chylomicra are involved in the 
transport of dietary lipid from the gut to the body tissues, while 
the latter three classes are involved in the transport of endogenous 
lipid. The principal features of the structure and function of 
human plasma lipoproteins are summarised in Table 3. 1. 
In the domestic fowl, which lacks a functional intestinal lymphatic 
system, absorbed dietary lipid enters the portal system as large 
VLDL or 'portomicra' (Bensadoun & Rothfeld, 1972) rather than as 
chylomicra (and VLDL) via the lymphatic system as typically occurs 
in mammals. 
Chicken VLDL (density < 1.006 g/ml) consists predominantly of 
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Table 3.1 
Principal features of the structure and function of the major classes of human plasma lipoproteins 
Density (g/ml) 
Diameter (nm) 
Components (as % of 
dry wt.) 
Protein 
Triacylglycerol 
Cholesterol and 
cholesteryl esters 
Phospholipids 
Major apoproteins 
Minor apoproteins 
Function 
Chylomicra 
< 0.95 
75 - 1000 
1 - 2 
83 
8 
7 
B 
C-I, C-II, C-III 
A-I, A-II 
Transport 
dietary triacyl-
glycerol and 
cholesterol from 
intestines. 
VLDL 
0. 95 - 1.006 
30 - 70 
lO 
50 
22 
18 
B 
C-1, C-II, C-III 
E 
A-I, A-II 
D 
Transport triacyl-
glycerol and 
cholesterol 
from the liver to 
various tissues. 
LDL 
1.019 - 1.063 
20 - 25 
25 
10 
43 
22 
B 
Major cholesterol-
transporting 
lipoproteins 
HDL 
1. 063 - 1. 21 
10 - 15 
50 
3 
18 
29 
A-I, A-II 
C-I, C-11, C-111 
D 
E 
Involved in 
reverse cholesterol 
transport from 
peripheral tissues 
to the liver. 
triacylglycerol (Yu et al., 1976) and is produced mainly in the liver 
and then exported via the blood to other tissues. Tho t- .... ;"""1,-,li/I"OY"nl I 11•.:,_ I, I I ...... '-"J I~ IJ ........... , ""• 
undergoes lipolysis by the action of lipoprotein lipase, an enzyme 
located on the luminal surface of endothelial cells of capillaries 
in body tissues (Scow et al., 1976; Kompiang et al., 1976). The free 
fatty acids produced can enter the tissues or some can remain in 
the blood. 
Chicken LDL (density 1.006 1.063 g/ml), in comparison with chicken 
VLDL, has a decreased content of triacylglycerol and increased 
proportions of other components (Yu et al., 1976). Chicken HOL 
(density 1.063- 1.21 g/ml) is produced in the liver and consists 
mainly of protein with phospholipid being the next most abundant 
constituent (Kruski et al., 1975; Evans et al., 1977). 
Although the lipoproteins have been presented above as distinct 
fractions, it must be remembered that within each fraction there is 
a range of densities, and that fractions are structurally and 
functionally inter-related, the whole being regarded as a dynamic 
system. The transfer of lipid and apoprotein components from one 
fraction to another has been shown to take place and the production 
of some lipoproteins relies on the use of catabolic products 
(remnants) of others. (For reviews see Smith et al., 1978a; Havel 
et al., 1980; Mahley et al., 1984). For example, LDL is formed from 
remnants of VLDL in many animals. 
Free fatty acids are normally transported in the avian blood mainly 
bound to albumin (Butler, 1971) although they are capable of binding 
to other blood components such as triacylglycerol-rich lipoproteins, 
a fact which becomes important at the onset of egg-laying in hens, 
(Leclercq et al., 1979) when there is a large increase in the 
concentration of such lipoproteins. 
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2. Alterations in the metabolism and transport of lipid in laying hens 
and oestrogen-treated birds. 
At the onset of egg-laying the liver assumes the role of synthesising 
the lipids and proteins required by the developing egg (Heald & 
Badman, 1963; Hawkins & Heald, 1966). Marked elevations in the 
plasma levels of lipid and egg-yolk proteins are observed during the 
fourteen days prior to the onset of laying, when the plasma lipid 
level can rise to 10 - 14 g/100 ml plasma compared to 0.2 - 0.5 g/ 
lOOml plasma in immature hens. At the time the first egg is laid 
the level of total plasma lipid decreases to 1.5- 3 g/100 ml (Heald 
& Rockledge, 1964) 
Walker et al. (1961) reported that 70%- 80% of the lipaemia was 
caused by accumulating triacylglycerol, the remainder being 
phospholipids together with a smaller quantity of cholesterol. 
These large increases in lipids were shown to be predominantly 
associated with VLDL and, to a lesser extent, LDL (Hillyard et al., 
1972; Chapman et al,,l977). 
Oestrogen-treatment of male and immature female domestic fowl has 
been shown to lead to an accumulation of plasma lipids and proteins 
similar to that observed in laying hens and it is possible that 
similar metabolic processes are involved (Lorenz, 1954; Schjeide 
et al., 1963; Bergink et al,, 1974; Chan et al., 1976). The bulk of 
the plasma lipids constituting the lipaemia in oestrogen-treated 
domestic fowl are triacylglycerols, predominantly in the form of 
VLDL (Kudzma et al., 1973, 1975, 1979; Luskey et al., 1974; Chan et 
~., 1976, 1977). It has been shown that oestrogen-treatment of 
immature female domestic fowl results in a dramatic increase in the 
plasma levels of VLDL (400-fold) with a lesser increase in LDL 
(70-fold) and a marked decrease in HDL (Kudzma et al., 1979). 
Similar alterations in lipoprotein levels have been observed at the 
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onset of egg-laying in hens involving an increase in the levels of 
VLDL (200-folrl) and an approximately 50% decrease 1n Ur'll IIUL /\1 .. -.L. _, \ I U t:: ~ C1 I • , 
1976). The accumulation oftriacylg1ycerol in the plasma of 
oestrogen-treated birds may be due to an increase in the rate of 
hepatic production of VLDL or a decrease in the removal of VLDL from 
the blood, or a combination of these effects. Oestrogen treatment 
has been shown to increase the rate of synthesis of VLDL in avian 
liver (Luskey et al., 1974; Kudzma et al., 1975). In addition, it 
has been reported that the fractional turnover rate of VLDL-
triacylglycerol in oestrogen-treated hyperlipaemic birds was 
substantially less than that in untreated birds, despite the fact 
that the total turnover rate was nearly 50-fold greater (Kudzma 
et al,,l975). Furthermore, Bacon et al. (1978) noted a decreased 
rate of clearance of VLDL-triacylglycerol from the plasma of laying 
hens. 
These studies suggest that oestrogen causes increased VLDL 
production in avian liver, leading to a massive increase in plasma 
VLDL levels. Under these circumstances, despite the reported 
increase in total turnover rate of plasma VLDL, the magnitude of 
this lipaemia appears to be so great that it exceeds the capacity of 
the organism to rernove lipid from the plasma. 
As well as changes in the quantities of lipoproteins in the plasma, 
egg-laying or oestrogen treatment has been shown to cause a number 
of compositional changes in the lipoprotein fractions. Elevated 
triacylglycerol and phospholipid and diminished cholesterol contents 
of VLDL in laying hens have been observed, when compared with non-
laying birds (Yu et al.,l976; Evans et al.,l977). Griffin et al. 
(1984) suggested that such lipid compositional changes in VLDL in 
laying hens are primarily due to oestrogen-induced changes in the 
pattern of lipid synthesis. Kudzma etal. (1979) reported that LDL 
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and HDL in the plasma of oestrogen-treated sexually immature hens 
were enriched with triacylglycerol while the proportion of 
cholesterol in all lipoprotein fractions decreased. 
. t With the onset of egg-laying the size of VLDL particles dim1nshes 
1\ 
(Chapman~-, 1977) and the LDL particles are larger (Hillyard 
et al.,1972; Chapman et al.,1977) compared to non-laying birds. In 
oestrogen-treated non-laying hens Kudzma et al. (1979) found that 
lipoproteins of density less than 1.060 g/m1 could not be grouped 
clearly into discrete VLDL and LDL fractions on the basis of 
discontinuous density distributions. Instead, these lipoproteins 
possessed a continuous spectrum of densities, up to 1.060 g/ml. 
Analysis of the apoprotein composition of these lipoproteins showed 
that plasma VLDL from non-laying birds contains at least six 
apoproteins whereas only two major apoproteins are present in VLDL 
from oestrogen-treated birds, a high molecular weight component. 
(Mr 250,000) which also predominates in the untreated state, and a 
low molecular weight apoprotein (Mr 7,000). The latter component 
is normally only present, if at all, in very small amounts in 
untreated birds and it has been called apo-VLDL-II by Jackson et al. 
(1977). Kudzma et a1. (1979) have also shown that, in the untreated 
state, the apoprotein composition of VLDL and LDL were dissimilar 
whereas, after oestrogen treatment, they were indistinguishable. 
Furthermore, the lipid composition of VLDL and LDL were similar 
after oestrogen-treatment. These observations, therefore, suggest 
that in oestrogen-treated birds, the 'VLDL' and 'LDL' represent a 
single lipoprotein class, with essentially similar lipid and 
apoprotein composition, which exhibits a continuous spectrum of 
density, up to 1.060 g/ml. 
Several investigators have demonstrated an increased production of 
the apoproteins of VLDL and LDL in oestrogen-treated birds (Chan et 
~.,1976, 1978, 1980; Kudzma et al.,l979; Lin & Chan, 1980). The 
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increase in apo-VLDL-II synthesis is due to increased concentration 
of hepatic mRNA coding fot the apopr·otein (Chan et al.,1978, 1980; 
Codina-Salada et al., 1983) which is translated on membrane-bound 
ribosomes before association with lipid, in the cisternae of 
endoplasmic reticulum and Golgi apparatus, and eventual release into 
the plasma (Lin & Chan, 1982; Higgins & Hutson, 1984). 
The differences, both quantitative and qualitative, between plasma 
lipoproteins (mainly VLDL) from laying hens or oestrogen-treated 
birds and non-laying untreated birds are believed to be a reflection 
of the fact that the laying hen synthesises specialised lipoproteins 
(including vitellogenin) for transfer to the yolk in developing 
oocytes (Christie & Moore, 1971; Griffin et al.., 1984). This is 
--
strongly supported by observations, amongst others that (a) the size 
distribution of plasma lipoproteins is similar to that of yolk 
lipoproteins (Bacon et al., 1973), (b) lipid and fatty acid 
compositions of plasma and yolk triacylglycerol-rich lipoproteins 
are similar (Christie & Moore, 1972) and (c) the structure of 
plasma apo-VLDL-II (Jackson et al.,l977) appears to be the same as 
that reported for ape-vitelline I of yolk (Dopheide & Inglis, 1976). 
Fujii et al. (1984) detected a marked alteration in the percentage 
contributions of particular fatty acids in both liver and plasma 
lipids of the hen when approaching lay. In particular, oleate 
(18:1) increased and decreases were observed in stearate (18:0) and 
arachidonate (20:4). The altered fatty acid compositions of the 
plasma and liver lipids of the laying hen were similar to that of 
yolk lipid suggesting that lipids of a particular composition are 
being transported to the developing egg. Furthermore, oestrogen-
induced changes in the fatty acid composition of liver lipids in 
immature pullets have been reported which are similar, in some 
respects, to those occurring in the laying hen (Balnave & Pearce, 
1975; Pearce & Balnave, 1975), with increases in the percentages of 
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palmitate (16:0), palmiteolate (16:1) and oleate (18.1) and decreases 
in those of stearate (18:0) and linoleate (18:2). However, the 
resultant fatty acid composition of liver lipids from treated birds 
was seen to be intermediate between the untreated, immature and 
the mature, egg-laying pattern (Pearce & Balnave, 1975), and the 
percentage of palmitate (16:0) in plasma and liver lipids in 
oestrogen-treated pullets was substantially greater than that in 
the mature laying hen (Balnave, 1971). Clearly, oestrogen plays a 
significant role in the changes observed in the fatty acid 
compositions of 1ipids as the hen approaches lay. That such changes 
may not be reproduced exactly by exogenous oestrogen administration 
is to be expected since, undoubtedly,tbe physiological state of the 
laying hen is not determined solely by oestrogen and other ovarian 
and endocrine secretions may exert an influence (Balnave, 1969; 
Balnave & Pearce, 1974). It must also be remembered that the egg-
laying process itself, involving the removal of lipid from the 
body, may exert a significant physiological effect which is 
obviously lacking in oestrogen-treated birds. 
The liver is the main site of lipogenesis in avian species (Leveille 
et al_., 1968; O'Hea & Leveille, 1969; Brady et al., 1976) and is also 
the main site of production of lipoproteins such as VLDL. Using 
the technique of functional hepatectomy, Ranney & Chaikoff (1951) 
demonstrated that the liver was responsible for the development of 
lipaemia in the oestrogen-treated cockerel. After oestrogen 
treatment of male and immature female birds, and at the onset of 
lay in the mature hen, there is an increase in the total lipid 
content of the liver, particularly triacylglycerols, whtch is 
associated mainly with LDL and VLDL (Pearce, 1971; Pearce & Brown, 
1971: Balnave & Pearce, 1974; Kudzma et al.; 1975; Pearce & Balnave, 
1975). In such conditions, there is a proliferation of the 
endoplasmic reticulum and the Golgi apparatus together with an 
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increase 1n the number of associated ribosomes and mitochondria 
(~chjeide et al., 1963, 1974: Tarlow et al., 1977). Consequently, in 
the early stages of the transformation of hepatic activity induced 
by oestrogen treatmen~ or egg-laying, much of the lipid and protein 
synthesised would appear to be used for membrane biosynthesis so 
increasing the cellular capacity for the subsequent production of 
proteins and lipids for export to the developing oocyte. 
In most mammals, plasma free fatty acids are important precursors 
of plasma lipids which are manufactured in the liver (Havel, 1961). 
In the domestic fowl, however, the liver is a most active site of 
de novo fatty acid synthesis (Leveille et al.,l968). Attempts have 
been made to correlate changes in hepatic lipogenic activity, both 
from non-lipid precursors and pre-formed fatty acids, with the 
increased levels of liver and plasma lipids in the laying hen and 
oestrogen-treated bird. Studies using liver slices and in vivo 
techniques have shown that the liver of the oestrogen-treated bird 
has an enhanced capacity to synthesise lipids, de novo, from non-
lipid precursors (Kudzma et al., 1973, 1975; Dashti et al., 1983) and 
Courtney (1984) has shown that in oestrogen-treated immature male 
chicks, the increase was apparent 3~ - 7! hours after injection, 
although a statistically significant increase did not occur until 
14 - 17 hours post-injection. However, studies of liver slices 
from laying hens have indicated a lower level of hepatic lipid 
synthesis de novo when compared to immature, non-laying, female 
birds (Weiss et al., 1967; Duncan, 1968, 1970). Investigations 
in vitro, designed to measure the capacity of the liver to 
incorporate pre-formed fatty acids into complex lipids, have shown 
increased hepatic capacities in both oestrogen-treated birds and 
laying hens (Hawkins & Heald, 1966; Duncan, 1970; Kudzma et a~., 
1975; Courtney, 1984). 
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At this point, it is of interest to note that elevated free fatty 
ac~d levels have been observed in the plasma of laying hens (Heald 
& Badman, 1963; Heald & Rockledge, 1964) and oestrogen-treated 
birds (Kudzma et al., 1973, 1975) when compared to non-laying, 
untreated birds. An understanding of the origin of the raised 
plasma free fatty acid concentrations is an important step in an 
evaluation of the relative roles of hepatic fatty acid synthesis 
de novo and hepatic lipogenesis from pre-formed fatty acids. The 
free fatty acids may have been released by the lipolysis of 
triacylglycerol in adipocytes or have been synthesised de novo at 
extra-hepatic sites. Another possibility, however, is that they 
may have been released from VLDL-triacylglycerol circulating in 
the blood, by the action of lipoprotein lipase in peripheral tissue. 
A detailed knowledge, therefore, of the time sequence of the 
increased plasma triacylglycerol content and the free fatty acid 
content of the plasma of laying hens and oestrogen-treated birds 
might provide information about the early events occurring in the 
elevated hepatic production of lipids. For example, if the increase 
in plasma free fatty acids occurs before the increase in plasma 
triacylglycerol this might suggest that the fatty aicds originate 
from extra-hepatic sources and are being transported to the liver 
for incorporation into complex lipids. Conversely, if the free 
fatty acid level increases after the appearance of increased levels 
of plasma triacylglycerol, this might imply that the liver was the 
site of origin of these fatty acids, implicating fatty acid 
synthesis de novo. Kudzma e~. (1973) reported that the rise in 
plasma free fatty acid levels did not occur until after the 
oestrogen-induced hypertriacylglycerolaemia in young chicks was 
well established and suggested, therefore, that the over-production 
of triacylglycerol by the liver was not dependent upon fatty acids 
arriving from extra-hepatic sources. It must be noted at this 
stage, however, that an increase in plasma free fatty acid levels 
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was observed in control birds. Pageaux ~· (1981), working with 
oestrogen-treated immature female quail, observed a decrease in 
plasma free fatty acid levels within one hour of injection, followed 
by a subsequent increase in concentration suggesting that initially, 
at least, the liver may have removed free fatty acids from the 
plasma. 
The aim of the work presented in this chapter was to produce (a) a 
detailed account of the changes occurring in the levels of 
phospho1ipid, triacy1g1ycero1 and free fatty acids in the liver and 
blood of oestrogen-treated immature male chicks and {b) a 
description of the changes in fatty acid compositions of particular 
liver and plasma lipids in similarly treated birds. A detailed 
time-course of changes was determined in an effort to elucidate some 
of the physiological responses to oestrogen treatment and to 
correlate these changes with other observations in this thesis and 
elswehere. 
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METHODS 
l. Animal housing 
The birds were housed as described in Chapter 2, and used in 
experiments when aged between 3 and 5 weeks. Oestrogen-treated 
chicks were injected intramuscularly with 17~-oestradiol (0.75mg/ 
100 g body wt.) dissolved in propane-1,2-diol. Control birds 
received an equivalent volume of propane-1,2-diol only. 
2. Killing of animals/Preparation of plasma 
Birds were killed between 11.00 hrs and 13.00 hrs in order to 
minimise the effects of possible diurnal variations in behaviour 
and physiology. The birds were weighed and then killed by 
decapitation and the livers were quickly excised, weighed, rapidly 
frozen in liquid nitrogen and then stored at -20°C for future assays. 
Blood was collected from the severed necks of the birds into glass 
scintillation vials which contained 1 ml of 127 mM-NaCl, 10 mg/ml 
EDTA, pH 7.4. About 5 ml of blood was routinely collected and mixed 
with the anti-coagulant to give a final concentration of about 
2 mg EDTA/ml of blood. Plasma was separated by low-speed 
centrifugation at 4°C, the volume measured and some aliquots were 
stored frozen for future assays while other aliquots were used 
immediately for the isolation of lipoproteins. 
3. Isolation of a Very Low Density Lipoprotein fraction 
Lipoproteins of a density less than 1.006 g/ml were isolated from 
whole plasma by the ultracentrifugal flotation method described by 
Havel et al.(l955). Aliquots of plasma (1 - 3 ml depending on the 
experimental treatment of the bird) were carefully overlaid with 
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KBr (density= 1.006 g/ml), to give a final volume of 5 ml. 
Following centrifugation at 125,000 ~for 16 h at 4°C in a swing-out 
rotor (r = 8.18 em) lipoproteins of density less than 1.006 g/ml 
av. 
were recovered from the top of centrifuge tubes using a pasteur 
pipette. Random checks indicated that no triacylglycerol remained 
in the clear infranatant. Lipid extractions were performed on the 
VLDL (density <1.006 g/ml) fractions. 
4. Lipid extraction procedure 
Lipids were extracted from whole plasma, VLDL fractions and from 
liver by the rapid method described by Bligh & Dyer (1959). Whole 
plasmawasdiluted with 154 mM-NaC1 to an extent dependent upon the 
experimental treatment of the bird. Diluted plasma (1.6 ml) was 
mixed thoroughly with 6 ml of chloroform/methanol (1:2,v/v). 
Subsequent additions of 2 ml chloroform and 2 ml distilled water 
were each followed by thorough mixing and, following low-speed 
centrifugation, the bottom phase, consisting of lipiG dissolved in 
chloroform, was removed and used for assays of free fatty acids, 
phospholipid and triacylglycerol. Lipid extractions of VLDL 
aqueous samples involved a similar procedure, the only difference 
being that either 1.6 ml or 3.2 ml of aqueous sample were used. 
Aliquots of the lipid extracts from VLDL were used subsequently in 
lipid assay procedures and thin-layer chromatography. 
Lipid extraction of liver involved the homogenisation of liver 
samples and an aliquot of 154 mM-NaCl calculated to yield 2.4 ml 
aqueous phase, with 9 ml of chloroform/methanol (1:2,v/v) using a 
teflon-glass homogeniser. The tissue was disrupted with 10 'up and 
down' strokes of the rotating pestle. The extraction was completed 
by the addition of chloroform (3 ml) and water (3 ml). After mixing, 
the phases were separated by centrifugation and aliquots of the 
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lipid extract were used in lipid assay procedures and thin-layer 
chromatography. 
used for analysis 
0.005% (w/v) BHT. 
In the production of lipid extracts which would be 
of fatty acid composition, all solvents contained 
Lipid extracts not used immediately were stored 
under nitrogen, in sealed glass containers, in the dark at -zooc 
for a maximum of 14 days. 
5. Assay of triacylglycerol 
Triacylglycerols were measured using a slight modification of the 
Sigma Diagnostic Kit procedure described in the Sigma Technical 
Bulletin No. 405 (1978). Aliquots of lipid extract, in chloroform, 
were transferred to vials and evaporated to dryness under a stream 
of nitrogen. Isopropanol (5 ml), distilled water (0.2 ml) and 
activated alumina (0.8: 0.2 g), an adsorbant used for the removal 
of interfering substances, were added and the vials shaken for 5 
minutes. Blank and standard assays were included along with 
duplicate test assays. Standard assays contained 4.8 ml isopropanol, 
0.2 ml distilled water and 0.2 ml triolein standard (300 mg triolein/ 
100 ml isopropanol). Following low-speed centrifugation at 4°C, 
an aliquot (2 ml) of the clear supernatant was transferred to a 
clean test tube and 0.5 ml lM-KOH was added with mixing. Each tube 
was incubated for 5 minutes at 60°C causing the release of glycerol 
by saponification of the triacylglycerol. Periodate solution (0.5 ml), 
prepared by dissolving 125 mg sodium m-periodate in 50 ml 2M-acetic 
acid, was added to the cooled contents of each tube, with mixing. 
After exactly 10 minutes at room temperature, during which time the 
glycerol was oxidised to formaldehyde, 3 ml of a chromogenic reagent 
was added, with mixing, and the tubes capped with aluminium foil and 
incubated for 30 minutes at 60°C. The chromogenic reagent was 
prepared by mixing 2M-ammonium acetate (20 ml), isopropanol (40 ml) 
and acetylacetone (0. 15 ml). The prepared reagent was kept for at 
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least one day before use, since aging was required to obtain maximum 
colour in the final reaction in which yellow diacety1dihydrolutidine 
was formed. 
Formaldehyde+ NH; + Acetylacetone --.oiacetyldihydrolutidine. 
The absorbance of the cooled solution was measured at 410 nm and 
readings were completed within 20 minutes of the end of the 
incubation period. 
A standard curve was prepared, using the triolein standard of 
300 mg/100 ml isopropanol, and was linear up to 0.75 mg triacyl-
glycerol. The chromogenic reagent and periodate solution were 
stored in the dark at 4°C and replaced each month. 
6. Assay of phospholipid 
Phospholipid estimations were carried out by the method of Raheja 
et al (1973). Aliquots of lipid extract, in duplicate, were 
evaporated to dryness under a stream of nitrogen in thick-walled 
tubes. Duplicate blank and standard assays were included. 
Standard assays were performed by evaporating to dryness 1.0 ml of 
0.17 mM-dipalmitoyl phosphatidycholine (chloroform solvent). 
Chloroform (0.5 ml) and chromogenic reagent (0.2 ml) were added and 
the contents mixed. Each tube was heated in a boiling water bath 
for exactly 3 minutes, then cooled and 3 ml of chloroform added. 
The contents were mixed thoroughly and centrifuged at low speed for 
5 minutes at room temperature. The absorbance of the lower 
chloroform layer was measured at 716 nm. A standard curve was 
prepared using dipalmitoyl phosphatidylcholine (0. 17 mM) in 
chloroform as a standard. The assay was linear in the range of 
0 - 0.3 ~moles of phospholipid. 
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Preparation of the chromogenic reagent involved, first1y, dissolving 
ammonium molybdate (Q ,..,\ ..;t"'\ ,..J..;("'+..;11-...J 1.1-,.+-("\V'O {C.fi ,......,, .......... ..J ... .CJ...-.-\V '::JI Ill Ul.;)l..liiC:U VVOI..C:I \UU 1111/ OIIU, Oll.t::l 
adding a few drops of concentrated hydrochloric acid to ensure 
complete dissolution, this solution was used to prepare two further 
solutions: 
Solution 1 
Redistilled mercury (5 g) was added to a mixture of 20 ml of 
concentrated hydrochloric acid and 40 ml of the ammonium molybdate 
solution. The mixture was stirred on a magnetic stirrer for 
45 minutes, then filtered to produce a red-brown filtrate. 
Solution 2 (Acid molybdate) 
This was prepared by carefully adding 100 ml of concentrated 
sulphuric acid to 20 ml of the ammonium molybdate solution. 
The final chromogenic reagent was prepared in a fume cupboard by 
very carefully adding Solution 2 to Solution 1 with stirring at oac. 
The resultant dark green solution (25 volumes) was mixed with 
methanol (45 volumes), chloroform (5 volumes) and distilled water 
(20 volumes). The chromogenic reagent was stored in the dark at 
4oc for 6 months 1 +h..Q..n. r.JLr\G\c..Qd, 
7. Assay of free fatty acids 
Total free fatty acids in plasma and liver samples and albumin-bound 
free fatty acids in plasma were determined, using two separate 
procedures. 
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(a) Total free fatty acids in plasma and liver 
A modification of the method described by Antonis (1965) was used. 
This method is based on the production of the copper salt of the 
fatty acids in chloroform followed by estimation of the copper 
content of the organic phase by reaction with zinc dibenzyldithio-
carbamate. Silicic acid (1.2 ~0. 1 g) was slurried with 7.5 ml 
diisopropyl =ether, in stoppered tubes. The ether had been passed 
through a column of activated alumina just before use to remove 
peroxides. Plasma (0.5 ml) was added and the mixture was well 
mixed for 1.5 minutes. The silic acid adsorbant removed phospholipids, 
which were a source of interference, without affecting the levels of 
free fatty acids. Following low-speed centrifugation for 2 minutes 
to precipitate the silic acid, 5 ml of the ether supernatant was 
removed and transferred to glass centrifuge tubes which had 
previously been 'siliconised' using dimethyldichlorosilane (0.5%,v/v) 
in heptane. The ether was evaporated to dryness under a stream of 
nitrogen and the lipid redissolved in 5 ml chloroform. 'Copper 
reagent' (2.5 ml), consisting of 3.8% (w/v) copper sulphate, 
pentahydrate, 0.45 M-triethanolamine and 0.05 M-acetic acid, in 
final concentrations, was added and mixed thoroughly with the lipid 
extracts. Each tube was then centrifuged at low speed for 10 
minutes and care was taken to remove all of the excess upper aqueous 
copper phase by aspiration with a pasteur pipette. A 3 ml aliquot 
of the chloroform extract was placed into a clean tube and colour 
was developed by the addition of 0.5 ml of zinc dibenzyldithio-
carbamate (0.3%, w/v} in chloroform. The absorbance of each tube 
was measured, after 15 minutes at room temperature, at 440 nm. 
A similar procedure was adopted for the measurement of free fatty 
acids in liver samples, the only difference being that aliquots. 
(1.5- 2.0 ml) of liver lipid extract in chloroform were evaporated 
to dryness under a stream of nitrogen in stoppered tubes prior to 
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the addition of diisopropyl ether and silicic acid. 
Standard curves were produced using 2 mM-sodium palmitate in Krebs 
Ringer phosphate buffer, pH 7.4 (Dawson, 1969), containing 3% (w/v) 
BSA (fatty acid-free). Assays were performed in duplicate, blank 
assays and standard assays being included in each series of assays. 
The sodium palmitate was prepared by the saponification of 25.6 mg 
palmitic acid by 1.1 ml of 0.1 M-NaOH at 60°C prior to dilution to 
50 ml with Krebs Ringer phosphate buffer. pH 7.4, containing 3% (w/~) 
BSA, and was stored frozen. The 'copper reagent' and zinc 
dibenzyldithiocarbamate (0.3%, w/v) in chloroform were stored in the 
dark at 4°C and replaced every 2 months. 
(b) Albumin-bound free fatty acids 
The levels of free fatty acids bound to albumin in the plasma were 
determined using the method of Griffin & Mitchell (1984). 
Triacylglycerol-rich lipoproteins were selectively precipitated 
from aliquots (0.5 - 0.7 ml) of plasma in plastic minifuge tubes by 
dilution with an equal volume of 0.2% (w/v) dextran sulphate in 
200 mM-magnesium chloride, 10 mM-Tris/HCL, pH 7.4 (at 25°C). After 
20 minutes at room temperature, the precipated lipoproteins were 
pelleted by centrifugation at 1000 ~for 10 minutes. Highly 
lipaemic plasma samples required 2 volumes of dextran sulphate/Mg 2 + 
reagent to cause complete sedimentation. Albumin-bound free fatty 
acids in the supernatant were then assayed using the very sensitive 
method of Itaya (1977). Aliquots (0.6 ml) of each supernatant were 
mixed thoroughly, for 1.5 minutes, with 0.65 ml of 1M-sodium 
phosphate, pH 6.5, and 5 ml chloroform in stoppered tubes. This 
process removed phospholipids. After centrifugation at low speed 
for 5 minutes, the chloroform phase was mixed with 2.5 ml of the 
'copper reagent' (3.8% (w/v) Cuso4, 5H 2o, 0.45 M-triethanolamine, 
0.05 M-acetic acid) in 'siliconised' glass centrifuge tubes. Excess 
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aqueous 'copper reagent' was removed by aspiration with a pasteur 
pipette and 3 ml of the lower chloroform was removed to a clean tube. 
Colour was developed by the addition of 0.75 ml of a 0.1% (w/v) 
solution of a mixture of diphenylcarbazone and diphenylcarbazide 
(5:95) in methanol. The absorbance was measured at 550 nm. 
Standard curves were constructed using 0.2 mM-sodium palmitate in 
Krebs Ringer phosphate buffer, pH 7.4 (Dawson, 1969), containing 3% 
(w/v) BSA (fatty acid-free). Assays were performed in duplicate, 
blank assays and standard assays being included in each series of 
assays. 
8. Assay of DNA 
The DNA content of liver tissue was determined by the method 
described in Chapter 2. 
9. Thin-layer chromatographic separation of lipids 
Lipid extracts from VLDL fractions and liver samples were evaporated 
to dryness under nitrogen, dissolved in a small volume of chloroform, 
and aliquots (40 - 50 ~1) applied as 2 em 'streaks' to activated 
plates of Kieselgel 60 H. The solvent system used to separate lipid 
classes was light petroleum (b.p. 40° -60°C)/diethyl ether/acetic 
acid (60:40:1~ by vol.). Plates were run in chromatography tanks 
which had previously been 'flushed' with nitrogen just before use, 
and the solvent system contained 0.005% (w/v) BHT. These 
precautions were adopted to minimise oxidation of fatty acids. 
Authentic neutral lipid standards and oleic acid were run on the 
same plates. After development and drying, the separated lipid 
standards were visualised by exposure of the appropriate portion of 
each plate to iodine vapour. Silica gel was scraped off the non-
exposed portions of the plates from those areas corresponding to the 
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positions of lipid standards. Scraped plates were later fully 
exposed to iodine vapour to check that the correct areas had indeed 
been scraped. The scrapings were collected into small bijou bottles, 
flushed carefully with nitrogen and sealed tightly. Bottles were 
stored in the dark at -20°C for up to 10 days before being used for 
g. 1.c. analysis. 
10. Gas-liquid chromatography analysis of the fatty acid composition 
of lipid classes from VLDL and liver 
(a) Preparation of fatty acid methyl esters. 
Fatty acid methyl esters were prepared by a modification of the method 
of Morrison & Smith (1964). For phospholipid samples, sufficient 
boron trifluoride (14%, w/v) in methanol (approx. 0.3 ml) was added 
to the bijou bottles to 'wet' the silica gel samples. 'Tuf-bond' 
teflon seals were placed in the screw caps before the bottles were 
sealed tightly and heated at 100°C for 15 minutes. For triacylglycerol 
samples, methanolysis was achieved by the addition of 1 ml of a 
mixture of boron trifluoride (14%, w/v) in methanol/hexane/methanol 
(25:20:55, by val.) to the silica gel samples followed by heating at 
100°C for 30 minutes. After cooling the bottles, a stream of 
nitrogen was passed over the samples to remove the bulk of the low 
boiling point contaminants and to volatilise residual boron 
trifluoride reagent. Fatty acid methyl esters were eluted from the 
dry samples with n-hexane and the silica gel was removed by 
filtering each suspension through a glass-wool plugged pasteur 
pipettes. The filtrates were then evaporated, under a stream of 
nitrogen, to minimal volumes (5 - 10 ~1) and aliquots injected onto 
the g. l.c. column. 
(b) Gas-liquid chromatography of fatty acid methyl esters 
Separation was carried out using a Shimadzu GC-9A Series gas 
-77-
chromatograph. The glass columns used were 2 m long with a 2 mm 
internal diameter and 6 mm externa1 diameter and were obtained from 
JJ (Chromatography) Ltd., King's Lynn. They were packed with a 
cyano-silicone stationary phase, 10% Alltech CS-5, on a chromasorb 
WAW 100 - 120 mesh support. Nitrogen was used as the carrier gas 
and the resolved components were detected by a flame ionisation 
combustion system (hydrogen/air). The detector was connected to a 
Trilab 2 computing integrator with graphics, supplied by Trivector 
Scientific Ltd., which calculated the area of individual peaks and 
the percentage contribution of each peak to the total peak area. 
Since peak area is directly related to the mass of resolved 
component, percentage area contributions were an indication of the 
percentase mass contribution of individual fatty acids to total 
fatty acid mass. The detector responded in direct proportion to 
the load of sample applied over the range 10-8 g to 10-4 g 
pentadecanoate methyl ester (Fig. 3. 1). 
A preliminary experiment, in which column efficiency (number of 
theoretical plates) and resolution of peaks were determined over a 
range of carrier gas Flow rates, indicated that a flow rate of 
50 ml/minute, measured at the inlet side of the column, was optimal 
(Fig. 3. 1). The number of theoretical plates, which is a measure 
of the relative sharpness of a peak (Schupp, 1968), was calculated 
as follows:-
No. theoretical plates 
r- ., 2 
= 16 I Rt II IW 
- ..... 
where Rt =the retention time (in min.) of the resolved solute. 
W =the peak width (in min.) at the base line cut by tangents 
of the slopes of the peak. 
The resolution of two component peaks, palmitate (16:0) and 
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Figure 3.1 
(a) The effect of carrier gas flow rate on the column efficiency 
(no. of theoretical plates) and the resolution of separation 
during gas-liquid chromatographic analysis. 
Columns were packed as described in the Methods section and run 
isothermally at 2l0°C. 
Column efficiency at each carrier gas flow rate was calculated, 
as described in the text, from data obtained after injecting 
palmitate (16:0) methyl ester on to the column. Resolution at 
each carrier gas flow rate was calculated, as described in the 
Methods section, from data obtained after injecting palmitate 
(16:0) methyl ester and palmitoleate (16:1) methyl ester on to 
the column. 
• values for column efficiency. 
0 values for resolution. 
(b) Calibration curve of the magnitude of the g. l.c. detector 
response with varying amounts of pentadecanoate (15:0) methyl 
ester applied to the column. 
Columns were packed as described in the Methods section and run 
isothermally at 2l0°C. 
For each particular mass of pentadecanoate (15:0) methyl ester 
applied to the column, the magnitude of the detector response 
was recorded. 
Each value plotted represents the mean of 3 recordings. 
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palmitoleate (16:1), was calculated using the equation:-
Resolution = 2 ARt 
(Wl + W2) 
where ~Rt =the difference between the retention times (in min.) 
of the two components 
w1 and w2 are the peak widths (in min.) at the base line cut 
by tangents of the slopes of the peak. 
A carrier gas flow rate of 55 ml/minute was adopted, being a 
compromise between the optimal flow rate (50 ml/minute) and higher 
flow rates which reduce analysis time. The two columns (one 
reference) were run in a temperature program, with one temperature 
'ramp', as follows:-
Initial temperature = 2l0°C 
Initial time 10 min. 
Program rate = 4°C/mi n. 
Final temperature = 250°C 
Final time = 7 min. 
Peaks were identified by comparison of their retention times with 
those of the following authentic fatty acid methyl ester standards; 
12:0, 14:0, 14:1, 16:0, 16:1, 18:0, 13:1, 18:2, 18:3, 20:0, 20:1, 
20:2, 20:3, 20:4, 22:0, 22:4, 22:6, 24:0. 
11. Statistical analysis 
Data were expressed as the mean value ~ standard error of the mean 
and were analysed statistically by Student's 't' test, levels of 
statistical significance being indicated where appropriate. 
Probability values (p) of 0.05 or less were taken to be significant. 
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RESULTS 
1. Changes in 1ipid 1eve1s in p1asma fo1lowing oestrogen treatment 
The administration of 17~-oestradiol (0.75 mg/100 g body wt.) to 
young male chicks caused a substantial and pro1onged increase in the 
concentration of triacy1g1ycerol (Fig. 3.2a) and phospholipid 
(Fig. 3.2b) in the plasma, when compared with contro1 birds. 
Significant increases in the concentration of triacylglycerol 
(p<O.OOl) and phospholipid (p<0.05) were first observed at 7 hours 
following injection. At 4 hours after oestrogen treatment both 
triacylglycero1 and phospholipid levels were greater than control 
values but these differences were not statistically significant. 
From 7 - 44 hours after injection there were continuous increases in 
triacylg1ycerols and phospholipids when compared to controls, such 
that the greatest levels were observed 44 hours after injection. At 
this time, 26.7-fold and 4.8-fold increases over corresponding control 
values were observed for triacylglycerols and phospholipids 
respectively. 
The mean concentration of total free fatty acids in the plasma of 
oestrogen-treated birds was significantly lower than the control 
value (p< 0.01) at 2 hours after injection (Fig. 3.2c). At this time, 
the contr·ol value was 2.06-fold greater than the oestrogen-treated 
value and 2.00-fold greater than the untreated (zero-time) value while 
the oestrogen-treated and untreated values were not significantly 
different from each other. Free fatty acid concentrations in the 
plasma of oestrogen-treated and control birds were not significantly 
different at all time-points subsequent to 2 hours. 
2. Changes in lipid levels of VLDL and in leve1s of albumin-bound free 
fatty acids in the plasma following oestrogen treatment 
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Table 3.2 
The effect of a single dose of 17~-oestradiol (0.75 mg in propane-1,2-diol/100 g body wt.), or of 
propane-1,2-diol only, on the total plasma concentrations of triacylglycerol (TG), phospholipid (PL) 
and free fatty acids (FFA) at varying times after injection. 
Each oestrogen-treated chick received a single intramuscular injection of 0.75 mg 17~-oestradiol in 
propane-1,2-diol/100 g body weight. Control chicks received an equivalent volume of propane-1,2-diol 
only. At the indicated times after injection, chicks were sacrificed and plasma collected as described 
in the Methods section. The triacylglycerol, phospholipid and free fatty acid contents of the plasma 
were determined by the procedures described in the text. Chicks were aged 3~ - 5 weeks. 
OE = values for oestrogen-treated chicks. 
C = values for control chicks. 
Values are the means(: S.E.M.) of 3- 8 birds; the number of birds involved in each group is given in 
parentheses. 
Data were analysed statistically by Student's 't' test. Levels of statistical significance indicated 
without parentheses are for oestrogen-treated values with respect to corresponding control values. 
Levels of statistical significance indicated within parentheses, are for that particular value with 
respect to the corresponding untreated value. 
* significant at p <0.05 
#significant at p<O.Ol 
¥ s i g n i f i cant at p < 0 . 00 1 
The lipid concentration data are illustrated graphically in Fig. 3.2. 
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Figure 3.2 
The effect of 17~-oestradio1 in propane-1,2-diol, or of propane-
1,2-diol alone, on the total plasma concentrations of 
triacylglycerol (TG), phospholipid (PL) and free fatty acids (FFA) 
at varying times after injection. 
Consult the legend of Table 3.2 for details of experimental 
procedures. 
• values for untreated birds . 
0 values for oestrogen-treated birds. 
• values for control birds, injected with 
propane-1,2-diol. 
(a) Triacylglycerol (TG) in plasma (mg/100 ml) 
(b) Phospholipid (PL) in plasma (mM) 
(c) Total free fatty acids (FFA) in plasma (mM) 
The results are expressed as means (~ S.E.M.) of 3- 8 
observations. 
Those values plotted without error bars indicate that the S.E.M. 
was not sufficiently large to represent on the axes used. 
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Variations in the concentrations of triacy1glycerols and phospholipids 
associated only with the VLDL fraction following oestrogen treatment 
are presented in Fig. 3.3a and 3.3b. At 6 hours after injection the 
oestrogen-treated birds showed an increased VLDL-triacylglycerol 
concentration when compared with control birds but this increase was 
not significant. A significant increase (p<0.01) in the concentration 
of VLDL-triacylglycerol was observed 13 hours after oestrogen 
treatment. From 13 - 48 hours after oestrogen treatment the VLDL-
triacylglycerol concentrations were significantly greater than 
corresponding control values and a maximum increase (29.6-fold) was 
observed at 37 hours ( p < 0. 001) . The mean concentration of VLDL-
triacylglycerol in oestrogen-treated birds 48 hours after injection 
was slightly lower than that observed at 37 hours although there was 
no significant difference between the two values. 
Significant increases (p< 0.01) in VLDL-phospholipid concentrations 
were observed in oestrogen-treated birds, compared to controls, at 
all time-points after injection. From 6 - 48 hours after oestrogen 
treatment there was a continuous increase in VLDL-phospholipid such 
that at 48 hours a 96.7-fold increase over controls was observed. 
Following oestrogen administration the concentrations of albumin-
bound free fatty acids were lower than corresponding control values 
at all time-points (Fig. 3.3c). Only at 24 hours following injection, 
however, was this decrease significant (p< 0.01), the oestrogen-
treated value being 52% of the control value. 
3. Changes in liver lipid levels following oestrogen treatment 
(a) Triacylglycerols 
The triacylglycerol content of liver tissue was expressed on a whole 
organ basis (mg triacylglycerol/liver) and on a 'cellular' basis 
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Table 3.3 
The effect of a single dose of 1~-oestradiol {0,75mg in propane-1,2-diol/100 g body wt.), or of 
propane-1,2-dio1 only, on the concentrations of VLDL-triacylglycerol (VLDL-TG), VLDL-phospholipid 
(VLDL-PL) and albumin-bound free fatty acids (FFA) in the plasma of young chicks , at varying times 
after injection. 
Each oestrogen-treated chick received a single intramuscular injection of 0.75 mg 1~-oestradiol in 
propane-1,2-diol/100 g body weight. Control birds received an equivalent volume of propane-1,2-diol 
only. At the indicated times after injection chicks were sacrificed and plasma collected. Albumin-
bound free fatty acids were assayed and VLDL isolated using procedures described in the Methods 
section. Triacylglycerol and phospholipid contents of the VLDL fraction were determined, as 
described in the text. Chicks were aged 3~ - 5 weeks. 
OE = values for oestrogen-treated chicks. 
C = values for control chicks. 
Values are the mean (: S.E.M.) of 4- 8 birds; the number of birds involved in each group is given in 
parentheses. 
Data were analysed statistically by Student's 't' test. Levels of statistical significance indicated 
without parentheses are for oestrogen-treated values with respect to corresponding control values. 
Levels of statistical significance indicated within parentheses, are for that particular value with 
respect to the corresponding untreated value. 
# significant at p< 0.01 
¥ significant at p< 0.001 
Lipid concentration data are illustrated graphically in Fig. 3.3. 
Time after injection (h) 
6 13 
0 DE c DE c 
# 
VLDL-TG in plasma 63.8 65.4 6D.6 190.9 52.7 
( mg/ 1DD fitll ! 6.9 ! 6. 8 ! 8.8 ! 25.5 ! 9. 5 
(8) ( 6) ( 4) (6) ( 4) 
# # 
VLDL-PL in plasma 0.15 D.31 0.17 l. 23 0.17 
( tnl~) ! 0 D1 ! 0.03 ! 0.02 ! 0.20 ! 0.03 
(8) (6) ( 5) (6) (6) 
Albumin-bound FFA 0.25 0. 15 0.26 0.15 0.28 
in plasma ( mN) ! 0.03 ! 0.03 ! 0.09 ! 0.02 ! 0.06 
( 4) (6) (4) (6) (6) 
Body Itt. (g) 320 355 350 378 368 
! 7 ! 31 ! 29 ! 17 !ll 
(8) (6) ( 5) (6) ( 6) 
24 37 
DE c DE 
¥ ¥ 
651.0 51.4 1529 
! 58.7 ! 8.1 ~ 133 
( 6) (6) (6) 
¥ ¥ 
3.87 0.12 8.23 
! 0. 37 ! 0.01 ! 0. 70 
(6) (6) ( 6) 
# 
D. 15 0.29 0.21 
! 0. 03 ! 0.03 ! 0.07 
( 6) ( 6) ( 5) 
385 330 376 
! 14 ! 30 ! 14 
( 6) ( 6) (6) 
-- -
c DE 
# 
51.6 1438 
! 16.9 ! 233 
( 5) (6) 
# 
D. 13 9.67 
! 0.02 ! 1. 44 
( 6) ( 6) 
0.31 0.30 
! O.D6 ! 0. 07 
( 6) (6) 
363 380 
!10 ! 16 
( 6) (6) 
48 
c 
5( 
= t
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Figure 3.3 
The effect of 17~-oestradiol in propane-1,2-diol, or of propane-
1,2-diol alone, on the concentrations of VLDL-triacylglycerol 
(VLDL-TG), VLDL-phospholipid (VLDL-PL) and albumin-bound free 
fatty acids (FFA) in the plasma of young chicks, at varying times 
after injection. 
Consult the legend of Table 3.3 for details of experimental 
procedures. 
... values for untreated birds . 
0 values for oestrogen-treated birds. 
• values for control birds, injected with 
propane-1,2-diol. 
(a) VLDL-triacylglycerol (VLDL-TG) in plasma (mg/100 ml) 
(b) VLDL-phospholipid (VLDL-PL) in plasma (mM) 
(c) Albumin-bound free fatty acids (FFA) in plasma (mM) 
The results are expressed as means (: S.E.M.) of 4- 8 
observations. 
The values plotted without error bars indicate that the S.E.M. 
was not sufficiently large to represent on the axes used. 
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(mg triacylglycerol/mg DNA). After oestrogen treatment, elevations 
in iiver triacylglycerois, compared to controls, were observed at 
all time-points. Significant increases, however, were first observed 
at 7 hours (p<O.OS) when expressed on a whole organ basis (Fig. 3.4a) 
and at 11 hours (p<O.Ol) when expressed on a 'cellular' basis 
(Fig. 3.4b). A build-up of triacylglycerol was observed up to 20 
hours after oestrogen treatment. At this time there was a 6.6-fold 
increase in the whole organ content and a 6.0-fold increase in the 
'cellular' content of triacylglycerol in the liver suggesting that 
the increase in liver triacylglycerol in the first 20 hours after 
oestrogen treatment occurs in the absence of a significant amount of 
cell division. At 26 hours after injection there was a decrease in 
the mean level of triacylglycerol in the liver of oestrogen-treated 
birds when compared to oestrogen-treated birds 20 hours after 
injection but this decrease was not statistically significant. 
Subsequently, there was a further increase in liver triacylglycerol 
content such that, at 34 hours, a 23-fold increase in oestrogen-
treated birds compared to controls was observed when the results were 
expressed on a whole organ basis (Fig. 3.4a) and a 15-fold increase 
was observed when the results were expressed on a 'cellular' basis. 
(Fig. 3. 4b) 
(b) Phospholipids 
The effect of oestrogen treatment on the phospholipid content of chick 
liver was determined and the results were expressed on a whole organ 
basis (pmol phospholipid/liver; Fig. 3.5a) and on a 'cellular' basis 
(ymol phospholipid/mg DNA; Fig. 3.5b). The administration of 
oestradiol- 17~ caused a substantial increase in the mean total 
phospholipid content of chick liver, compared with control birds, 
during the period 7- 44 hours after injection (Fig. 3.5a). At each 
time-point during this period, the difference between the values 
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Table 3.4 
The effect of a single dose of 17@-oestradiol (0.75 mg in propane-1,2-diol/100 g body wt.), or of 
propane-1,2-diol only, on the liver content of triacylglycerol (TG), phospholipid (PL) and free fatty 
acids (FFA) and the liver weight at varying times after injection. 
Each oestrogen-treated bird received a single intramuscular injection of 0.75 mg 17~-oestradiol in 
propane-1,2-diol/100 g body weight. Control chicks received an equivalent volume of propane-1,2-diol 
only. At the indicated times after injection, chicks were sacrificed and their livers removed and 
weighed. The triacylglycerol (TG), phospholipid (PL), free fatty acid (FFA) and DNA contents of the 
liver tissue were determined by the procedures described in the text. Chicks were aged 3~ - 5 weeks. 
OE = values for oestrogen-treated birds. 
C = values for control birds. 
Values are the mean (± S.E.M.) of 2 - 8 birds; the number of birds involved in each group is given in 
parentheses. 
Data were analysed statistically by Student's 't' test. Levels of statistical significance indicated 
without parentheses are for oestrogen-treated values with respect to corresponding control values. 
Levels of statistical significance indicated within parentheses are for that particular value with 
respect to the corresponding untreated value. 
* significant at p< 0.05 
# significant at p< 0.01 
¥ significant at p< 0.001 
The liver lipid content data are presented graphically in Fig. 3.4, Fig. 3.5 and Fig. 3.6. For body 
weights, consult Table 3.2. 
Time after injection (h) 
2 4 7 ll 15 2D 26 3<~ 44 
D DE c DE c DE c DE c DE c OE c OE c DE c DE c 
---·----~-·-~---
# (*) # * * # (d) * • 
TG whole organ content lOS :!: 7 112:!: 82:!: 143~ 118:!: 288:!: 160:!: 381"~ 69:!: 657:!: 79! 737± lll~ 492! 124~ l662f ll! 1362! 98! (mg.) (8) 9 15 17 2 32 43 65 16 121 26 170 23 127 12 33D 8 4D5 4 
(5) (5) (2) ( 3) ( 5) (5) ( 5) ( 5) (5) ( 5) (5) (5) (4) ( 5) ( 5) ( ·~ ) ( 4) ( 4) 
# * * * ¥ (·•) * TG 'cellular' content 3. l :!: 0.2 3. 7! 2. 7! - - 8.2 ± 4 .8± ll. 7t 2. 2 ± 17.5:!: 2.4:!: 21.3:!: 3. 6! 14. l:!: 3.6:!: 32.8 ~ 2. 2:!: 2 7. 3! 2. 64: (mgTG/mg DNA) (8) 0.4 0.6 l.O 1.2 1.7 0. 5 3.7 D.B 5.2 0.7 2.5 D.3 2.7 0.2 6.6 0.3 
(5) (5) ( 5) ( 5) ( 5) ( 5) (5) (5) (5) (5) (4) ( 5) ( 5) ( 4) ( 4) ( 4) 
* * # # # # PL whole organ content 418 ! 28 419! 453! 454:!: 458:!: 562! 478! 4 79! 458: 573:!: 438! 615:!: 393! 617! 451:!: 764:!: 418! 746:!: 488:!: (lJmoles) (8) 33 40 40 28 26 22 46 35 35 17 42 30 41 27 55 29 36 48 
(5) (5) (2) (3) ( 5) ( 5) ( 5) ( 5) (5) ( 5) { 5) (5) (5) (5) (5) ( ~~ ) ( 5) (4) 
(*) # (#) # ¥ # * * PL 'cellular' content 12.2:!: D.6 13.5! 14.4! 14.9:!: 13. 7:!: 16 .D! 14.5! 14.8: l4.D! 16.8:!: 13.0:!: 17.5:!: 13. l:!: 15.9: 13. 3:!: 15. 9! 13 .D! 15.5! 12.7! (pmoles PL/mg DNA) (8) 0.4 0.5 0.5 0.7 0.2 D.3 0.5 D.6 l.O D.5 D.6 D.5 D.6 0. 5 D.9 D.2 D.8 D.21 
(5) (5) (2) ( 3) ( 5) ( 5) (5) ( 5) ( 5) (5) ( 5) ( 5) { 5) ( 5) ( 5) ('I) { 5) {4) 
# * * FFA whole organ content 8.7 :!: 1.2 7. l! 8.0! 6.2:!: 6.2! 8. 5 ~ 8.8:!: 9. 7: 9.5! 12.7:!: 8.3! 13. 9:!: 9.8:!: lD.6! 6.2! 12.2:!: 6. D! 14 .D:!: 8. 9 ~ {)Jmoles) (8) 1.5 1.2 D.7 1.4 D.B l.l l.l 0.8 2.0 1.3 2.0 1.0 0.6 l.D 2.0 0.3 1.3 1.4 
(5) (5) (2) ( 3) ( 5) ( 5) ( 5) ( 5) ( 5) ( 5) (5) ( 5) ( 5) (5) ( 5) ( 4) ( 5) (4) 
* FFA 'cellular' content 0.25! O.D3 0.24! D.26! - - 0.23! 0.27! D.3l:!: 0.29! 0.37: 0.24! 0. 39! 0.33! D.28! 0. 18~ 0.25! 0.19: 0.29! 0.23:!: (JJ!nOles FFA/mg DNA) (8) O.D6 D.03 D.03 D.04 O.D2 0.03 0.06 0.03 D.D5 D.D2 D.D2 D.D2 O.D4 D.Ol 0.01 0.01 
(5) ( 5) (5) ( 5) ( 5) ( 5) ( 5) ( 5) ( 5) ( 5) ( 5) ( 5) ( 5) (4) ( 5) ( 4) 
# ¥ ~ * ¥ ¥ Liver weight (as% 3.3D! 0.10 3.44! 3.4D! 3.68:!: 3. 78! 4. 18! 3. 78:!: 3.82:!: 3. 12! 4. 18! 3. 22:!: 4.48! 3. 16:!: 4. 56! 3. 58! 5. 48! 3. 18! 5. 20! 3. 18! 
body wt.) (8) 0.06 0. ll 0.12 0.06 0.06 0.24 0. 16 O.DB 0. 12 0.05 0.07 0. 17 0.28 0. 10 0.22 0. 08 0.27 D. 15 
(5) ( 5) ( 5) ( 4) ( 4) ( 4) ( 5) ( 5) ( 4) ( 5) (5) ( 5) ( 5) ( 5) ( 5) ( 4) ( 5) ( 4) 
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Figure 3.4 
The effect of 17~-oestradiol in propane-1,2-diol, or of propane-
1,2-diol alone, on the liver content of triacylglycerol at 
varying times after injections. 
Consult the legend of Table 3.4 for details of experimental 
procedures. 
• values for untreated birds. 
0 values for oestrogen-treated birds. 
• values for control birds, injected with 
propane-1,2-diol. 
(a) Triacylglycerol (TG) content of liver (mg TG/liver) 
~ (b) Triacylglycerol (TG) content of liver (mg TG/DNA) 
A 
The results are expressed as means (~ S.E.M.) of 2 - 8 
observations. 
Those values plotted without error bars indicate that the S.E.M. 
was not sufficiently large to represent on the axes used. 
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for oestrogen-treated and control birds was statistically significant 
(p <.0.05), with the exception of the vAlues obtained at 11 hours 
after injection when the amount of phospholipid per liver declined in 
the oestrogen-treated chicks. The maximum value was observed at 
34 hours after injection of oestrogen, when the total phospholipid 
content of chick liver was 1.8-fold greater than the control value. 
When the levels of phospholipid in liver tissue were expressed on a 
'cellular' basis (~mol. phospholipid/mg DNA) the mean values for 
oestrogen-treated birds were greater than those for control birds 
during the period 4- 44 hours after injection (Fig. 3.5b). However, 
those differences at 4 hours and 11 hours after injection were not 
significant. A maximum amount of phospholipid/mg DNA was apparent 
20 hours after oestrogen treatment, being 1.3-fold greater than the 
corresponding control value (p<O.OOl). 
(c) Free fatty acids 
The mean level of free fatty acids in liver, expres3ed both on a whole 
organ basis (~mol FFA/liver; Fig. 3.6a) and on a cellular basis 
(;mol FFA/mg DNA; Fig. 3.6b) was greater than the corresponding 
control values from 11 - 44 hours after oestrogen treatment. 
Significant increases (p<0.05), however, were first observed after 
26 hours when the oestrogen-treated levels of FFA/liver and FFA/mg DNA 
were 1.69-fold and 1.55-fold greater than the corresponding control 
values, respectively. Significant increases in the amount of FFA/ 
liver were also observed 36 hours (p<O.OS) and 44 hours (p <0.05) 
after oestrogen treatment, values being 2.04-fold and 1.58-fold 
greater than the corresponding control values, respectively (Fig. 3.6a). 
The elvation in the amount of FFA/mg DNA was only significant at 
26 hours (p<0.05) and 44 hours (p<0.05) after oestrogen treatment, 
the value at the latter time-point being 1.26-fold greater than the 
corresponding control value. 
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Figure 3.5 
The effect of 17~-oestradiol in propane-1,2-diol, or of propane-
1,2-diol alone, on the liver content of phospholipid at varying 
times after injection. 
Consult the legend of Table 3.4 for details of experimental 
procedures. 
~ values for untreated birds. 
0 values for oestrogen-treated birds. 
• values for control birds, injected with 
propane-1,2-diol. 
(a) The phospholipid (PL) content of liver (~mol PL/liver) 
(b) The phospholipid (PL) content of liver (~mol PL/mg DNA) 
The results are expressed as means (! S.E.M.) of 2- 8 
observations. 
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Figure 3.6 
The effect of 17~-oestradiol in propane-1,2-diol, or of propane-
1,2-diol alone, on the liver content of free fatty acids at 
varying times after injection. 
Consult the legend of Table 3.4 for details of experimental 
procedures. 
A values for untreated birds. 
0 values for oestrogen-treated birds. 
• values for control birds, injected with 
propane-1,2-diol. 
(a) Free fatty acid (FFA) content of liver (~mol FFA/liver) 
(b) Free fatty acid (FFA) content of liver (~mol FFA/mg DNA) 
The results are expressed as means (: S.E.M.) of 2- 8 
observations. 
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Variations in the liver weight (as% of body wt.) following oestrogen 
treRtmert are presented in Table 3.4. The changes are similar to 
those reported and discussed in Chapter 2. 
4. Changes in the fatty acid composition of plasma and liver lipids 
following oestrogen treatment 
Gas-liquid chromatographic analysis of the fatty acid composition of 
lipid in the diet revealed that the predominant fatty acid was 16:0 
(palmitate) (Fig. 3.7a). Other major constituents were 18:1 (oleate), 
18:2 (linoleate) and 18:0 (stearate). 
(a) Liver triacylglycerols 
Changes in the molar ratio of unsaturated:saturated fatty acids in 
liver triacylglycerols are presented in Table 3.5. This molar ratio 
in untreated. animals was 1.13 and, after oestrogen treatment, it 
became significantly greater than the control values at 24 hours 
(p<O.OOl), 37 hours (p<0.05) and 48 hours (p<0.05). In general, 
the control values were similar to the untreated value, except at 
24 hours after injection, when the control value was significantly 
lower (p< 0.01) than the untreated value. (Table 3.5). 
Details of the fatty acid composition of liver triacylglycerols are 
shown in Table 3.6. In untreated animals, the predominant fatty acids 
were 18:1 and 16:0, while 18:0, 18:2 and 16:1 (palmitoleate) 
contributed to a lesser extent (Fig. 3.7b). After oestrogen treatment, 
a number of marked changes occurred in the fatty acid composition of 
liver triacylglycerols (Fig. 3.8). At 6 hours after injection, 
the percentage contribution of 16:0 for oestrogen-treated birds was 
significantly greater than that for control birds (p<0.05). 
Furthermore, values for oestrogen-treated and control birds at 6 hours 
were higher than the corresponding value in untreated birds although 
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Table 3.5 
The effect of a single dose of 17~-oestradiol in propane-1,2-diol, or of propane-1,2-diol only, on the 
molar ratio of unsaturated:saturated fatty acids in liver triacylglycerol, plasma VLDL~triacylglycerol 
and plasma VLDL-phospholipid at varying times after injection. 
Each oestrogen-treated bird received a single intramuscular injection of 0.75 mg 17~-oestradiol in 
propane-1,2-diol/100 g body weight. Control birds received an equivalent volume of propane-1,2-diol 
only. At the indicated times after injection birds were sacrificed and VLDL isolated from the 
collected plasma, as described in the Methods section. Following lipid extraction procedures, 
triacylglycerol from the liver and VLDL, and phospholipid from the VLDL were subjected to g. l.c. analysis. 
Consult the Methods section for full details of the experimental procedures employed. Mean molar ratios 
were calculated for each lipid class from the percentage fatty acid compositions of individual birds. 
Birds were aged 3~ - 5 weeks. 
OE = values for oestrogen-treated birds. 
C = values for control birds. 
Values are the means (~ S.E.M.) of 3- 10 birds; the number of birds involved in each group is given in 
parentheses. 
Data were analysed statistically by Student's 't' test. Levels of statistical significance indicated 
without parentheses are for oestrogen-treated values with respect to control values. Levels of 
statistical significance indicated within parentheses are for that particular value with respect to the 
corresponding untreated value. 
* significant at p <0.05 
# significant at p <0.01 
¥ significant at p <0.001 For body weights consult Table 3.3. 
Time after injection (h) 
6 13 24 37 4:3 
0 OE c OE c OE c OE c OE c 
¥(*) ( #) 
* *(#) Molar ratio in liver 1. 13 1.14 1.28 l. 31 l. 14 1. 55 0.52 1.41 l. 18 l. 61 l. ('6 
triacylglycerol 
:to. 12 !0.07 !0.05 !o. 10 !0.04 !0.03 !0.03 !0.04 !0.07 !o. 07 !O. 12 
( 5) (6) (6) (6) (6) (6) (6) (6) (6) ( 5) ( 5) 
(#) (*) ( *) 
Molar ratio in VLDL- 1.22 1. 36 l. 57 1. 50 1. 32 1.26 l. 26 l. 38 l. 28 1. 34 ].5.1 
triacylglycerol 
!0.06 !0.06 !0.08 !0.07 !0.07 !0. 12 !O. 14 ~:o. 11 !0.09 !O. 10 !0.07 
(8) (5) ( 4) (5) (6) ( 4) (6) ( 5) ( 5) (6) ( 5) 
Molar ratio in VLDL- 1.06 1.06 1.09 l. 18 l. 20 1.04 1.06 l. 11 l. 15 1.09 l. 12 
phospholipid !0.05 !0.03 !0.01 !0.05 !O .03 !0.06 !0.02 !0.09 !0.04 ~0.03 :o.o6 
( 10) ( 5) (3) (6) (6) ( 5) (7) (6) (6) ( 4) ( 5) 
---------- ·- --------- ------ --------- -- -- --
-95-
Figure 3.7 
The fatty acid composition of lipid in the chick diet, and of 
liver triacylglycerol (liver-TG), VLDL-triacylglycerol (VLDL-TG) 
and VLDL-phospholipid (VLDL-PL) in untreated chicks. 
(a) Fatty acid composition of the chick diet(%, w/w). 
Lipid was extracted from the chick diet by the procedure of 
Bligh & Oyer (1959), as described in the Methods section. The 
lipid extract was subjected to methanolysis and the resultant 
fatty acid methyl esters analysed by gas-liquid chromatography, 
as described in the Methods section. 
Values are expressed as the means of 3 observations. 
(b) Fatty acid composition of liver triacylglycerol Cliver-TG; 
%, w/w). 
(c) Fatty acid composition of VLDL-triacylglycerol (VLDL-TG; 
%, w/w). 
(d) Fatty acid composition of VLDL-phospholipid (VLDL-PL; % w/w) 
Consult the legend of Table 3.5 for details of the experimental 
procedures employed in the analysis of the fatty acid composition 
of liver-TG, VLDL-TG and VLDL-PL from untreated birds. 
Values are expressed as the means of 5 - 10 observations. 
Fatty acids are numbered as fallows: 
1 2 3 4 5 6 7 8 9 
14:0 16:0 16: 1 18:0 18: 1 18:2 X18:3 0(18: 3 20:0 
10 11 12 13 14 15 16 17 
20: 1 20:2 20:3 20:4 22:0 22:4 22:6 24:0 
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only the difference between oestrogen-treated and untreated birds was 
significant (p<0,05)_ .At 24 hours after injection, the percentage 
contribution of 16:0 for oestrogen-treated birds was significantly 
lower than control birds (p<O.Ol). This may have been caused by the 
very high value for the control birds at this time (Fig. 3.8a), and 
further studies are required to determine whether this is a reproducible 
effect. 
At 24 hours after injection the percentage contribution of 18:0 for 
oestrogen-treated birds was significantly lower than control birds 
(p<O.Ol) and at this time, the control value was significantly 
higher (p<.O.Ol) than the corresponding untreated value (Fig. 3.8b). 
Similarly, the control values of 18:0 were significantly greater than 
the corresponding untreated value, at 13 hours (p<0.05) and 37 hours 
(p< 0.05) after injection. However, no significant differences 
were observed between the 18:0 values for oestrogen-treated and 
control birds at times other than 24 hours after injection. 
fhe levels of the principal saturated fatty acids, 16:0 and 18:0, and 
of the minor saturated fatty acid, 14:0 (Table 3.6), therefore, were 
all significantly increased in 24 hour control birds compared to all 
other control, treated and untreated values. 
The percentage contribution of 18:1 was significantly greater in 
oestrogen-treated birds than control birds at 13 hours (p<O.Ol), 
24 hours (p<O.OOl), 37 hours (p<0.05) and 48 hours (p<0.05) after 
injection (Fig. 3.8c). At 24 hours after oestrogen treatment, the 
extent of the increase in the percentage contribution of 18:1 in 
hormone-treated birds was enhanced by a significant decrease in the 
percentage contribution in control birds, relative to the untreated 
value (p<O.OOl). 
Oestrogen-treated values of 18:2 were significantly greater than the 
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Table 3.6 
The effect of a single dose of 17P-oestradiol (0.75 mg in propane-1,2-diol/100 g body wt.), or of 
propane-1,2-diol only,on the fatty acid composition of liver triacylglycerol at varying times after 
injection. 
Consult the legend of Table 3.5 for experimental details. 
Values are the means (~ S.E.M.) of 5 or 6 birds; consult Table 3.5 for the number of birds involved 
in each group. 
OE = values for oestrogen-treated birds 
C = values for control birds. 
Data were analysed statistically by Student's 't' test. Levels of statistical significance indicated 
without parentheses are for oestrogen-treated values with respect to corresponding control values. 
Levels of statistical significance indicated within parentheses are for that particular value with 
respect to the corresponding untreated value. 
* significant at p <0.05 
# significant at p <0.01 
¥ significant at p < 0. 00 1 
For body weights, consult Table 3.3. 
Some of these data are presented graphically in Fig. 3.7b and Fig. 3.8. 
Time after injection (h) 
Fatty 0 6 13 24 37 413 acid 
(j;,w/w DE c DE c DE c DE c DE c -·----.-
# 
* (*) ( *) (*) (*) 14:0 0. 8 ! 0. 1 0.8 ! 0.1 0.6 ~ 0.1 D.9 ~ 0.1 0. 5 ! 0. 1 0.4 ! D. 1 4.5!1.1 0. 5 ~ 0.1 0. 7 ~ 0. 1 0. 3 ~ 0. 1 0.4 ~ 0. 1 
* (*) # ( *) 16:0 32. 1 :.: 2. 5 39.0 ! 1.2 35.3 ! 0. 5 33.1! 1.3 33.4 ~ 1. 3 3D. 1 ! D. 8 43.1 ~ 2.5 31.1 ~ D.6 33.3 ! 1.4 27.3!1.1 32.0! 3.1 
16: 1 6.0 ! 1.0 7.8! D.3 7.7 !0.6 5.7 ! D.5 5.5 ~ 0.3 5.8 ~ 0.5 5.5 ~ 0.2 5.9 ~ D.5 5.0 ! D.4 6 1 :': 0. 7 7.2 :': 1.9 
(*) (*) # ( #) (*) 18:0 6.8 ~ 1.0 7.2!D.4 7.2 :!: 0.6 9.6 ! D.8 8. 5 :!: 0.4 8.0 :!: U.5 17.8 :!: 2.1 8.7 ~ D.6 9.0 ! D.7 7.8 ~ 0.6 7.2! 0.7 
(*) # (*) ¥ (*) ( ¥) * (*) ,, 18: 1 35.4 ~ 1. 6 39.2 ! l.D 4D. 1 ! l.D 42.3 ! 2.D 34.4 :!: l. 0 4D. 7 ! 1. 1 19.5 ! 1.9 41.3 ! 1.4 36.D! 1.5 39.8 ! 1. 1 34.7! 1.8 
# ¥ (*) 18:2 6.0~1.1 4.4 ! D.5 5.4 ! D.7 6.7 ! D.6 4.4 ! 0.3 B. 1 ~ D. 5 2.4 ! D.2 7.4~D.7 6. 1 :!: 0.4 6.2 ~ ).8 7.4! 0.4 
~18: 3 0. 2 :!: 0. 1 0.03 :!: 0. 1 0.04 :!: 0. 1 - 0.9 ~ 0.4 D.4 ~ 0.2 0.4 :!: D.2 0.2 :!: 0. 1 0.5 :!: 0.2 0.8 ~ J.Z 0.4 :!: 0.3 
o( 18:3 0. 1 ! 0. 1 -
- - - 0. 1 ! 0. 1 - 0.1 ! 0. 1 
* # 
20:0 1.0 ! U.6 0. 03 ! 0. 1 0. 4 ! 0. 1 0.02 ! 0. 1 1.1 :!: 0.2 0.1 :!: 0.1 - 0. 2 ~ 0.1 0.4 ~ 0.2 0.6 :': I]. 3 Ll. 6 :': 0. 2 
(*) (*) 
20: 1 0. 6 ~ 0. 1 0. 2 ! 0.1 0. 2 ~ 0. 1 0.6 ~ 0.2 1.1~0.5 0.9 ~ 0.5 0.2 ! 0.2 0. 5 ~ 0.1 0.6 :!: 0.3 0. 7 ~ ll. 3 0.9 : 0.4 
20:2 
- - - 0.1 ! 0. 1 0.5 ~ 0.3 -
- -
I 20:3 0. 1 ! 0. 1 0. 1 ~ 0.1 0.03 :!: 0. 1 0.1 :!: 0. 1 0. 3 ~ 0. 1 0. 3 :!: 0. 1 0. 1 :!: 0.1 0.3 ! 0. 1 0.2 ~ 0. 1 0.3 :': 0.2 ll. 4 ·.~ Ll. z 
* 
* (') 20:4 3.2 :': 0.9 1.1 :': 0.3 2.4! D.4 0.8 :': 0.3 4.3:!: 1.2 4.3 ~ 0.9 5. 5 ! 0.1 2.3 :': 0.2 3.9 ! 1.2 8.4 :!: ;>. 1 6.9 ~ 1.3 
* 
22:0 2.6 :': 1.6 - 0.1 :!: 0.1 - 1.1!0.4 0. 1 ! 0. 1 0. 2 :': 0. 1 0.3 :': 0.3 U.2! 0.2 0.5 + 0.5 0.6 ~ 0.3 
22: 4 0. 1 :!: 0. 1 -
- - 0.5! 0.3 - 0.1 :': 0.1 0.3 ~ 0.2 0. 1 ~ 0. 1 0. 2 + 0. 1 
22:6 
- - - - - - -
-
24:0 4.9 ! 3.2 0. 1 ! 0.1 0. 3 :!: 0.2 
# 
0.1 ~ 0.1 2.4 ~ 0.5 0.5 ~ 0.2 0.5 ~ 0.4 0. 9 :!: 0. 3 1.0:!: 0.4 1.9 ~ 1.0 1.1 + 0.5 
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Figure 3.8 
The effect of 17~-oestradiol in propane-1,2-diol, or of propane-
1,2-diol alone, on the proportions of palmitate (16:0), stearate 
(18:0), oleate (18:1), and linoleate (18:2) in liver 
triacylglycerol, at varying times after injection. 
Consult the legend of Table 3.5 for details of experimental 
procedures. 
• values for untreated birds. 
0 values for oestrogen-treated birds. 
• values for control birds, injected with 
propane-1,2-diol. 
(a) The proportion of 16:0 in liver triacylglycerol (%, w/w). 
(b) The proportion of 18:0 in liver triacylglycerol (%, w/w). 
The results are expressed as the means (: S.E.M.) of 5 or 6 
observations. 
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Fig. 3.8 - continued 
• value for untreated birds. 
0 values for oestrogen-treated birds. 
• values for control birds, injected with 
propane-1,2-diol. 
(c) The proportion of 18:1 in liver triacylglycerol (%, w/w). 
(d) The proportion of 18:2 in liver triacylglycerol (%. w/w). 
The results are expressed as the means (~ S.E.M.) of 5 or 6 
observations. 
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corresponding control values at 13 hours (p cO.Ol) and 24 hours 
(p <0.01) after injection (Fig. 3.8d), partially because of decreases 
in control values at this time; at 24 hours, the 18:2 control valuewas 
significantly lower than the untreated value (p <0.05). From 
0 - 24 hours after injection, there was a consistent decline in the 
control values of 18:2, followed by a recovery at 37 hours and 48 hours. 
Therefore, the levels of the unsaturated fatty acids, 18:1 and 18:2, 
were significantly decreased in 24 hour control birds compared to all 
other control, treated and untreated values. 
The major effect of oestrogen treatment on the fatty acid composition 
of liver triacylglycerol was to promote a substantial elevation in 
the molar ratio of unsaturated:saturated fatty acids from 13 - 48 
hours after injection (Table 3.5). This was caused largely by an 
elevation of the levels of 18:1 and 18:2 accompanied by a decline in 
the levels of 16:0 and 18:0 (Fig. 3.8). 
(b) VLDL-triacylglycerols 
Changes in ,the molar ratio of unsaturated: saturated fatty acids in 
VLDL-triacy1glycerols are presented in Table 3.5. The ratio in 
untreated animals was 1.22 and after oestrogen treatment there were 
no significant differences between hormone-treated and control birds. 
Details of the fatty acid composition of VLDL-triacylglycerols are 
shown in Table 3.7. In untreated birds, the predominant fatty acids 
were 16:0, 18:1, 18:2 and 18:0, in decreasing order of percentage 
contribution (Fig. 3.7c). After oestrogen treatment, no changes were 
observed in the percentage contribution of 16:0 (Fig. 3.9a) during 
the 48 hour post-injection period, whereas alterations were observed 
in other fatty acids. 
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At 6 hours after injection, the level of 18:0 in oestrogen-treated 
and control birds were diminished in relation to the untreated va1ue 
(Fig. 3.9b), the difference between the untreated and oestrogen-
treated values being significant (p<O.Ol). However, at no time 
after injection were there any significant differences between 
oestrogen-treated and control values of 18:0. 
Oestrogen-treated values of 18:1 were significantly greater than the 
corresponding control values at 13 hours (p<O.OOl), 24 hours (p<0.05) 
and 37 hours (p< 0.01) after injection (Fig.3.9c). At 48 hours after 
injection, the oestrogen-treated value for 18:1 was greater than the 
control value, although the difference was not significant. 
Conversely, oestrogen treatment caused a significant decrease in the 
percentage contribution of 18:2 in VLDL-triacylglycerol at 13 hours 
(p<O.Ol), 24 hours (p<0.05), 37 hours (p<O.Ol) and 48 hours (p<0.001) 
after injection, when compared to controls (Fig. 3.9d). Similarly, 
the percentage contribution of the minor component, 18:3 (<:<-linolenate), 
was significantly lower than control values at 24 hours (p<0.05) and 
48 hours (p< 0.05) after oestrogen treatment (Table 3.7). 
Therefore, the major effects of oestrogen treatment on the fatty acid 
composition of VLDL-triacylglycerol were to cause an elevation in the 
level of 18:1 from 13- 48 hours after injection accompanied by a 
decrease in the levels of 18:2 (Fig. 3.9). 
(c) VLDL-phospholipids 
Changes in the molar ratio of unsaturated:saturated fatty acids in 
VLDL-phospholipids are presented in Table 3.5. This molar ratio in 
untreated birds was 1.06 and throughout the time-course of the study, 
there were no significant differences between the molar ratios of 
-101-
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Table 3.7 
The effect of a single dose of 17p-oestradiol (0.75 mg in propane-1,2-diol/100 g body wt.), or of 
propane-1,2-diol only, on the fatty acid composition of VLDL-triacylglycerol at varying times after 
injection, 
Consult the legend of Table 3.5 for experimental details. 
Values are the means(~ S.E.M.) of 4- 8 birds; consult Table 3.5 for the number of birds involved in 
each group. 
OE = values for oestrogen-treated birds. 
C = values for control birds. 
Data were analysed statistically by Student's 't' test. Levels of statistical significance indicated 
without parentheses are for oestrogen-treated values with respect to corresponding control values. 
Levels of statistical significance indicated within parentheses are for that particular value with 
respect to the corresponding untreated value. 
* significant at p< 0.05 
# significant at p< 0.01 
¥ significant at p < 0. 001 
For body weights, consult Table 3.3. 
Some of these data are presented graphically in Fig. 3.7c and Fig. 3.9. 
lime after injection (h) 
Fatty 
6 13 acid 0 
(%,w/w) OE c DE 
24 37 q~ 
c DE c DE c DE c 
---·--
14:0 0.6 :! 0.2 0.7 ± 0.2 0. 3 :!: 0.1 0.4 :!: 0.1 . 1 ! 0.4 
(*} 
0.1 :! 0.1 2.6 :! 1.8 0.3 :! D.2 0.8 :! 0.4 l.D :!: D.2 D.8 :!: 0.1 
16:0 27.8! 1.5 26.2 :!: 2.9 23.8 ~ 3.2 28.6 ! 1.4 30 .4 ! D.5 29.3 ! l. 8 27.2:!: D.5 28.6 ! l. 5 3D.3 :!: 1.0 26.3 :!: 1.0 26.2 ! l. 1 
16: 1 4.3 ! 0.7 5.6 :!: 0.8 4.9 ! 0.6 5.6 ! 0.2 4 .9 ! D.2 6.2 :!: 1.6 3.7! D.4 5.4 ! D.6 5.D :!: 0.5 5.7 :!: 0.5 4.7 :!: 0.4 
( #) 
IB:D 9.4 ! 0.6 6.8 ! 0.3 7.7:!: D.9 8.7 ! D.2 8 .2 :!: D.5 11.0:!: 0.4 9.2 :!: 0.9 11.6!1.1 8.8 :!: 0.6 9. 9 :!: 1. 2 9.5 :!: 0.9 
¥ (¥) * (*) # ( #) (*) 
18: I 2S.5! 2.1 28. 1 ! 3. 5 28.9 :!: 2.3 38.0 ~ 1.3 28 .4 :!: 1.2 35.3 :!: 2.4 25.4 ! 1.8 35.9 :!: l. 7 27.3:!:1.1 34.3 :!: 3.0 29.2 :!: 0.8 
# (*) * ( ¥) # (¥) ¥ ( ¥} 
18:2 14.6 ! I. 3 13.7 ! 1.7 14.7 ! 1.4 11.4:!: 0.8 14 .9 :!: 0.6 6.9 :!: 0.7 17.2 ! 3.4 7.6! D.7 17.4:!: 1.3 7 .. 2 ! 0.8 16.4 :!: 1.0 
~18:3 D.3 ! 0.2 1.2 ! 0.8 6.4 :!: D.4 0.1 ! 0.1 0 .2 :!: 0. 1 0.2 :!: 0.2 D.2 ! 0.2 0.9 :!: 0.7 0. I :!: 0. I 0. 7 ! 0.5 0.5 ! 0.3 
* .. 
o\18: 3 0.4 ! 0.2 0.4 ! 0.2 0.4 :!: 0.1 D.2 :!: 0.1 0 . 5 :!: D. I 0.8 ! 0.2 0.6 ! D.3 0. 5 :!: 0. I 
20:0 1. 2 :!: 0.4 D.7 :!: D.2 1.2 :!: D.5 1.0 ! 0.3 .8 ! 0.6 0.7 ! 0.3 1.9 ! 0.6 1.2:!:0.7 2.4 :!: 0.9 2.8 :!: 1.3 2.0 :!: 0.4 
20: 1 1.2 : 0.3 2.0 ! 0.9 1.7 :!: 0.8 2. 7 :!: 2. 2 D .7 ! 0.2 0.7 :!: 0.2 0.7 :!: 0.3 0.4 ! 0.4 0.5 ! 0.2 0.9 :!: 0.7 1.2:!:0.3 
20:2 0. 1 :!: 0. 1 0.1 :!: 0. I D. I :!: 0.1 0.4 :!: 0.4 0.7 :!: 0.7 0.6 :!: 0.6 0. 04 :!: 0. 1 
20:3 1.2 ~ 0.4 2.5 :!: 1.4 1.7 : 1.5 0.2 :!: 0.1 0 . 3 ! 0. 2 1.4 :!: 1.2 0.5 ! 0.3 1.5 :!: 1.0 0. z :!: 0. 2 0.9! 0.7 U.9 : 0.3 
(*) 
20:4 3.8 :!: 0. 7 I. 1 :!: 0. 5 2.5 :!: 1.3 3. 2 :!: 0.8 3 .8 :!: 0.8 2.5!1.1 4. 3 :!: 0. 9 4.6 :!: 1.3 4. 6 :!: 0.8 5. I :!: .. I 5. 6 :: 0. 8 
22:0 2.4 :!: 0. 9 4. 2 :!: 2. 5 2.7:!: 1.4 1.4 :!: 1.3 0 . 7 -~ 0. 4 1.6 :!: 1.0 1.2 :!: 0.5 0. 7 :!: D. 5 1.0 :!: 0.6 I . 2 :!: (I. 7 0. 6 .,_ 0. 3 
(*) 
22:4 2.3 :!: 0.8 2. 2 :!: l. 1 1.9 :!: 0.9 0.6 :!: 0.4 .3 :!: 1.4 1.6 :!: 1 .2 l .D :!: 0.6 0.6 :!: D.6 0. 3 :!: D .2 2. I :!: C. 7 l. 1 ': 0.6 
22:6 0.1 :!: 0.1 - 0 .3 :!: 0.2 0. 4 :!: D .4 
(#) 
24:0 3.8 ~ 0.9 4.0 :!: 1.3 3.1 :!: 1.2 0.2 :!: 0.) 
( *) (#) ( *) (*) 
. l :!: D. 4 1.9 :!: 1.9 3. l :!: I. 4 0. 9 :!: D. 4 2.0 ! 0.9 0. 9 !: 0. 3 
-~-
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Figure 3.9 
The effects of 17~-oestradio1 in propane-1,2-diol, or of propane-
1,2-diol alone, on the proportions of palmitate (16:0), stearate 
(18:0), oleate (18:1) and 1ino1eate (18:2), in plasma VLDL-
triacylglycerol, at varying times after injection. 
Consult the legend of Table 3.5 for details of experimental 
procedures. 
• values for untreated birds. 
0 values for oestrogen-treated birds. 
• values for control birds, injected with 
propane-1,2-diol. 
(a) The proportions of 16:0 in VLDL-triacylglycerol (%, w/w). 
(b) The proportions of 18:0 in VLDL-triacylglycerol (%, w/w). 
The results are expressed as the means (~ S.E.M.) of 4- 8 
observations. 
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Fig. 3.9/continued 
• values for untreated birds. 
0 values for oestrogen-treated birds. 
• values for control birds, injected with 
propane-1,2-diol. 
(c) The proportion of 18:1 in VLDL-triacylglycerol (%, w/w). 
(d) The proportion of 18:2 in VLDL-triacylglycerol (%, w/w). 
The results are expressed as the means (! S.E.M.) of 4- 8 
observations. 
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Details of the fatty acid composition of VLDL-phospholipids are shown 
in Table 3.8. In untreated birds, the predominant fatty acids, in 
order of percentage contribution, were 16:0, 20:4 (arachidonate), 
18:0, 18:2 and 18:1 (Fig. 3.7d). After oestrogen treatment, a number 
of marked changes occurred in the fatty acid composition of VLDL-
phospholipids (Fig. 3. 10). Oestrogen-treated values of 16:0 were 
significantly greater than the corresponding control values at 13 
hours (p<O.Ol), 24 hours (p<0.05) and 37 hours (p<O.Ol) after 
injection (Fig. 3.10a). 
The injection of propane-1,2-diol into control birds caused a 
sustained decrease in the percentage contribution of 18:0 in VLDL-
phospholipid, when compared to untreated birds (Fig. 3. lOb). In 
addition, the administration of oestrogen caused a further decrease in 
18:0 levels at 24 hours and 37 hours after injection. The decrease in 
18:0 levels at 24 hours, 37 hours and 48 hours after hormone treatment 
was not significant with respect to control birds, but it was 
significant (p<0.05) with respect to untreated birds. 
Following oestrogen treatment there were significant increases, with 
respect to controls, in the percentage contribution of 18:1 at 13-
48 hours (p<O.OS) after injection (Fig. 3.10c). 
The administration of oestrogen or propane-1,2-diol caused a transient 
increase in the percentage contribution of 18:2 in VLDL-phospho-
lipids, when compared to untreated birds (Fig. 3. 10d). The highest 
level of 18:2 was observed at 6 hours after injection, then the level 
decreased to that of the untreated value. Little difference was 
observed between the oestrogen-treated and control birds, except at 
37 hours after injection when the oestrogen-treated value was 
-105-
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Table 3.8 
The effect of a single dose of 17~-oestradiol (0.75 mg in propane-1,2-diol/100 g body wt.), or of 
propane-1,2-diol only, on the fatty acid comosition of VLDL-phospholipid at varying times after 
injections. 
Consult the legend of Table 3.5 for experimental details. 
Values are the means (! S.E.M.) of 3 - 10 birds; consult Table 3.5 for the number of birds involved in 
each group. 
OE = values for oestrogen-treated birds. 
C = values for control birds. 
Data were analysed statistically by Student's 't' test. Levels of statistical significance indicated 
without parentheses are for oestrogen-treated values with respect to corresponding control values. 
Levels of statistical significance indicated within parentheses are for that particular value with 
respect to the corresponding untreated value. 
*significant at p<0.05 
# significant at p<O.Ol 
¥ significant at p<O.OOl 
For body weights, consult Table 3.3. 
Some of these data are presented graphically in Fig. 3.7d and Fig. 3.10. 
Time after injection (h) 
Fatty 0 6 13 24 37 48 
acid DE c DE c DE c OE c DE c 
* 
(#) ( *) (¥) 
14:0 0. 1 ! 0.1 0.2 ! 0.2 0.2 ! 0.2 0.4 ! D.2 0.9 ! D.2 0. 3 ! 0.1 D. 2 ! 0.1 1.0 ~ 0.2 0. 7 :!: D. 1 0.3 ! 0.2 0. 5 ! 0. :; 
# * # 
16:D 19.6 ! 1.3 22.9 :!: 0.9 17.6! 1.5 22.0 :!: 1.3 16.6 :!: 0.7 22.5 :!: 2. 1 16.6 ! 0.7 21.2 ~ D.7 16.8 :!: D.7 19.1 :!: 1. 7 17.6:!: u 
16:1 3.0 ! 0.7 2.0 :!: 0.3 2.4 ! 0.7 2.1 :!: D.4 3. 7 :!: 0. 7 1.6 :!: 0.4 1.6 :!: D.4 4.D :!: 0.6 2.7 :!: 0.5 3.7 ! 0.9 4.0 :!: 1.£: 
(#) (¥) (") (*I 
18:0 17.8:!:0.9 17.4 :!: 1. 1 15.9 ! 0.9 15.5 :!: 1.0 14.9 :!: 1.4 12.3 :!: 1.2 15. 1 ! 0. 9 12. 1 :!: D.8 15 .D ! 1.0 12.7 :!: 1 .6 12.5:!: u 
* (#) * * (*) * 
18: 1 9.6 ! 0.9 13.0 ! 1.4 11.9! 1.8 14.7 :!: 1.2 10.5 ! 0.6 12.5 :!: 1.3 7.9! 0.4 15.1:!:1.8 9.3 ! 0.9 13.5 ! 1 4 9.1 ! O.E: 
(HI (*) * 
18:2 11.5 :!: 2.2 19.3 ! 0.9 17.8:!:1.1 17.1:!:1.7 13.5 :!: 1.2 11.4 :!: 1.6 14.5 :!: 0.6 11.8 :!: 0.7 14.7 :!: 1.0 10.4!12 13.1:!:2.4 
~ 18:3 1.5 :!: 0.8 0.1 ! 0. 1 0.5 ! 0.2 0.2 :!: 0.2 0.4 :!: 0.2 0.4 :!: 0.2 0.3 :!: 0.2 0.6! 0.3 0.6 ! 0.4 
.,(18: 3 0. 1 :!: 0. 1 D. 1 :!: D. 1 D.2 :!: D.2 D.2 ! 0.2 
H * (#) ( #) 
20:D 6.6 ! 1.8 6.9 ! 1.4 12.0:!: 2.0 6.4 ! 1.0 10.9 :!: 1.0 1D.4 :!: 0.9 13.6 ! D.9 9.6 ! 1.7 11.7:!: 1.6 10.3 ! 1. 5 12.9 :!: 0. 9 
20:1 2.8 :!: 1.6 0. 2 :!: 0. 1 0.2 ! 0. 1 0. 2 :!: 0. 1 1.3 :!: 1.3 0.4 :!: 0.2 0. 4 ! 0. 1 0.5 :!: 0.2 0.5 :!: 0.5 1.4:!: 0.1 
( *) ( *) 
20:2 1.9 :!: 0.7 1.3:!: 0.7 0.1 :!: 0.1 0.5 :!: 0.2 0.6 ! 0.3 1.3 :!: 0.9 0.7:!: 0.3 0.6 :!: D.2 0.5 :!: 0.2 D.B :!: 0.5 0.3 :!: 0.2 
* 
20:3 1.3 :!: 0.5 0. 9 ! 0.1 0. 5 ! 0. 1 0.7:!: 0.2 0.5 ! 0.3 1.0 ! 0.3 1.0 :!: 0.2 D.9 :!: 0.2 0. 9 :!: 0. 1 1. 1 :!: D. 1 0. 5 :!: 0. 1 
H (*I * (*) (*) 
2D:4 18.5 :!: 1.8 13.5:!: 1.7 18.5 ! 2.4 15.7! 1.5 24. 1 ! 1. 8 19.2 ! 1.5 23.9 ! l.D 20.5 ! 2.6 23.2 ! 1.3 19.7 ! 2.5 21.8! 2.1 
(*) (*) 
22:0 2.1 :!: 0.6 0.6 ! 0.3 1.0!0.1 0.4 ! 0.1 1.1!0.4 2.7 :!: l.:i 1.7:!: 0.3 3.4 ! 2.2 1.7!·0.2 2.7 :!: 0.6 1.8:!: 0.7 
(*) 
22:4 1.8! D.7 0.3:!: 0.3 0.5 ! 0.5 2.7 :!: 2.7 0.5 :!: 0.5 1.3 ! 0.8 0.7:!: 0.3 - 0.8 ! 0.6 1.1!0.5 1.4 ! 0.8 
22:6 0. 1 ! 0. 1 0. 2 ! 0. 1 0.3 ! 0.2 0.4 ! 0.2 0. 04 ! 0. 1 0. 1 ! 0. 1 0.4 :!: 0. 1 0. 3 ! 0.1 0. 2 :!: 0. 1 0.3 t 0.2 0.2 + 0.2 
24:0 1.0 :!: 0.4 0.6 :t 0. 3 1.3 :!: D.6 1.3 :t 1.2 1.0 :± 0.4 0.9 ! 0.5 1.5 !0.1 0.5 ! 0.2 0.8 :!: 0.3 2.9 : 1.2 2. 3 ! 1. 2 
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Figure 3.10 
The effect of 17~-oestradiol in propane-1,2-diol, or of propane-
1,2-diol alone, on the proportions of palmitate (16:0), stearate 
(18:0), oleate (18:1), linoleate (18:2) and arachidonate (20:4) 
in plasma VLDL-phospholipid, at varying times after injection. 
Consult the legend of Table 3.5 for details of experimental 
procedures. 
• values for untreated birds. 
0 values for oestrogen-treated birds. 
• values for control birds, injected with 
propane-1,2-diol. 
(a) The proportion of 16:0 in VLDL-phospholipid (%, w/w). 
(b) The proportion of 18:0 in VLDL-phospholipid (%, w/w). 
(c) The proportion of 18:1 in VLDL-phospholipid (%, w/w). 
The results are expressed as the means (~ S.E.M.) of 3- 10 
observations. 
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Fig. 3.10 /continued 
& values for untreated birds. 
0 values for oestrogen-treated birds. 
• values for control birds, injected with 
propane-1,2-diol. 
(d) The proportion of 18:2 in VLDL-phospholipid (%, w/w). 
(e) The proportion of 20:4 in VLDL-phospholipid (%, w/w). 
The results are expressed as the means (: S.E.M.) of 3 - 10 
observations. 
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significantly lovJer than the control value (p< 0.05). 
Oestrogen-treated values of 20:0 (arachidate) were significantly 
lower than the corresponding control values at 13 hours (p<O.Ol) 
and 24 hours (p< 0.05) after injection (Table 3.8). At these times, 
the control levels of 20:0 were greater than the untreated value, the 
difference at 24 hours being significant (p<O.Ol), and the 
oestrogen-treated and untreated values were similar. 
The changes in the levels of 20:4 (arachidonate) after oestrogen 
treatment were similar to those observed in 20:0 in that the oestrogen 
treated levels of 20:4 in VLDL-phospholipids were significantly lower 
than control values at 13 hours (p<O.Ol) and 24 hours (p<O.OS) after 
injection (Fig. 3. lOe). At these times, the control values were 
significantly greater than the untreated value and the oestrogen-
treated and untreated values were similar. 
In summary, therefore, the major effects of oestrogen treatment on 
the fatty acid composition of VLDL-phospholipid was to cause an 
elevation in the level of 16:0 from 13 - 37 hours after injection, 
accompanied by an elevation in the level of 18:1 from 13- 48 hours 
after injection. These major alterations occurred together with 
minor alterations in the levels of 18:0, 18:2 and 20:4 (Fig. 3. 10). 
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DISCUSSION 
1. Changes in lipid levels in plasma following oestrogen treatment 
In untreated birds, the mean concentration of plasma triacylglycerol 
was 126 mg/100 ml and this value is within the range of the rather 
variable levels measured by other workers. Kudzma et al, (1975, 1979) 
reported triaculglycerol levels of 56 - 89 mg/100 ml plasma and 
100 I 
37 mg/ml plasma in 850 - 1000 g chicks (sex undetermined) and A 
9 week old pullets, respectively. Hillyard et al. (1956) measured 
a value of 187 mg/100 ml plasma in 2 month-old male birds and Chan 
et al. (1977, 1978) recorded values of 150 mg/100 ml and 162 mg/100 ml 
plasma, respectively in 3 week-old male chicks. 
The mean plasma concentration of phospholipid in untreated birds in 
this study was 3.5 mM and this agrees with the value of 3 mM which 
was measured by Hillyard et al. (1956) in 2 month-old cockerels. 
Following oestrogen treatment, there was a concomitant increase in 
phospholipid and triacylglycerol levels in plasma (Fig. 3.2). 
Increases were observed in both parameters at the 4 hour time-point 
although significant increases over controls were not observed until 
7 hours after injection. Maximum levels of phospholipids and 
triacylglycerols were measured 48 hours after oestrogen treatment. 
The increase in triacylglycero1s was the greater, however, being a 
27-fold increase over the control value compared to the 4.8-fold 
increase in phospholipids at 48 hours after injection. The observed 
accumulation of these two lipid classes may be a reflection of an 
increase in the rate of their release into the plasma, from the liver 
and the gut, and/or a decrease in the rate of their removal from 
this compartment. The rate of accumulation of both lipid classes 
follows the same pattern, in that from 26 - 34 hours after injection 
there was a high rate of accumulation whereas after 34 hours, the 
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rate slowed dramatically. The similar profile of appearance of 
phospholipid and triacyigiyceroi suggests that similar mechanisms 
may be involved in the accumulation of these lipid classes in the 
plasma. 
Similar increases have been observed by other workers following 
oestrogen treatment of birds, although the responses were not 
directly comparable since the dose and nature of the oestrogen 
used, and the sex, age and species of the birds used were not 
the same in all studies. 
Kudzma et al. (1973), after administering diethylstilboestrol of 
varying doses (0. l, 1.0 and 5.0 mg/day) for 18 days to 5 day-old 
chicks (sex undetermined) observed dose-dependent increases in 
plasma triacylglycerol levels such that concentrations of 1839, 
10241 and 12371 mg/100 ml plasma were recorded for the 3 dose levels 
used, respectively, compared to a control value of 27 mg/lGO ml 
plasma. The maximum mean plasma triacylglycerol concentration 
measured in oestrogen-treated birds in the present study was 
2727 mg/100 ml plasma and this lies within the range of values 
measured by Kudzma et al. (1973). 
Hillyard et al. (1956), using 2 month-old cockerels and administering 
24 mg diethylstilboestrol at 2 month intervals, recorded plasma 
triacylglycerol and phospholipid concentrations of 8000 - 14000 mg/ 
100 ml plasma and 27.54 mM, respectively, when the birds were 8 
months old. 
Chan et al. (1977) administered 17~-oestradiol (1 mg) to 3 week-old 
male chicks and observed increases in plasma triacylglycerols within 
10 hours of injection reaching a maximum at 48 hours (1500 mg 
triacylglycerol/100 ml plasma) before returning to control levels at 
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72 hours after treatment. However, using a dose of 5 mg l?a-
oestradiol, Chan et al., (1978) observed a decrease in plasma 
triacylglycerol concentration at 3 and 6 hours after injection and 
a subsequent increase, reaching a maximum (2780 mg/100 ml plasma) at 
48 hours after injection. No such initial decrease was observed in 
the present study and this could be a reflection of the differing 
doses of 17~-oestradiol used in the two studies since Chan et al. 
(1978) also reported that the extent of the initial decrease was 
dose-dependent. 
Dashti et al. (1983) administered diethylstilboestrol (40 mg/kg 
body wt.) in corn oil to 19 day-old male turkeys and measured plasma 
lipid levels 24, 48 and 72 hours after treatment. Maximum responses 
in triacylglycerol and phospholipid concentrations were observed at 
48 hours after injection, the oestrogen-treated values being 55-fold 
and 3-fold greater than the control values, respectively. 
Kudzma et al. (1975) administered 4 daily doses of diethylstilboestrol 
(2.0 mg/day) to 850 - 1000 g domestic fowl (sex undetermined) and 
observed an increased plasma triacylglycerol concentration of 4000 -
7000 mg/100 ml plasma. In a separate study, Kudzma et al. (1979) 
administered a total of 50 mg diethylstilboestrol over 10 days to 
9 week-old pullets and observed an increased plasma triacylglycerol 
level of 7000 mg/100 ml plasma. 
The isolation of a VLDL fraction in the present study included those 
large VLDL particles (portomicrons) produced at the gut and containing 
lipids of dietary origin. However, the portomicron fraction has been 
shown to provide only a negligible contribution to the lipaemia in 
oestrogen-treated birds (Kudzma et al., 1973) and the lipaemia has 
been shown to develop when food is withheld (Lorenz, 1954). Therefore, 
in this study, the assumption was made that the VLDL fraction from 
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oestrogen-treated birds consisted mainly of endogenous lipid. 
In the present study, the concentrations of VLDL-triacylglycerol and 
VLDL-phospholipid in the plasma of untreated birds were 64 mg/100 ml 
plasma and 0.15 mM, respectively. Chan et al. (1976, 1977) and 
Jackson et al. (1978) observed untreated VLDL-triacylglycerol and 
--
VLDL-phospholipid levels of 75 mg/100 ml plasma and 0.08 mM, 
respectively, in the plasma of untreated 3 week-old male chicks. 
Kudzma et al. (1975, 1979), however, have reported somewhat lower 
plasma concentrations of VLDL-triacylglycerol in 850 g - 1000 g birds 
(sex undetermined) and 9 week-old pullets, values being 30 mg/100 ml 
and 15 mg/100 ml plasma, respectively. These lower values could well 
be explained by the differences in the sex and age of the birds used. 
By comparing the total plasma concentrations of triacylglycerol and 
phospholipid in untreated birds with the plasma concentrations of 
VLDL-triacylglycerol and VLDL-phospholipid in similar birds, it can 
be seen that 51% of plasma triacylglycerol and only 4.3% of plasma 
phospholipid is associated with the VLDL fraction. Kudzma et al. 
(1979) and Chan et al. (1977) have shown that 41% and approximately 
50% of plasma triacylglycerol, in untreated 9 week-old pullets and 
3 week-old cockerels, respectively, is associated with VLDL. Kruski 
& Narayan (1972) determined the chemical composition of lipoprotein 
fractions in immature male birds and found that phospholipid 
compromised 23% and 24% of LDL and HDL, respectively, whereas 19% of 
VLDL consisted of phospholipid. Kudzma et al. (1979) have shown 
that, in immature female birds, HDL comprises 92% of the total 
lipoprotein fraction, the rest being LDL and a very small amount of 
VLDL. Therefore, in the untreated state, the low proportion of total 
plasma phospholipid associated with VLDL (4.3%) in the present study, 
is probably a reflection of the fact that the bulk of the plasma 
phospholipid is associated with the large pool of HDL and, to a 
lesser extent, LDL particles. However, chemical analysis of VLDL and 
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HDL has revealed that HDL 1s only 2% triacylglycerol whereas VLDL 
are triacy1g1yceroi-r1cn, the triacyigiycerol content being 29% of 
the total, (Kruski & Narayan, 1972) and so the low quantity of VLDL 
particles, in the untreated state, contribute about half of the 
total plasma triacylglycerol content. 
Oestrogen treatment leads to increases in the plasma concentrations 
of VLDL-triacylglycerol and VLDL-phospholipid. However, a difference 
was observed in the time after injection when the increases became 
significant (Fig. 3.3). At 6 hours post-injection. the VLDL-
phospholipid concentration was significantly greater than the control, 
representing a 1.8-fold increase, whereas at the same time, the 
VLDL-triacylglycerol concentration was only 10% higher than the 
control value and the difference was not significant. At 13 hours 
post-injection, the VLDL-phospholipid and VLDL-triacylglycerol 
concentrations were 7.2-fold and 3.6-fold greater, respectively, than 
the corresponding control values, both increases being significant. 
This suggests that, in the initial stages, there is a non-coordinate 
increase in some VLDL components. It is interesting to note that 
Chan et al. (1978, 1980) have observed non-coordinate responses in 
the plasma of oestrogen-treated male chicks, an initial decrease in 
total plasma triacylglycerol concentration taking place when the 
concentration of plasma VLDL apoprotein was increasing. 
Both VLDL-triacylglycerol and VLDL-phospholipid concentrations were 
seen to increase in the post-injection period, maximum concentrations 
being attained at 48 hours for VLDL-phospholipid and at 37 hours for 
VLDL-triacylglycerol although this latter value was not significantly 
different from the 48 hour value. At all time-points after oestrogen 
treatment, the extent of the increase was greater for VLDL-
phospholipid than it was for VLDL-triacylglycerol, maximum stimulation 
representing a 97-fold and a 30-fold increase, respectively. 
Calculations of the ratio of VLDL-triacylglycerol:VLDL-phospholipid 
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reveal that at zero time this ratio was 425 whereas at 37 hours after 
injection the oestrogen-treated value was 186 compared ~o the control 
value of 397. These observations of the two time-courses suggest 
that in response to oestrogen there is (a) an increase in the number 
of VLDL particles in the plasma accounting for large increases in 
VLDL-lipids and (b) an early and consistent alteration in the 
composition of the VLDL such that the ratio of triacylglycerol: 
phospholipid decreases representing a specific enrichment of the 
phospholipid component. Sinee theVLDL fraction represents a continuum 
of particles, with respect to composition and density (Kudzma et al. 
1979), an alteration of the triacylglycerol:phospholipid ratio in the 
fraction might involve an alteration in the density distribution of 
particles. Chapman et al. (1977) have reported a decrease in the 
size of VLDL particles and an increase in LDL particle size has been 
observed by Chapman et al. (1977) and Hillyard et al. (1972) when 
hens come into lay. 
The increases in plasma VLDL components after oestrogen treatment are 
similar to those observed by other workers. Chan et al. (1977) 
reported increases in plasma VLDL-protein, -phospholipid, -cholesterol 
and -triacylglycerol within 5 hours of administering 17a-oestradiol 
(l mg) to young male chicks, reaching peak levels at 48 hours after 
injection before returning to control levels 68 hours after treatment. 
Similarly, Chan et a1. (1978, 1980) observed an increase in plasma 
apo-VLDL-II 6 hours after injecting 3 week-old cockerels with 178-
oestradiol (5 mg/kg body wt.) rising steeply thereafter to an 18-fold 
increase over the basal level, 48 hours after injection. 
By comparing the time-courses of VLDL-associated lipids with those 
total lipid levels in plasma it should be possible to gain an 
indication of the importance of the changes in VLDL levels and 
composition in the development of the lipaemia following oestrogen 
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treatment. However, it must be recognised that any conclusions would 
be tentative, at best, since determinations of whole plasma lipids 
and VLDL-lipids were performed on two different groups of birds 
and at slightly differing time-points after hormone treatment. Such 
a comparison reveals that, over the 48 hour period, of the increase 
in total plasma triacylglycerol, only up to approximately 60% is 
comprised of VLDL-triacylglycerol. This suggests that a sizeable 
part of the developing hypertriacylglycerolaemia is accounted for by 
a concomitant increase in the levels of HDL and/or LDL fractions. 
Kudzma et al.(l979) reoorted that treatment of 9 week-old pullets with 
--
a total of 50 mg diethylstilboestrol, over 10 days, caused a 400-fold 
rise in the concentration of VLDL and a 70-fold rise in LDL. HDL 
levels dramatically decreased from representing 92% of total 
lipoproteins to only 1% upon oestrogen treatment. It was reported 
that the LDL fraction, as well as increasing in quantity ~as measured 
by LDL-protein in plasma), had a greater proportion of associated 
triacylglycerol. Hence it seems likely that the femainder of the 
oestrogen-induced hypertriacylglycerolaemia observed in the present 
study, was caused by increased levels of LDL. It should be noted 
that, after oestrogen treatment the VLDL and LDL are compositionally 
similar, with respect to lipid and apoprotein content, and this has 
led to the suggestion that the two represent a single lipoprotein 
class in which the •LoL• fraction represents remnant particles 
produced by hydrolytic modification of VLDL (Kudzma et al., 1979) 
A comparison of the increases of plasma VLDL-phospholipid and total 
plasma phospholipid after oestrogen treatment shows that, over the 
48 hour post-injection period, the VLDL fraction accounts for an 
increasing percentage of the total. At zero-time, the VLDL-phospho-
lipid level represents 4.3% of the total plasma phospholipid level 
(mentioned earlier in the Discussion) whereas a comparison of the 
last time-points of the two studies (48 hours and 44 hours) indicates 
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a 68% contribution to the total plasma phospholipid level. Such an 
observation is consistent IAiit-h tho l~v-no ~orvo~"3rl'"\ .;""' Ur\1 1'"",, ...... 1,... "'""1• ...,,,'- 1\.A.I':::f'- \.A\...\..ol\;;\,.L . .;H:: Ill 1\UL IC:VCI~ 
observed by Kudzma et al. (1979) after oestrogen treatment of birds, 
an increase in the number of VLDL particles and an enrichment of 
these particles in phospholipid, relative to triacylglycerol, 
discussed earlier. 
Measurement of total free fatty acids in plasma of untreated birds 
gave a mean value of 0.34 mM, which compares well with values 
of 0.2 - 0.3 mM reported by previous investigators (Heald & Badman, 
1963; Heald & Rockledge, 1964; Annison, 1971; Kudzma et al., 1973). 
The only significant difference observed between total plasma free 
fatty acid levels in oestrogen-treated and control birds was at 2 
hours after injection (Fig. 3.2) when the oestrogen-treated value 
was similar to the untreated value and the control value was 
significantly higher than the untreated value. This suggests that 
a high control value was caused by the injection/handling procedure. 
Plasma free fatty acid levels have been shown to increase after 
handling immature chickens (Freeman & Manning, 1976), probably due 
to the release of free fatty acids from adipocytes under the 
influence of glucagon (Sitbon et al., 1980). Since oestrogen 
treatment did not evoke a similar increase after 2 hours, the 
treatment either overrides the release of free fatty acids from 
the adipocytes and/or causes the enhanced removal of free fatty acids 
from the circulation at this time-point. A similar significant 
decrease in plasma free fatty acids was observed by Pageaux et a1. 
(1981) 1 hour after injecting 16-day old female quail with 
oestradiol benzoate (0.2 mg/kg body wt.) although increased levels 
were observed in the subsequent 23 hour period. It was suggested 
that, at least in the early stages, oestrogen treatment leads to 
the removal of fatty acids by the liver from the circulation. 
The results of the present study, in which no significant increases 
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in plasma free fatty acid levels were observed after oestrogen 
treatment, do not agree with previous reports of increased levels 
in oestrogen-treated and laying birds. Plasma free fatty acid 
levels of 1.4 mM have been reported in laying birds (Heald & Badman, 
1963; Heald & Rockledge, 1964). Kudzma et al. (1973) administered 
0.5 mg diethylstilboestrol/day to young chicks (sex undetermined) 
for 6 days and observed significantly elevated plasma free fatty 
acid levels after the second daily dose. Thereafter, oestrogen-
treated birds exhibited free fatty acid levels similar to control 
birds, although both groups of birds had increasing free fatty acid 
levels throughout the six-day period. Hypertriacylglycerolaemia 
was apparent from 2 - 6 days in the experiment and it was suggested 
that the over-production of triacylglycerol by the liver was not 
dependent upon fatty acids arriving from extra-hepatic sources, since 
elevated free fatty acid levels appeared after the hypertriacyl-
glycerolaemia. In the present study, plasma free fatty acid levels 
were not elevated before triacylglycerol levels rose and, therefore, 
it could be argued that the hypertriacylglycerolaemia may not be 
dependent on hepatic lipogenesis involving pre-formed free fatty 
acids arriving from extra-hepatic sources, suggesting that only 
hepatic lipogenesis de novo is important, in the elevated triacyl-
glycerol levels, at least in the early stages. This argument, 
however, is open to question since an increased flux of free fatty 
acids from peripheral tissues to the liver, involving increased 
release into the blood, increased uptake and an increased turnover of 
free fatty acids, need not manifest itself with increased free fatty 
acid levels in the plasma. 
VLDL lipids are hydrolysed by lipoprotein lipase at the luminal 
surface of endothelial cells in the capi1laries (Scow et al., 1976), 
causing the production of free fatty acids. In the present study, 
however, even when the hypertriacylglycerolaemia was well-established 
there were no increases in plasma free fatty acid levels and such an 
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observation might be explained by one or more of the following:-
(a) Increasing amounts of VLDL-triacylglycerol were hydrolysed but the 
free fatty acids released were quickly removed from the 
circulation; 
(b) the increasing VLDL-triacylglycerol levels rapidly saturated 
lipoprotein lipase; 
(c) VLDL particles showed a reduced susceptibility to the hydrolytic 
action of lipoprotein lipase. In support of this possibility, 
Griffin (1981) has shown that VLDL from laying hens are only 
hydrolysed to a limited extent by isolated lipoprotein lipase and 
has suggested that the VLDL have a low content of a lipoprotein 
lipase activator protein. 
Following oestrogen treatment, there was a decrease in the mean 
levels of plasma albumin-bound free fatty acids compared to controls 
(Fig. 3.3) at all time-points after injection, although only at 24 
hours post-injection was this decrease significant. Comparison of 
the time-courses of total plasma free fatty acids (Fig. 3.2c) and 
albumin-bound free fatty acids (Fig. 3.3c) suggests that this 
reduction is the result of a greater proportion of the total free 
fatty acids being bound to triacylglycerol-rich lipoproteins after 
oestrogen treatment. This is consistent with the observations that 
oestrogen treatment leads to an increase in plasma VLDL levels and 
that in laying hens much of the plasma free fatty acids are associated 
with the elevated levels of VLDL (Leclerq et al., 1979). Griffin & 
Mitchell (1984) reported that only approximately 5% of plasma free 
fatty acids in laying hens was albumin-bound, representing 
concentrations of 0.02 - 0.05 mM. In the present study, a tentative 
comparison of the concentrations of albumin-bound free fatty acids, 
measured in one group of birds, and total free fatty acids in plasma, 
measured in a different group of young male chicks, suggests that in 
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the untreated state, 74% of total plasma free fatty acids were 
albumin-bound. A similar comparison of albumin-bound free fatty 
acid levels 24 hours after oestrogen treatment and total free fatty 
acid levels in plasma 26 hours after oestrogen treatment suggests 
that 40% of total plasm~ free fatty acids were albumin-bound, 
representing a concentration of 0.15 mM. The differences between 
these figures and those reported by Griffin & M.itchell (1984) may 
be due to differences in the age and sex of the birds. 
2. Changes in the levels of liver lipids following oestrogen treatment 
Liver lipid levels were expressed both on a whole liver and on a 
'cellular' basis, the assumption being made that each cell contains 
the same amount of DNA after oestrogen treatment. Significant 
increases in the amount of triacylglycerol per 'cell' and per liver 
were first observed 11 hours and 7 hours after hormone treatment, 
respectively. At 7 hours after oestrogen administration, the 
'cellular' content of triacylglycerol showed a 1.7-fold increase 
over the control value but this increase was not statistically 
significant. The liver triacylglycerol levels determined were a 
reflection of the balance between (a) the rate of appearance of 
triacylglycerol in the liver and (b) the rate of removal of 
triacylglycerol from the liver, mainly in the form of lipoproteins. 
It is likely that increased synthesis of triacylglycerol plays a 
major role in the accumulation of liver lipids since the increase 
in liver triacylglycerols accompanies the appearance and development 
of hypertriacylglycerolaemia. 
At 20 hours after oestrogen treatment, there was a 6.6-fold increase 
in the whole organ content and a 6.0-fold increase in the 'cellular' 
content of triacylglycerol in the liver, with respect to control 
birds whereas maximum liver triacylglycerol levels were reached 34 
hours after hormone treatment, representing 23-fold and lS~foJd. 
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increases, over controls, in the whole organ and 'cellular' contents, 
respectively (Fig. 3.4). During the 44 hour post-injection period a 
consistent increase in mean liver weight, expressed as a percentage 
of body weight, was observed in oestrogen-treated birds when compared 
to control birds representing a 1.4-fold increase at. 20 hours and a 
1.7-fold increase at 34 hours. These observations, when considered 
together, suggest that the increase in liver weight and liver 
triacylglycerol in the first 20 hours after oestrogen treatment 
occurs in the absence of a substantial amount of cell division 
whereas at 34 hours after oestrogen treatment, the increases may be 
in part, due to an increase in liver cell division. 
Oashti et al. (1983) administered diethylstilboestrol (40 mg/kg 
body wt.) to 19 day-old male turkeys and observed increased liver 
triacylglycerol levels, expressed as triacylglycerol per unit weight 
of liver, reaching a maximum 48 hours after injecticn, representing 
a 3.7-fold increase over controls. 
Increases in liver phospholipid levels occurred at the same time as 
increases in liver triacylglycerol content, in the present study, 
significant increases being observed at 7 hours after oestrogen 
treatment in both the whole organ and 'cellular' phospholipid levels 
when compared to controls (Fig. 3.5). Concurrent increases were 
observed in liver and plasma phospholipid levels after hormone 
treatment suggesting that oestrogen administration led to coordinated 
increases in the hepatic synthesis and secretion of phospholipid. A 
difference was observed between the time-course of hepatic phospho-
lipid accumulation after oestrogen treatment and the time-course of 
hepatic triacylglycerol accumulation in that maximum liver phospho-
lipid content, on a 'cellular' basis, was observed at 20 hours after 
injection whereas the maximum triacylglycerol 'cellular' content of 
liver was observed at 34 hours. Following oestrogen treatment, 
phospholipid is needed for both lipoprotein synthesis and for 
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membrane proliferation in order to increase the synthetic capacity 
of hepatocytes, and therefore it is diffucult to gauge the 
significance of the difference in the hepatic accumulation of 
phospholipid and triacylglycerol expressed on a cellular basis. 
Expression of liver phospholipid levels on a whole organ basis shows 
that a maximum was attained 34 hours, rather than 20 hours, after 
oestrogen treatment and this may be due to an increase in cell 
division occurring in the period 20 - 34 hours post-injection. 
Significant increases in the liver levels of free fatty acids, 
expressed on a whole organ basis, were observed at 26 hours, 34 
hours and 44 hours after oestrogen treatment, compared to controls, 
although non-significant increases were apparent at the 15 hour and 
20 hour time-points. Expression of the liver free fatty acid data 
on a 1 Cellular 1 basis showed significant increases, with respect to 
controls, at 26 hours and 44 hours after oestrogen treatment 
(Fig. 3.6). The extent of the significant increases were greater 
for the free fatty acid levels expressed on a whole organ basis than 
the levels expressed on a 1 Cellular 1 basis and this may be a 
reflection of the involvement of cell division in the observed 
increase in liver size following oestrogen treatment. For instance, 
at 34 hours post-injection, 1.3-fold and 2.0-fold increases were 
observed in the liver levels of free fatty acids, expressed on a 
ce11u1ar basis and a whole organ basis, respectively. 
Hawkins & Heald (1966) reported a 2-fold increase in the free fatty 
acid pool in livers of hens when coming into lay and their value of 
0.62 - 0.84 ~moles/g wet liver for immature hens is in good 
agreement with that of 0.80 ~moles/g wet liver measured in untreated 
birds in the present study. 
Hepatic free fatty acids, measured in the present study, could have 
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arisen from a number of sources including uptake from the plasma 
and fatty acid synthesis de novo from non-lipid precursors. The 
observations of increasing hepatic lipid levels after oestrogen 
treatment are consistent with other reports of variations in hepatic 
lipogenesis and in levels of liver VLDL components after similar 
treatment. Courtney (1984) administered 17a-oestradiol (1.0 mg/ 
100 g body wt.) to 3- 5 week-old male chicks and measured lipogenic 
activity in liver slices from birds killed at differing times after 
injection. Significant increases in lipogenesis de novo, assayed 
by measuring the incorporation of 3H20 into lipids, and lipogenesis 
from pre-formed fatty acids, as measured by the incorporation of 
[9, 10 - 3H} palmitate into lipids, were observed 14 - 44 hours after 
oestrogen treatment reaching maximal 2.4-fold and 2.47-fold increases 
at 40 - 44 hours, respectively. In both instances, the majority 
of the recovered radioactivity was in the form of triacylglycerol 
(approximately 90%). A slight, though not statistically significant, 
increase in lipogenesis de novo was also observed 3~ - 7~ hours 
after oestrogen treatment. Courtney & Manning (1984) reported 
increased hepatic fatty acid synthetase activity, expressed as total 
organ activity, in young male chicks 48 hours after receiving an 
injection of 17a-oestradiol (0.75 mg/100 g body wt.), when compared 
to control birds. Interestingly, in the same experiments, Courtney 
(1984) and Courtney & Manning (1984) reported significant increases 
in hepatic lipogenesis de novo and in the specific activity of 
hepatic fatty acid synthetase in control birds, with respect to 
untreated birds, up to 17 hours and up to 26 hours after injection 
of vehicle, respectively. This is consistent with the measurements 
of hepatic free fatty acid levels in the present study which 
show that, from 15- 20 hours after injection, both the oestrogen-
treated and control values increased, although the control values 
were not significantly different to untreated values. 
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Chan et al. (1976) injected 3 week-old male chicks with diethyl-
sti1boestro1 (2.5 mg) before measuring the rate o( V_l.DL synthesis 
in liver slices, assayed by the incorporation of L3Hj lysine into 
immunoprecipitated protein, from birds killed at differing times 
after treatment. An increase in VLDL synthesis was observed within 
2 hours of injection and reached a maximum at the 24 hour time-
point, representing a 6-fold increase over controls. In a similar 
experiment in which 17~-oestradiol (1 mg) was used, Chan et al. 
(1977) reported a maximal 4-fold increase in VLDL synthesis in liver 
slices from birds killed 17 hours after hormone treatment. Studies 
by Codina-Salada et al. (1983) supported these observations by 
demonstrating an increase in the number of molecules of mRNA coding 
for apo-VLDL-II in hepatocytes, in vivo, within 1 - 3 hours of 
injecting 5 week-old cockerels with 17~-oestradiol (5 mg/kg body wt.). 
Increased liver lipid levels in oestrogen-treated young female birds 
have been reported which are similar to those in oestrogen-treated 
young cockerels. Balnave & Pearce (1974) reported no increase in 
liver lipid content, expressed as the weight of lipid per 100 g liver, 
of 4 week-old pullets in the first 12 hours after treatment with 
oestradiol dipropionate (2 mg). In a later experiment, however, the 
same treatment of similar birds led to an increase in liver lipid 
content (as% of liver wt.), from 4.69% in controls to 15.81% two 
days after injection (Pearce & Balnave, 1975). Pearce & Brown (1971) 
administered oestradiol dipropionate (15 mg), in the form of a 
subcutaneous implant, to immature pullets for one week causing an 
approximately 50% increase in levels of total liver lipids, expressed 
as weight of lipid/liver, when compared to controls. However, 
expression of the liver lipid content as the percentage of wet liver 
weight showed no statistically significant difference. 
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3. Changes in the fatty acid composition of plas~~ and liver lipids 
following oestrogen treatment 
The fatty acid composition of triacylglycerol isolated from the liver 
and from the VLDL fraction of plasma lipoproteins of untreated birds 
are similar, in that 16:0, 18:1, 18:0, 18:2 and 16:1 were found to 
be the m.ajor components. However, distinct differences are evident 
in the percentage contributions of each major fatty acid component 
of liver triacylglycerol and VLDL-triacylglycerol, the most obvious 
being with respect to 18:2. In liver triacylglycerol, 6% was 
comprised of 18:2 whereas the figure was approximately 15% in VLDL-
triacylglycerol. Similar differences between liver and plasma 
lipids have been reported by other workers. Balnave (1971) observed 
that the percentage contributions of 18:2 to the fatty acid 
compositions of total lipids from liver and blood, in immature 
pullets, were 18% and 28%, respectively, and the percentage 
contributions of 18:0 in the two tissues were 30% and 18% 
respectively. Balnave (1971) suggested that the differences observed 
with the immature birds might have been physiologically important, 
especially the greater levels of 18:2 observed in the blood. Fujii 
et al. (1984) also observed a much greater percentage of 18:2 in 
the plasma total lipid of 21 day-old male chicks than the liver 
total lipid, values of 13% amd 23% being reported, respectively. 
A comparison of the fatty acid composition of total lipid in liver 
and plasma cannot yield a great deal of information simply because 
there are many liver lipids, such as membrane phospholipids, which 
are not produced for export and hence there is no clear logical 
relationshop between total lipids in the liver and those in the 
circulation. On the other hand, comparison of the fatty acid 
composition of triacylglycerol in the liver and in the plasma is 
more logical, since this lipid is produced largely for export. One 
reason for the differences observed in the triacylglycerol 
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compositions in the present study could be that, although VLDL-
associated tricylglycerul is synthesised in the liver, only certain 
molecular species may be released into the plasma as lipoprotein. 
Christie & Moore (1972) proffered a similar explanation of the 
differences they observed in the lipid compositions of plasma and 
liver triacylglycerols and phospholipids in laying hens. On the 
other hand, lipoproteins in the plasma are susceptible to 
modification by enzymes such as lipoprotein lipase, which 
hydrolyses triacylglycerols, and lecithin:cholesterol acyltrans-
ferase which transfers unsaturated fatty acids from position 2 of 
phosphatidyTcholine to cholesterol. Similar plasma lipoprotein 
metabolism, therefore, could also explain, in part, the observed 
differences in fatty acid composition of triacylglycerol from liver 
and VLDL. A further explanation is that the VLDL fraction isolated 
in the procedure adopted in the present study, and others, includes 
the portomicron VLDL particles whose triacylglycerol is composed of 
fatty acids of dietary origin. It is interesting to note that 
since the oestrogen-induced increase in VLDL-triacylglycerol in the 
plasma of chicks is' due almost completely to the release of VLDL 
from the liver (Kudzma et al., 1973), the extent of any possible 
modification of the fatty acid composition of VLDL-triacylglycerol 
by the portomicron fraction would be greatly reduced after 
oestrogen treatment. 
The fatty acid composition of VLDL-phospholipid in untreated chicks 
differs from that of VLDL-triacylglycerol mainly in that 20:4, a 
major component of animal phospholipids (Gurr & James, 1980), and 
18:0 are present in larger proportions and that the proportions of 
16:0, 16:1, 18:2 and especially 18:1 are decreased. 
Although direct comparisons are not available, the fatty acid 
compositions of liver and VLDL-triacylglycerol and VLDL-phospholipid 
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from untreated birds in the present study are consistent with the 
literature. Fujii et a1. (1984) reported that the major fatty acids 
of liver and plasma total lipids in 21 day-old male chicks were 16:0, 
18:0, 18:1 and 18:2 with smaller contributions of 16:1 and 20:4. 
The molar ratios of unsaturated/saturated fatty acids for liver 
triacylglycerol, VLDL-triacylglycerol and VLDL-phospholipid from 
untreated birds, in the present study, were 1. 13, 1.22 and 1.06 
respectively, indicating that in all cases there was a greater 
proportion of unsaturated fatty acids. Fujii et al. (1984) reported 
a molar ratio of 0.88 for total liver lipid in 21 day-old male 
chicks, the difference between their value and that of 1.13 for 
liver triacylglycerol in the present study probably being due to the 
difference in lipid classes studied and the greater sensitivity, 
in the present study, in the detection of polyenoic long chain 
fatty acids (20 carbon atoms and above). 
Following oestrogen treatment, the proportion of 18:1 in liver-
triacylglycerol was significantly greater than the proportion in 
control birds, the increase being observed from 13 - 48 hours after 
injection. This increase accompanies the observed accumulation of 
liver triacylglycerol, which has been discussed earlier. Other 
oestrogen-induced compositonal changes in liver triacylglycerol are 
not as persistent. Six hours after oestrogen treatment the 
proportion of 16:0 was significantly greater than both the 
corresponding control and untreated values. Dashti et al. (1983) 
after administering diethylstilboestrol (40 mg/kg nody wt.) to 
19 day-old male turkeys and killing them 48 hours later, observed 
a significant increase in those liver triacylglycerols rich in 
16-carbon fatty acids. Of these fatty acids, 16:0 is the major 
product of fatty acid synthesis in avian cells (Brodie et al., 1964), 
so the increased proportion of 16:0 observed in the present study 
might, therefore, be a reflection of increased fatty acid synthesis 
de novo. 
-127-
One of the more obvious changes in liver triacylglycerol was 
observed 24 hours after injection, when control birds exhibited 
markedly different fatty acid composition to untreated birds. 
Significant increases, with respect to untreated birds, were 
observed in the saturated fatty acids 14:0, 16:0 and 18:0 whereas 
significant decreases were observed in the unsaturated fatty acids 
18:1 and 18:2. These changes are reflected in the molar ratio of 
unsaturated:saturated fatty acids for liver triacylglycerol in 
control birds, 24 hours after injection, the value of 0.52 being 
significantly lower than that of 1.13 for untreated birds. The 
possibility exists that the markedly different fatty acid composition 
of liver triacylglycerols in control birds, 24 hours after injection, 
was the result of experimental error. However, the 1 mean 1 fatty 
acid composition quoted for these birds was derived from analysis on 
6 birds, each of which had distinctly altered liver triacylglycerol 
fatty acid compositions. A perhaps more likely exp1anation, 
therefore, is that the observed fatty acid composition of liver 
triacylglycerol in 24 hour control birds, was the result of the 
handling/injection procedure and/or a metabolic effect of the 
propane-1,2-diol injection vehicle. 
Other changes in the fatty acid composition of liver triacylglycerol 
after oestrogen treatment include an elevation of the proportion of 
18:2 at 13 hours and 24 hours after injection, when compared to 
control birds, although this may be due, in part, to a decrease in 
control values at this time. The proportions of 20:0 arid 20:4 in 
liver triacylglycerol of oestrogen-treated birds decreased, compared 
to controls, at 6 hours and 13 hours after injection, although in 
each case, the oestrogen-treated value was not significantly 
different from the corresponding untreated value. 
The overall effect of the compositional changes in liver 
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triacylglycerol following oestrogen treatment was, therefore, an 
increase in the proportion of unsaturated fatty acids at the 
expense of saturated fatty acids. This is reflected in the change 
in the molar ratio of unsaturated:saturated fatty acids which 
changed from 1.13 in the untreated state, to 1.61 at 48 hours after 
injection. Fujii et al. (1984) observed a similar increase in this 
ratio in total liver lipids from 21 day-old male chicks which had 
received 6 daily injections of 17~-oestradiol (20 mg/kg body wt.) 
the value rising from 0.88 to 1.32. 
Following oestrogen treatment, an increase in the level of VLDL-
triacylglycero1 was apparent in the plasma of male chicks, the 
liver being responsible for the bulk of this increase. It is 
therefore interesting to note any similarities and differences 
between the fatty acid compositional changes observed in liver-
triacylglycerols and plasma VLDL-triacylglycerol following oestrogen 
treatment. The increase in the proportion of 18:1 observed in 
liver triacylglycerol was also observed in VLDL-triacylglycerol, 
the increase being apparent from 13 - 48 hours post-injection. The 
significantly different composition of liver triacylglycerol in 
control birds 24 hours post-injection, however, was not observed 
in the VLDL-triacylglycerol of the same birds. Such differences 
between liver triacylglycerol and VLDL-triacylglycerol in non-
lipaemic control birds can be explained by the fact that not all 
the molecular species of liver triacylglycerol might be released 
into the plasma and also that the composition of liver triacylglycerol 
released into the plasma as VLDL-triacylglycerol will be masked by 
the composition of the pre-existing pool of plasma VLDL-triacyl-
glycerol. This last consideration will be especially important in 
oestrogen-treated hypertriacylglycerolaemic chicks with larger 
plasma VLDL-triacylglycerol pools and it is interesting to note that 
the slight variations in the levels of 16:0, 20:0 and 20:4 in liver 
triacylglycerol following oestrogen treatment were not apparent in 
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the VLDL-triacylglycerol of the same birds. 
A major difference between the composition of liver triacylglycerol 
and VLDL-triacylglycerol after oestrogen treatment is apparent when 
the proportion of 18:2 is studied. In VLDL-triacylglycerol, the 
proportion of 18:2 is significantly reduced, with respect to control 
and untreated birds and birds, at 13 - 48 hours after oestrogen 
treatment, the reduction coinciding with elevated VLDL-triacyl-
glycerol levels. Linoleate (18:2) is an essential fatty acid, 
implying that it cannot be synthesised de novo by the animal and must 
be obtained from the diet. It is possible, therefore, that the 
dietary intake of 18:2 may be insufficient to meet the increased 
demand for fatty acid incorporation into triacylglycerols in the 
liver, following oestrogen treatment, before being released into the 
plasma. A decrease in the low levels of o(-linolenate (18:3), an 
essential fatty acid, in VLDL-triacylglycerol from 24 - 48 hours 
after oestrogen treatment supports this explanation. It is 
interesting to note, however, that a reduction in 18:2 levels was not 
observed in liver triacylglycerol of oestrogen-treated birds. 
Similar reduction in the proportion of 18:2 in the plasma lipids of 
oestrogen-treated birds have been reported by other workers. Fujii 
et al. (1984) reported a decrease in the proportion of 18:2 in 
total plasma lipids of 21 day-old oestrogen-treated cockerels, from 
23% to 10%, and Balnave (1971) reported a similar decrease in 18:2 
levels in the plasma lipids of oestrogen-treated 16 week-old 
pullets, from 28% to 16%. In both reports it was noted that the 
proportion of 18:2 in the liver and plasma lipids of oestrogen-treated 
birds were similar contrary to the situation in untreated birds, 
where the proportion of 18:2 in plasma lipids was higher than that in 
liver lipids. These observations are consistent with the similar 
fatty acid compositions of liver and VLDL-triacylglycerol from 
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oestrogen-treated birds in the present study. For example, 48 hours 
after treatment, the proportion of 18:2 in triacy1glycero1 from 
liver and VLDL were 6.2% and 7.2%, respectively. Such observations 
are probably a reflection of an increased hepatic synthesis of 
triacylglycerol for specific release into the plasma as VLDL-
triacylglycerol. 
The molar ratio of unsaturated:saturated fatty acids in VLDL-
triacylglycerol following oestrogen treatment does not significantly 
differ from the control value throughout the 48 hour period and 
this is explained by the fact that the major changes involve an 
increase in one unsaturated fatty acid, 18:1, and a decrease in 
another unsaturated fatty acid, 18:2. 
An increase in the proportion of 18:1 also occurred in VLDL-
phospholipid, at 13 - 48 hours after oestrogen treatment and 
this change occurred as the level of VLDL-phospholipid in plasma 
increased. Lipiello et al. (1979) reported increased stearyl-CoA 
desaturase activity in crude microsomal extracts from the liver of 
male chickens (800- 1200 g body wt.) which had been injected with 
17~-oestradio1 (3.5 mg/100 g body wt.). A 7-fo1d increase in the 
specific activity of the enzyme was observed in the 24-hour period 
following injection and the activity remained high through 48 hours 
before declining at 72 hours post-injection. Therefore, the 
increases in 18:1 in the plasma and liver lipids of oestrogen-
treated birds in the present study may be due to an increase in 
hepatic stearyl-CoA desaturase activity within 13 hours of injection. 
Stearyl-CoA desaturase introduces a single double-bond into stearic 
acid (18:0) producing oleic acid (18:1). A decrease in the 
proportion of 18:0 in VLDL-phospho1ipid was evident 24 - 48 hours 
after oestrogen treatment, although, at each time-point, the 
decreased oestrogen-treated value was significantly lower than 
the untreated value and not significantly different from 
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the corresponding control value. No significant decreases in the 
proportions of i8:0 in the liver and VLDL-triacylglycerol of 
oestrogen-treated birds were detected. The changes in VLDL-
phospholipid composition after oestrogen treatment also differed 
from the responses in triacylglycerol in that a persistent increase 
in the proportion of 16:0 was observed in VLDL-phospholipid, the 
increase over controls being significant from 13 - 37 hours after 
oestrogen treatment. This increase could be a reflection of 
increased hepatic fatty acid synthesis de novo leading to a large 
supply of 16:0, the major product of fatty acid synthesis in avian 
systems (Brodie et al., 1964), for incorporation into phospholipids. 
In contrast, oestrogen treatment produced only a transient increase 
in the proportion of 16:0 in liver triacylglycerol, at 6 hours post-
injection, but there was no oestrogen-induced increase in the 
proportion of 16:0 in VLDL-triacylg1ycerol. 
Contrary to the situation in VLDL-triacylglycerol, there was no 
persistent decrease in the proportion of the essential fatty acid 
18:2 in VLDL-phospholipid following oestrogen-treatment. However, 
both oestrogen-treated and control birds exhibited greatly increased 
18:2 proportions in VLDL-phospholipid at the 6 hour time-point, 
compared to untreated birds, suggesting that this may be a 'stress' 
effect evoked by the handling/injection procedure. 
Decreases in 20:0 and 20:4 occurred in VLDL-phospholipid at 13 hours 
and 24 hours after oestrogen treatment, with respect to controls. 
However, in both cases the difference seemed to be due to an increase 
in the corresponding control value, the oestrogen-treated values not 
being significantly different to the untreated value. Since 20:4 
is an essential fatty acid the diminished proportion of 20:4, in 
VLDL-phospholipid after hormone treatment, may be a reflection of 
an inability to match the increasing demand for fatty acids with a 
specific supply of 20:4. 
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No change in the mo1ar ratio of unsaturated:saturated fatty acids 
in VLDL-phospholipids was observed following oestrogen treatment, 
the increase in the proportion of the unsaturated fatty acid, 18:1 
being balanced by an increase in the proportion of the saturated 
fatty acid, 16:0. 
Following oestrogen treatment, the bulk of the VLDL-phospholipid· 
and VLDL-triacylglycerol is synthesised in the liver, involving the 
incorporation of fatty acids in the form of 'activated' fatty 
acyl-CoA thioesters. It has been shown that the biosynthetic 
pathways for the synthesis of phospholipid and triacylglycerol are 
very similar, in the initial stages, leading to the production of 
phosphatidic acid (and diacylglycerol). It is well documented, 
however, that there is a degree of specificity in the way fatty acids 
are incorporated into the developing acylglycerols. In general, 
phosphclipid metabolism makes more extensive demands on a supply of 
unsaturated fatty acids than does triacylglycerol metabolism (Gurr & 
James, 1980). It has also been shown that in laying hens there is 
a degree of specificity in the positions occupied by fatty acids in 
triacylglycerol and phospholipid molecules (Christie & Moore, 1972). 
Stereospecific analysis of, for instance, plasma triacylglycerols 
revealed that 16:0 constituted over 70% of the fatty acids in 
position 1 of the glycerol moiety while position 2 was occupied 
largely by 18:1 and 18:2 and position 3 comprised over 70% 18:1 with 
most of the remaining saturated components. A similar analysis of 
phosphatidyl choline from the plasma of laying hens revealed that 
position 1 was occupied largely by saturated fatty acids and 
position 2 by unsaturated components. 
It is obvious that the changes occurring in the composition of 
VLDL-phospholipid and VLDL-triacylglycerol after oestrogen treatment 
are similar in some respects, notably the increase in the proportion 
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of 18:1, and different in other respects, the proportion of 16:0 
increasing in VLDL-phospho1ipid while remaining unchanged in 
VLDL-triacylglycerol. Such a situation might arise if oestrogen 
were to affect the size and composition of the hepatic fatty 
acyl-CoA pool, from which specific types of fatty acids were 
incorporated in triacylglycerols and phospholipids. 
The changes in fatty acid composition of blood and liver lipids 
observed in the present study are generally in agreement with 
similar reports of compositional changes in lipids of oestrogen-
treated male and female domestic fowl, although differences in the 
age and sex of the birds and dose of oestrogen used in each study 
may account for any slight differences in results. Balnave (1969) 
administered oestradiol dipropionate (10 mg) to 6 week-old male 
chicks over a 10 day period, involving 5 injections, and observed 
an altered liver lipid fatty acid composition consisting of increases 
in the proportions of 16:0, 16:1 and 18:1 and decreases in 18:0, 
18:2. 20:3 and 20:4. The molar ratios of unsaturated:saturated 
fatty acids were reported to have increased from 0.79 to 0.94 and 
from 1.12 to 1.35 in two separate experiments. 
In another report, Balnave (1971) administered oestradiol 
diopropionate (20 mg) to 16 week-old female birds over a 7 day 
period and observed increases in the proportions of 16:0 and 18:1 
and decreases in 18:0 and 18:2 in plasma lipids. Similar changes 
were reported in the liver lipids of the birds although an increase 
in 16:1 was also observed. 
Balnave & Pearce (1975) administered oestradiol dipropionate (2 mg) 
to 4 week-old female birds on alternate days over a period of 9 days. 
Birds were killed at 1, 2, 4 or 9 days after the commencement of 
hormone treatment. A study of the fatty acid composition of liver 
lipids during this period indicated increases in the proportions of 
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16:0, 16:1 and 18:1 and decreases in 18:0 and 18:2. 
Fujii et al. (1984) administered 17a-oestradiol (20 mg/kg body wt.) 
to 15 day-old male chicks over a period of 6 days. An increase in 
the proportion of 18:1 and decreases in the proportions of 18:0, 
18:2 and 20:4 were observed in both total plasma and total liver 
lipids. In the same study, Fujii et al. (1984) observed increases 
in the levels of serum oestradiol in maturing hens reaching peak 
values a few days before the production of the first egg, which 
occurred at an average age of 147 days. Changes in the composition 
of liver and plasma lipids occurred concomitantly with the increase 
in endogenous oestradiol, such that they closely resembled the 
fatty acid composition of the yolk lipids from the same birds and 
the compositions of liver and plasma lipids of the oestrogen-treated 
cockerels. 
In the present study, oestrogen treatment seemed to cause a shift 
in the lipid metabolism of the male chicks similar, in many res~ects, 
to the changes in lipid metabolism in laying hens, which involve 
the production of large quantities of specific lipids for 
incorporation into the developing eggs. 
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CHAPTER 4 
THE EFFECT OF OESTROGEN TREATMENT ON 
THE ACTIVITY OF ACETYL-CoA CARBOXYLASE 
IN MALE CHICK LIVER 
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INTRODUCTION 
1. De novo synthesis of long-chain saturated fatty acids 
Changes in the rate of lipogenesis in a variety of animals are often 
accompanied by corresponding changes in the activities of lipogenic 
enzymes (Numa & Yamashita, 1974; Wakil et al., 1983). In birds, 
the major site of de novo lipogenesis is the liver (Goodridge & Ball, 
1967a; O'Hea & Leveille, 1969) in contrast to the situation in many 
mammals, such as the rat, where adipose tissue is the major site, 
(Romsos & Leveille, 1974). 
The de novo biosynthesis of long-chain saturated fatty acids is 
controlled by two cytosolic enzymes; acetyl-CoA carboxylase (acetyl-
CoA:carbon-dioxide ligase (ADP-forming), E.C.6.4. 1.2) and fatty acid 
synthetase (an enzyme system.) 
Acetyl-CoA carboxylase catalyses the ATP-dependent carboxylation of 
acetyl-CoA to produce malonyl-CoA (reaction (1)), the activated 
.donor of 2-carbon units in the process of long-chain fatty acid 
synthesis catalysed by fatty acid synthetase (reaction (2)). 
Mg2+ 
Acetyl-CoA + HC03 + ATP ~ malonyl-CoA + AOP +Pi (1) 
Acetyl-CoA + 7 malonyl-CoA + 14NAOPH + 14H+ --+ palmitate + 
8CoA + 7C02 + 6H20 + 14NAOP+ (2) 
In many cells, the production of malonyl-CoA from acetyl-CoA is 
regarded as the rate-limiting step in de novo fatty acid synthesis 
(Vernon, 1980). This reaction occurs early in the fatty acid 
synthetic sequence and is the first committed step, malonyl-CoA 
having no other apparent metabolic alternative. Therefore, the 
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reaction catalysed by acetyl-CoA ccttboxylase satisfies the 
accepted criteria for a regulatory step in a biosynthetic pathway 
(Monad et a 1., 1965). 
The NADPH required in reaction (2) is usually produced by the action 
of 'malic' enzyme (malate dehydrogenase (decarboxylating; NADP+), 
E.C. 1. 1. 1.40.), as shown in reaction (3), and/or the pentose phosphate 
pathway enzymes, glucose 6-phosphate dehydrogenase (E.C. 1.1. 1.49) 
and 6-phosphogluconate dehydrogenase (E.C. 1.1.1.44), although it 
has been suggested that the pentose phosphate pathway only plays a 
minor role in birds (Goodridge, 1968a). This pathway is active in 
the chick embryo but declines during incubation, being virtually 
inactive at hatching, and in the adult bird (Pearce & Brown, 1971). 
'malic 1 
L-malate + NADP+ ~ pyruvate+ C02 + NADPH + H+ 
enzyme 
( 3) 
Acetyl-CoA, produced in th~ mitochondria from pyruvate is converted 
to citrate which leaves the mitochondria and is cleaved in the 
cytoplasm to yield acetyl-CoA by the action of ATP citrate lyase 
(E.C.4.1.3.8) :-
ATP citrate 
citrate + ATP + CoA Acetyl-CoA + oxaloacetate + ADP + Pi 
lyase 
Acetyl-CoA can also leave the mitochondrial matrix by conversion to 
acetyl-carnitine which enters the cytoplasm and is re-converted to 
acetyl-CoA. 
The cytoplasmic acetyl-CoA can be used by acetyl-CoA carboxylase in 
the production of malonyl-CoA (reaction (1)). Palmitic acid produced 
by reactions (1) and (2) can be further elongated by mitochondrial 
or microsomal enzyme systems, and/or converted to unsaturated fatty 
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acids by desaturation enzyme systems (Johnson et al., 1969). Fatty 
acids can then be used in the production of complex lipids such as 
triacylglycerols and phospholipids. 
2. Acetyl-CoA carboxylase and its regulation 
Acetyl-CoA carboxylase is located in the cytoplasm and electron-
microscopic studies have shown that the enzyme exists as a large 
filamentous polymer with a molecular weight of 4 million to 
11 million (Gregolin et al., 1966a; Kleinschmidt et aL, 1969; Moss 
et al., 1972). Watkins et al. (1977) have provided indirect 
evidence for the occurrence of the filamentous polymeric form 
in vitr~with cultured chicken liver cells using a 'digitonin-rapid-
stop' technique. Digitonin perforates the plasma membrane making 
it permeable to cytosolic acetyl-CoA carboxylase at a rate 
inversely related to the cellular concentration of citrate and the 
apparent state of polymerisation. Acetyl-CoA carboxylase from 
animal species shows a requirement for citrate or isocitrate, the 
absence of which leads to inactivation (Martin & Vagelos, 1962; 
Matsuhashi et al., 1962; Waite & Wakil, 1962). Citrate activation 
--
of the crude or purified acetyl-CoA carboxylase is accompanied by 
po1ymerisation of the enzyme (Gregolin et al., 1966a, 1966b; Numa 
et a 1., 1966). 
Studies on the inactive protomeric form of the enzyme are somewhat 
conflicting. Mackall & Lane (1978), using chicken liver acetyl-CoA 
carboxylase, suggested that a protomer consists of two non-identical 
subunits, both with molecular weights of approximately 230,000. 
However, more recently, Wada & Tanabe (1983) presented evidence 
suggesting that the chicken liver enzyme is composed of only one 
kind of subunit with a molecular weight of 220,000. All workers 
agree that the protomer contains one molecule of biotin, a prosthetic 
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group, which is covalently bound. It has also been shown that rat 
liver acety1-CoA carboxylase consists of one kind of subunit with 
a molecular weight of 230,000 (Tanabe et al., 1975). 
The reaction catalysed by acetyl-CoA carboxylase is believed to 
proceed in two steps as follows:-
M 2+ 
- g E-biotin + ATP + HC0 3 ~ E-biotin~ C0 2 + ADP +Pi (l) 
E-biotin ~ CO~ + acetyl-CoA ~ E-biotin + ma1ony1-CoA (2) 
~ 
where E-biotin represents acetyl-CoA carboxylase. 
The first step represents the carboxylation of the enzyme-bound 
biotin, and the second step the transfer of the 'activated' carboxyl 
group to acetyl-CoA. 
It is generally accepted that the acetyl-CoA carboxylase step is 
the rate-limiting step in the biosynthesis of long-chain fatty acids 
in animal cells. The regulation of acetyl-CoA carboxylase is 
effected by short-term changes in the catalytic efficiency of a 
fixed mass of the enzyme and by long-term changes in the amount of 
the enzyme. 
Two mechanisms are known to control the catalytic efficiency of the 
enzyme; allosteric modulation by metabolites and covalent 
modification of the enzyme involving phosphorylation and 
dephosphorylation. It is possible to regulate the amount of the 
enzyme by changes in the rate of synthesis and/or the rate of 
degradation of the enzyme. A brief description of these regulatory 
mechanisms is presented below, and further details can be obtained 
from several excellent reviews (Lane et al., 1974; Numa & Yamashita, 
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1974; Kim, 1983; Numa & Tanabe, 1984). 
As mentioned earlier, acetyl-CoA carboxylase from animal tissues 
requires a hydroxy tricarboxylic acid allosteric effector for full 
catalytic activity, activation being accompanied by polymerisation 
of the enzyme (Gregolin et al., 1966a, l966b; Numa et al., 1966). 
Many studies have been performed to establish whether or not 
citrate regulation is important in vivo. The concentration of 
citrate has been measured by a number of workers (Spencer & 
Lowenstein, 1967; Numa, 1974; Siess et al., 1978), both at the 
cellular and subcellular level, but difficulty has been encountered 
in carrying out these measurements. Siess et al. 1978) using a 
'digitonin-rapid-stop' technique on liver cells have shown that 50% -
75% of the cellular citrate is cytoplasmic. This work contradicts 
YJLh~ 
the measurements of Tubbs & Garland (1964) and Le~ille (1971), which 
/1 
suggested that the major fraction of citrate may be in the 
mitochondria. Given the difficulty in determining accurate sub-
cellular citrate concentrations it is understandable that some 
workers state that the cytoplasmic concentration of citrate is close 
to the concentration required for half-maximal activation of acetyl-
CoA carboxylase (Numa & Tanabe, 1984) whereas others state that the 
cytoplasmic citrate concentration, in vivo, is too low to produce 
any appreciable activation of the enzyme. Not surprisingly, 
different studies attempting to correlate cellular citrate 
concentration and the rate of fatty acid synthesis conflict (see 
Kim, 1983). 
Another positive allosteric effector of acetyl-CoA carboxylase is 
CoA (Yeh & Kim, 1980; Yeh et al., 1981). The enzyme contains one 
CoA binding site per subunit and CoA binding is not affected by the 
presence of citrate. CoA activation of the enzyme is accompanied 
by polymerisation. However, if CoA activation is carried out with 
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an enzyme preparation which has never been exposed to citrate, CoA 
activation occurs in the absence of polymerisation. 
Long-chain fatty acyl-CoA, the end-product of fatty acid synthesis, 
acts as a negative feedback allosteric effector of acetyl-CoA 
carboxylase (Bortz & Lynen, 1963; Numa et al., 1965), being 
competitive with respect to the activator, citrate, and non-
competitive with respect to the enzyme substrates. Binding of 
palmitoyl-CoA to the enzyme has been shown to accompany the adoption 
of a protomeric enzyme form (Ogiwara et al.; 1978). Physiological 
states which are known to depress hepatic fatty acid synthesis, such 
as fasting (Lyon et al., 1952; Numa et al., 1970) and high-fat diets 
(Hill et al., 1958), lead to an increased long-chain fatty acyl-CoA 
concentration in the liver (Gruynn et al., 1972) suggesting that 
fatty acyl-CoA inhibition is effective in vivo. 
The immediate end-product of the acetyl-CoA carboxylase catalysed 
reaction, malonyl-CoA, has also been shown to be a potent inhibitor 
of the avian liver enzyme (Gregolin et al., 1966c). Inhibition is 
competitive with respect to acetyl-CoA and citrate, and the 
malonyl-CoA has been shown to promote depolymerisation (Gregolin et 
al., l966c, l968a). 
Acetyl-CoA carboxylase has been shown to be regulated by a covalent 
modification mechanism whereby the enzyme is inter-converted between 
an inactive phosphorylated and an active dephosphorylated form 
(Carlson & Kim, 1973). The enzyme has been shown to become 
disaggregated to protomeric and intermediate forms when 
phosphorylated (Lee et al., 1973; Lee & Kim, 1978; Shiao et al., 
1981). However, these disaggregated forms exhibit different 
properties from those of the protomers formed in the absence of 
citrate (Lee~., 1973), in that full activity was not restored 
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when the phosphorylated protomeric form of the enzyme was incubated 
with citrate. This indicates that the phosphorylated Fonu of the 
enzyme is intrinsically less active than the dephosphorylated form. 
Lee & Kim (1979) showed that acetyl-CoA carboxylase from rat adipose 
tissue can be covalently phosphorylated at two types of site, only 
one of which leads to inactivation. This might explain the results 
of Halestrap & Denton (1974} and Pekala et al. (1978) who concluded 
that phosphorylation of the enzyme was of no physiological 
significance. 
Studies have indicated that the phosphorylated, inactivated forms of 
the enzyme are more prone to the inhibitory effects of long-chain 
fatty acyl-CoA than the dephosphorylated forms, whereas the 
dephosphorylated forms require less citrate for maximum activation 
(Carlson & Kim, 1974). 
Specific endogenous acetyl-CoA carboxylase phosphatase (Krakower & 
Kim, 1981) and acetyl-CoA carboxylase kinase (Shiao et al., 1981; 
Lent & Kim, 1982) have been isolated, the kinase being c.AMP 
independent. However, when various tissues are treated with c.AMP, 
or dibutyryl c.AMP, acetyl-CoA carboxylase is inactivated (Allred 
& Roehrig, 1972, 1973; Lee et al., 1973; Harris, 1975). The exact 
site of c.AMP involvement in acetyl-CoA carboxylase activity is 
unclear. Hardie & Guy (1980) and Brownsey & Hardie (1980) suggest 
that the enzyme from rat mammary glands is phosphorylated and 
inactivated by the catalytic subunit of c.AMP-dependent protein 
kinase. Watkins et al. (1977) reported that, in the chicken liver 
cell system, c.AMP affects the formation of cellular citrate which 
in turn affects the polymeric status of the carboxylase. 
It is now generally accepted that hormones such as glucagon and 
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and adrenaline, which raise intro-ce11u1ar levels of c./\MP, cause 
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means of covalent modification (see Kim, 1983). However, it is 
obvious that the control of lipogenesis, and acetyl-CoA carboxylase 
in particular, involves both allosteric and covalent modulation, 
the two fulfilling different yet complementary roles (Hardie, 1981). 
In addition to the regulation by changes in the catalytic efficiency 
per enzyme molecule, the amount of acetyl-CoA carboxylase has been 
shown to alter in accord with the rate of fatty acid synthesis in a 
variety of dietary, hormonal, developmental and genetic conditions 
(Numa, 1974; Numa & Yamashita, 1974). For instance, studies have 
shown that the increase or decrease in the hepatic enzyme content in 
re-fed or diabetic rats is due solely to a corresponding change in 
the rate of synthesis of the enzyme, whereas the decrease in the 
enzyme content in fasted rats is due to both dimished synthesis and 
accelerated degradation of the enzyme (Nakanishi & Numa, 1970). 
The increase in enzyme content in the liver of growing chicks is 
caused by accelerated synthesis of the enzyme (Teraoka & Numa, 1975). 
Such changes in enzyme content reflect long-term adaptation to a 
particular condition whereas short-term changes are brought about by 
allosteric and/or covalent modulation. 
3. The effect of diet on hepatic lipogenesis and lipogenic enzymes 
In many animals, starvation or a high fat, low carbohydrate diet are 
accompanied by depressed hepatic lipogenesis and co-ordinate 
reduction in the activities of lipogenic enzymes, including glucose 
6-phosphate dehydrogenase, ATP citrate lyase, 'malic' enzyme, 
acetyl-CoA carboxylase and fatty acid synthetase. This situation 
can be reversed by re-feeding following starvation or by feeding a 
low fat, high carbohydrate diet (Masoro, 1962; Numa & Yamashita, 
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1974; Romsos & Leveille, 1974). In this respect, birds are similar 
to rats although a difference does exist in the extent of the 
response to re-feeding after starvation. In birds, hepatic lipo-
genesis increases on re-feeding and the lipogenic enzyme activities 
return to normal or slightly above normal levels (Goodridge, 1968b; 
Muiruri etal., 1975; Shapiraetal., 1979). However, inre-fed 
rats, there is a very high increase in lipogenic enzyme activity, 
including glucose 6-phosphate dehydrogenase, 'malic' enzyme and ATP 
citrate lyase, and hence lipogenesis, to levels well above normal 
rats. (Romsos & Leveille, 1974). This could imply that lipogenesis 
is more tightly controlled in avian liver than rat liver. 
4. The effects of hormones on hepatic lipogenesis and lipogenic enzymes 
(a) Effects of hormones other than gonadal hormones 
Kompiang & Gibson (1976) have shown that relatively large doses of 
insulin increase hepatic lipogenic enzyme activity. Using a mono-
layer culture of non-proliferating hepatocytes, Tarlow et al. (1977) 
observed high rates of fatty acid synthesis in the presence of 
insulin, the absence of insulin leading to a decline in lipogenesis. 
With respect to avian adipose tissue, insulin does not depress 
lipolysis (Heald et al., 1965) and only elevates lipogenesis slightly, 
if at all (Goodridge & Ball, 1966). This is in oppositfon to the 
effect of insulin in rats (Jungas & Ball, 1963; Goodridge, l968c). 
Glucagon appears to be the major avian lipolytic hormone, intravenous 
injection of glucagon into domestic fowl having been shown to cause 
a rapid increase in plasma free fatty acid levels (Heald et al., 
1965). Fatty acid synthesis, studied in the chicken hepatocyte 
system of Tarlow et al. (1977) is inhibited by glucagon. In avian 
species, insulin seems to potentiate the stimulation of lipolysis 
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effected by glucagon in adipose tissue (Langslow & Hales, 1969) 
whereas in rat adipose tissue insulin is definitely anti-lipolytic 
(Jungas & Ball, 1963) and, therefore, antagonistic to glucagon. 
This difference in response to hormones is only one of a series of 
differences between birds and mammals in the endocrine control of 
carbohydrate and lipid metabolism (Pearce, 1977). 
Catecholamines are activators of lipolysis in mammalian adipose 
tissue (Ball & Jungas, 1961) but are relatively insignificant in 
lipolysis in avian adipose tissue (Carlson et al., 1964; Langslow 
&Hales, 1969). 
Thyroid hormones have been shown to stimulate rat hepatic lipogenesis, 
monitored by the incorporation of [1 - 14~ acetyl-CoA into fatty 
acids, and the activity of the following lipogenic enzymes in rat 
liver and adipose tissue; acetyl-CoA carboxylase, fatty acid 
synthetase, ATP citrate lyase, 'malic' enzyme, glucose 6-phosphate 
dehydrogenase and 6-phosphogluconate dehydrogenase. In birds 
thyroxine has been shown to increase hepatic 'malic' enzyme activity 
when supplied with food and water ad libitum (Chandrabose & 
Bensadoun, 1971). 
The development of birds is accompanied by major changes in 
nutritional and hormonal status which promote changes in hepatic 
lipogenesis (Pearce, 1980). In chicks, hatching marks a change from 
a high fat, low carbohydrate diet (egg yolk) to a low fat, high 
carbohydrate diet (cereal-based mash). This change is accompanied 
by a large increase in hepatic lipogenesis (Goodridge, l968d) and in 
the activities of some lipogenic enzymes, including acetyl-CoA 
carboxylase, fatty acid synthetase, ATP citrate lyase and 'malic' 
enzyme (Felicioli & Gabrielli, 1967; Goodridge, 1968b, 1973b; 
Arinze & Mistry, 1970; Ryder, 1970; Joshi & Sidbury, 1975). The 
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emergence of hepatic lipogenic enzyme activities has been studied 
with respect to possible hormonal influences. Thyroid hormones 
have been shown to increase the activities of acetyl-CoA carboxylase, 
ATP citrate lyase, fatty acid synthetase and 'ma1ic' enzyme in 
cultured chick embryo hepatocytes (Goodridge et al., 1974; Goodridge 
& Fischer, 1978). Insulin, administered in vivo, has been 
implicated in the stimulation of chick embryo hepatic fatty acid 
synthetase activity (Joshi & Wakil, 1978). The activities of 
acetyl-CoA carboxylase, fatty acid synthetase and 'malic' enzyme 
have all been shown to be stimulated by the in vivo treatment of 
chick embryo liver tissue with insulin alone or in conjunction with 
thyroid hormones (Goodridge & Adelman, 1976; Goodridge & Fischer, 
1978; Joshi & Aranda, 1979). It is apparent that there is an 
intricate interplay of both hormonal and nutritional stimuli which 
contribute to the changes occurring in lipogenic enzyme activities 
during the early development of the chick liver. 
Two other hormones which have been shown to affect avian lipogenesis 
are prolactin and growth hormone which are responsible, in the 
pigeon, for a food-dependent increase in hepatic lipogenesis and in 
the activity of lipogenic enzymes, including 'malic' enzyme and ATP 
citrate lyase (Goodridge & Ball, 1967b; 1967c). 
(b) Effects of gonadal hormones 
A number of physiological changes are observed in the development of 
young female chicks into sexually mature, egg-laying hens and changes 
in the hepatic lipogenic activity have been well reported. The 
hepatic specific activities of the lipogenic enzymes, ATP citrate 
lyase and 'malic' enzyme are relatively high in 4 - 7 week-old 
female chickens. However, these values subsequently decline with 
age in the non-laying sexually immature female, then increase again 
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as the birds reach sexual maturity and come into lay (Pearce, 1971, 
1972; Pearce & Brown, 1971). Thus, the laying hen has similar 
specific activities to those found in young birds (aged 4 - 7 weeks) 
whereas the non-laying sexually immature female bird has similar 
specific activities to those of the cockerel. These observations 
are in agreement with the work of Leveille (1969b) who found similar 
levels of hepatic lipogenesis in the laying hen and the young bird. 
The administration of oestrogen to immature female birds results in 
biochemical and physiological changes similar to those found when 
the female comes into lay (Lorenz, 1954). With regard to changes in 
the lipogenic activity of female birds, short-term oestrogen 
treatment (~ 2 days, 1 - 2 mg oestradiol dipropionate/bird) resulted 
in increased specific activities of ATP citrate lyase and 'malic' 
enzyme in the livers of 4-week old pullets (Balnave & Pearce, 1974; 
Pearce & Balnave, 1975, 1976). Prolonged oestrogen treatment (4 mg 
~-oestradiol-3-benzoate/bird/day for 6 days) has also resulted in 
increased activities of oviduct and hepatic fatty acid synthetase 
in 1-month old pullets (Aprahamian et al., 1979). Furthermore, 
Pageaux et al. (1981), using 16-day old female quail, have reported 
a rapid increase in the specific activity of hepatic acetyl-CoA 
carboxylase within 3 hours after oestrogen treatment (0.2 mg 
oestradiol benzoate/kg body wt.), although this study appears to 
have lacked adequate controls. 
Many workers have demonstrated that oestrogen treatment of male 
birds evokes changes in liver metabolism similar to those occurring 
when the female comes into lay (Chan et al., 1976; Tata, 1976; 
Shapiro, 1982). For example, an increase in the specific activity 
of 'malic' enzyme has been reported for the livers of oestrogen-
treated roosters (de Vellis & Schjeide, 1967) and LippiEllo et al. 
(1979) obtained increased stearyl-CoA desaturase specific activity 
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in rooster liver, up to 48 hours after birds had received a single 
injection of 17~-oestradiol (3.5 mg/100 g body wt.). Immature male 
chicks, treated with the synthetic oestrogen diethylstilboestrol, 
have been shown to exhibit increased specific activities of hepatic 
choline kinase (E.C.2.7. 1.32) and hepatic phosphatidylethano1amine-
N-methy1transferase (E.C.2. 1. 1. 17), enzymes involved in phospholipid 
biosynthesis (Vigo et al., 1981). The increase in choline kinase 
activity was shown to be due to an increase in the amount of the 
enzyme (Paddon et al., 1982). Coleman et a1. (1977), studying 
enzymes involved in triacylglycerol and phospholipid biosynthesis, 
detected increases in total hepatic activities of fatty acid:CoA 
ligase (AMP-forming) (E.C.6.2. 1.3), ~-glycerol 3-phosphate: acyl-
CoA acyltransferase (E.C.2.3. 1. 15) and diacylglycerol acyltransferase 
(E.C.2.3. 1.20), in oestrogen-treated immature birds (male and 
female), without changes in their specific activities. The total 
. hepatic activity of diacylglycerolcholine-phosphotransferase 
(E.C.2.7.8.2) was found to increase although the specific activity 
decreased .. 
Fatty acid synthetase can exist in a phosphorylated form, with 
reduced activity, and a dephosphorylated active form (Qureshi et al., 
1975). In addition, it is activated by some phosphorylated sugars 
(Wakil et al., 1966) and inhibited by fatty acyl-CoA derivatives 
(Butterworth et al., 1966; Aprahamian et al., 1979), high 
concentrations of CoA (Stern et al., 1982) and malonyl-CoA (Plate 
et al., 1968; Cox & Hammes, 1983). Because of these characteristics 
(for reviews, see Numa & Yamashita, 1974; Volpe & Vagelos, 1976) it 
has been suggested that fatty acid synthetase may, in some 
circumstances, be the rate-limiting enzyme in fatty acid synthesis. 
For instance, Donaldson (1979) suggests that fatty acid synthetase 
plays an important role in the control of lipogenesis, in the chicken, 
when lipogenesis is minimal. Courtney & Manning (1984) have shown 
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that, following a single injection of 17a-oestradiol (0.75 mg/100 g 
body wt.), immature male chicks exhibit increased totai hepatic 
fatty acid synthetase activity, compared to control birds, after 
26 hours post-injection. Interestingly, these workers also reported 
that an early increase (~ 26 h) in fatty acid synthetase activity 
following oestrogen treatment is due to the injection procedure, 
since a similar increase is observed in control birds. 
The administration of exogenous oestrogen to immature birds, both 
male and female, results in the increase in activity of many key 
enzymes involved in hepatic lipogenesis. Furthermore, such 
increases in lipogenic enzyme activity correlate very well with the 
results from studies of oestrogen-treated birds in which the rate 
of hepatic lipogenesis has been measured, either in vivo or ~ 
vitro. For instance, the administration of exogenous oestrogen to 
young chicks (sex undetermined), in vivo, increased the rate of 
de novo fatty acid synthesis in liver slices, monitored by the 
incorporation of [1- 14~ acetate (Kudzma et al., 1973). Similarly, 
Courtney (1984) measured increased de novo fatty acid synthesis in 
liver slices from oestrogen-treated immature male chicks, as 
determined by the incorporation of [1 - 14c] acetate and 3H20 into 
lipids. Furthermore, oestrogen treatment increased the rate of 
incorporation of preformed fatty acids into hepatic glycerolipids, 
in vivo (Kudzma et al., 1975), and in liver slices, in vitro 
(Courtney, 1984). Increases in the rate of de novo lipogenesis, 
monitored by the incorporation of 3H20 into hepatic glycerolipid 
in vivo, have also been observed in oestrogen-treated immature male 
turkeys (Dashti et al., 1983). 
While oestrogens have been shown to have a major involvement in the 
physiological changes observed when the hen comes into lay (Lorenz, 
1954), androgens and progestagens have also been shown to be 
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involved, to some extent (Balnave & Pearce, 1974). In particular, 
androgens exert significant influences on hepatic lipid metabolism 
in the domestic fowl. For example, testosterone treatment of 4-week 
old pullets (2 mg testosterone propionate/bird) caused increases in 
the specific activities of ATP citrate lyase and 'malic' enzyme in 
liver after 1 day of hormone treatment (Pearce & Balnave, 1973; 
Balnave & Pearce, 1974). However, Pearce (l977b) injected laying 
hens with a daily dose of testosterone propionate (1 mg/kg body wt.) 
for 4 days and observed significantly reduced specific activities 
of hepatic ATP citrate lyase and 'malic' enzyme 24 hours after the 
last injection. The apparently contradicting results in pullets and 
laying hens could be explained by differences in the age of animal 
used, in the hormone dose level used and in the duration of hormone 
treatment employed. 
The involvement of progestagens in the regulation of lipogenesis is 
unclear, since progestagen treatment of domestic fowl has not been 
found to have marked effects on hepatic lipid metabolism, in general, 
or on hepatic lipogenic enzyme activities, in particular (Balnave, 
1969; Balnave & Pearce, 1974). 
In the light of the reports of increased activities of a number of 
lipogenic enzymes in oestrogen-treated birds, the aim of the present 
study was to investigate the effect of oestrogen treatment on 
hepatic acetyl-CoA carboxylase activity in immature male chicks. 
This enzyme is believed to be the rate-limiting enzyme in de novo 
fatty acid synthesis in many cases, and for this reason, the enzyme 
is worthy of detailed study in the liver of oestrogen-treated 
birds. Furthermore, attempts were to be made to correlate any 
changes in enzyme activity with changes in the profile of liver and 
plasma lipids, in an effort to determine the importance of acetyl-
CoA carboxylase in the enhanced lipogenesis promoted by oestrogen 
treatment. 
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METHODS 
1. Animals 
(a) Housing 
Birds were kept under the same conditions as reported in the Methods 
section of Chapter 2 and were used when aged between 3 - 5 weeks. 
(b) Oestrogen treatment 
Unless indicated otherwise, oestrogen-treated birds received an 
intramuscular injection of l7~-oestradio1 (0.75 mg/100 g body wt.), 
dissolved in propane-1,2-dio1 (0. l ml/100 g body wt.). Control birds 
received an equivalent volume of the propane-1,2-diol vehicle only. 
(c) Sacrifice of birds 
All birds were sacrificed between 11.00 and 13.00 hours to minimise 
any possible diurnal variation in the parameters under investigation. 
Birds were weighed and then killed by decapitation. The livers 
were removed quickly, weighed and rapidly chilled on ice. A portion 
of each liver was weighed and stored at -20°C for future DNA 
estimation. 
2. Solutions 
(a) Preparation and assay of acetyl-CoA 
Acetyl-CoA was prepared by the method of Smith et al. (1966). 
Acetic anhydride was reacted with CoA in bicarbonate solution at 
oo - 5°C, the final pH being adjusted to a value between pH 1 - 3. 
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The method of Chase (1967 was used to determine the concentration 
of acetyl-CoA. In this assay, given an excess of oxaloacetate and 
5,5'-dithiobis(2-nitrobenzoic acid), the differences between the 
free thiol content of the preparation and the total thiol content 
after incubation with citrate synthase was used to estimate acetyl-
CoA concentration. The production of 5-thio-nitrobenzoate was 
measured by following the increase in absorbance at 412 nm using a 
Pye Unicam SP8-100 spectrophotometer. Acetyl-CoA solutions 
(pH 1 - 3) were diluted to the required concentration (2 mM) with 
distilled water and then stored at -20°C. Fresh solutions were 
prepared every 3 weeks. 
(b) Preparation and storage of stock sodium [14c] bicarbonate. 
Sodium [14c] bicarbonate was mixed with non-radioactive sodium 
bicarbonate solution to produce a stock solution. The precise 
specific radioactivity of the stock solution was determined 
immediately after its preparation. Aliquots (50- 100 )Jl) of this 
solution were diluted with non-radioactive sodium bicarbonate and 
1 ml samples were mixed with 10 ml of xylene-Triton X-100(2:1, v/v) 
containing 2,5-diphenyloxazole (5.5 g/1) and 1,4-di(2-(5-pheny1-
oxazo l yl)) benzene ( 0. 1 g/ 1) . Radioactivity was determined in a 
Packard 300CD Tri-Carb Liquid Scintillation Counter. Stock 
solutions of sodium [14c] bicarbonate, with a specific radioactivity 
of 0.22 - 0.38 ~Ci per ~mole, were stored at room temperature in a 
series of heat-sealed glass ampoules. Each ampoule contained 
sufficient sodium [ 14 ~1 bicarbonate for 30 assays of acetyl-CoA 
carboxylase and, after opening, the contents were used immediately. 
(c) Other solutions. 
Stock solutions were prepared and stored as follows: IM-Tris/HCl of 
a variety of pH values (6.9- 8.2 at 25°C), 0.2 M-magnesium chloride, 
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0.8 M-potassium citrate, 0.1 M-dithiothreitol, 0.65 M-potassium 
chloride, iO mM-EDTA, pH7.0, and 0.2 M-potassium phosphate, pH7.0, 
were stored at 4°C and replaced at fortnightly intervals. The 
following solutions were stored at -20°C and replaced every 3 
weeks; 8 mM-ATP, pH7.0, and 4.8 mg/ml BSA (fatty acid poor). 
Postassium bicarbonate (0. 1 M) was prepared on the day of use. 
These solutions were mixed to prepare the various buffers and 
1 Cocktails 1 on their day of use. 
3. Acetyl-CoA carboxylase 
(a) Enzyme preparation 
Since acetyl-CoA carboxylase is a soluble cytoplasmic enzyme, a 
particle-free supernatant (PFS) was prepared from each liver. 
Portions of the chilled livers were homogenised using a teflon-glass 
homogeniser with 2 volumes of ice-cold homogenisation buffer 
consisting of 94 mM-potassium phosphate, 0.5 mM-EDTA, 0.2 mM-
dithiothreitol, 65 mM-potassium chloride and 5 mM-potassium 
bicarbonate, at pH7.0. The tissue was disrupted with 8 1 Up and 
down 1 strokes of the rotating pestle and care was taken not to cause 
foaming. Volumes of homogenates were measured and they were then 
centrifuged at 100,000 ~ (rav. 6.4 em) for 1 hour at 4°C in a M.S.E. 
Prepsin 50 centrifuge. The supernatants were diluted with an ice-
cold dilution buffer, consisting of 50 mM-potassium phosphate, 
0.1 mM-EDTA and 0.5 mM-dithiothreitol, at pH7.0, prior to assay 
for acetyl-CoA carboxylase. 
(b) Assay of acety1-CoA carboxylase activity 
Enzyme activity was determined by following the rate of acetyl-CoA-
dependent [14c] bicarbonate incorporation into an acid-stable product. 
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All procedures were performed in a fume cupboard. Unless otherwise 
stated, the assay system contained, in a final volume of 0.4 ml, 
100 mM-Tris/HCl (pH7.4 at 25°C), 8 mM-magnesium chloride, 11 mM-
potassium citrate, 0.25 mM-acetyl-CoA, 0.6 mg/ml BSA (fatty acid 
poor), 3 mM-dithiothreitol, 1 mM-ATP, 25 mM-sodium [14c] bicarbonate 
(0.22 - 0.38 ~Ci/~mole) and an aliquot of the diluted PFS. The pH 
of the assay system, at the incubation temperature of 37°C, was 
pH7.05. 
'Blank' assays contained all components except enzyme (or ATP or 
acetyl-CoA). Assays were performed in duplicate or triplicate at 
37°C and were started by the addition of 100 pl of 'Start Cocktail' 
at 37°C, containing sodium r4c] bicarbonate and ATP, to 300 pl 
of 'Assay Cocktail', containing the other components, which had been 
pre-incubated at 37°C for 15 minutes. The reactions were stopped 
after 1.5 minutes by the addition of 100 ~1 of 6 M-hydrochloric acid 
and the tubes were immediately stoppered. 14co2, released from 
non-incorporated ~ 4 c] bicarbonate, was trapped by filter paper, 
dampened with sodium hydroxide solution, suspended from the stoppers. 
After 30 minutes, the contents of each tube were transferred to 
scintillation vials, then each tube was washed out with 1 ml of 
0.5 M-sodium bicarbonate. The washings were added to the 
corresponding vials and the contents were dried ~own overnight at 
50°C before being re-dissolved in 1 ml of distilled water and radio-
activity measured as described previously. 
One unit of acetyl-CoA carboxylase activity was defined, in this 
study, as the amount of enzyme required to catalyse the incorporation 
of 1 )Jmole of [14c] bicarbonate into acid-stable product (malonyl-
CoAl per minute at 37°C, under the assay conditions described. 
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4. Protein determination 
The protein content of each enzyme preparation was determined as 
described in the Methods section of Chapter 2. 
5. DNA determination 
The DNA content of portions of liver from each bird was determined 
as described in the Methods section of Chapter 2. 
6. Statistical analysis 
Data were analysed statistically by Student's 't' test. Probability 
values (p) of 0.05 or less were taken to be significant. Standard 
errors are provided to show the degree of variance and levels of 
statistical significance are indicated. 
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RESULTS 
1. Characterisation of the procedure for the assay of acetyl-CoA 
carboxylase activity 
(a) Loss of radioactivity from the 'Start Cocktail' and the 'assay 
cocktail' during the enzyme assay 
Starting the acetyl-CoA carboxylase assay involved the addition of 
100 pl of 'start cocktail', containing sodium [14c] bicarbonate and 
ATP, to a pre-incubated 'assay cocktail' that contained the liver 
extract. The 'start cocktail' was prepared just before it was 
needed by mixing stock solutions of sodium [14c] bicarbonate of 
known specific radioactivity with ATP solution. For the 5 minutes 
before its use the 'start cocktail' was placed in the 37°C water 
bath to thermally equilibrate. During this thermo-equilibration 
period, and during the 1.5 minute assay periods, it was known that 
there was likely to be a loss of carbon dioxide from the cocktails, 
leading to a reduction in bicarbonate concentration and radio-
activity (Manning et al., 1976). Assuming that the loss of 14co2 
--- 12 
occurred at the same rate as that of co2, the specific radio-
activity would remain constant throughout. However, it was 
important to determine the extent of the loss of radioactivity, 
during the complete assay procedure, since this would be an 
indication of the reduction in the concentration of bicarbonate, 
one of the substrates of the reaction. Assays started later in the 
procedure would obviously receive a reduced amount of bicarbonate 
in comparison to those started earlier and it was necessary to 
ensure that the bicarbonate concentrations during each 1.5 minute 
assay were still optimal or near-optimal. 
In order to quantify the loss of radioactivity from the 'start 
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cocktail' a number of 'start cocktails' were prepared and incubated 
Samples were removed at regular 
intervals and, after di1ution in non-radioactive sodium bicarbonate, 
radioactivity was determined using liquid-scintillation counting as 
described previously. Figure 4. la shows the extent of the loss of 
radioactivity from the 'start cocktail' during a typical experiment. 
The 'start cocktail' was prepared at zero-time, stored on ice for 
5 minutes and subsequently incubated at 37°C for 20 minutes. At the 
end of the incubation, the level of radioactivity had reduced by 16%, 
compared to the zero-time level. However, the loss of radioactivity 
from the 'start cocktail' during the first 5-minute period, while 
stored on ice, was negligible ( < 1%). 
The results of a similar experiment, designed to follow the loss of 
radioactivity from an individual assay tube containing 100 pl of 
'start cocktail' and 300 pl of 'assay cocktail' at 37°C, are 
presented in Figure 4. lb. During the first 1.5 minutes of the 
incubation period the radioactivity of the assay system (0.4 ml) 
diminished by 5%, while at the end of 10 minutes the radioactivity 
had reduced by 26%. 
(b) Identification of the acid-stable products of the enzyme assay. 
The acid-stable products of the assay were identified by thin-layer 
chromatography, using the method of Myers & Huang (1969). Assays 
were performed as described previously except the incubation time 
was 3.5 minutes and the specific radioactivity of sodium [14c] 
bicarbonate was 1.2 ~Ci per pmole. These changes were adopted to 
increase the amount of radioactive bicarbonate incorporated into 
acid-stable products. After the reactions had been stopped, 
precipated protein was removed by centrifugation and 5.25 pmoles 
of each of the following standards were added; citrate, malate, 
aspartate and malonate. After drying down overnight at 50°C, the 
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Figure 4.1 
The loss of radioactivity from 1 Start cocktail 1 held on ice or 
at 37°C, and from assay incubations at 37°C. 
(a) Loss of radioactivity from 1 Start Cocktai1 1 • 
1 Start cocktail 1 (2.5 ml) containing sodium [14c] bicarbonate 
(40 mM) and ATP (8 mM), was prepared as described in the Methods 
section. 
The 1 Start cocktail 1 was kept on ice for 5 minutes and 
subsequently incubated at 37°C for a further 20 minutes. 
Samples (50 ~1) were removed at regular intervals during the 25 
minute period and radioactivity determined as described in the 
text. 
(b) Loss of radioactivity from an assay incubation. 
1 Start cocktail 1 (100 }Ill was added to 300 JJl 1 assay cocktail 1 , 
as described in the Methods section, and was incubated at 37°C. 
Final concentrations in the assay system were 60 mM-Tris/HCl 
(pH 7.5 at 25°C), 0.2 mM-acetyl-CoA, 3 mM-dithiothreitol, 20 mM-
potassium citrate, 8 mM-magnesium chloride, 0.6 mg/ml BSA, 2 mM-
ATP and 10 rnM-sodium [14c] bicarbonate. The assay system, however, 
did not contain enzyme. Samples (25 ~1) were removed during an 
11-minute incubation period and radioactivity determined as 
described in the text. 
a. 
I'll 
.... 
..!~:: 
u 
0 
u 
.... 
u 
I'll 
0 
"0 
I'll 
0:: 
b. 1. 1 
:J.-
0·-ou 
.::2":J. 
c-
·- E 
>-aJ 
........ 
>~ 
.... (/) 
~>-
0 10 
"0 (/) 
I'll (/) 
0::1'0 
1.0 
0. 9 
0.8 
0.7 
0.6 
1.5 
1.4 
1.3 
100 
1.2 
1.1 
1.0 
0.9 
0 5 10 1 5 20 25 
Time after preparation of cocktail (minutes) 
~c 
.... > 
I ·-0 .... 
80 ~ ~ 
N .2 
.... "0 
7'~· 0 I'll 
'-' o\O 1. 
60 
100 
90 QJ >-E .... 
·z ·;:; 
80 b ".;:i 
!.. u 
QJ I'll 
70 N 0 
.... "0 
0 I'll 
60 o\Ci !.. 
0.5~----~------T------r------~----~----~ 50 
0 2 4 6 8 10 12 
Time of incubation (minutes) 
acid-stable products and standards were re-dissolved in 100 ~1 of 
distilled water. Aliquots (25)Jl) were measured for radioactivity 
and 6 ul aliquots were spotted on to a number of MN300 cellulose 
TLC plates of 250 ~m thickness. Malonyl-CoA (0. 15 ~mol in 3~1) 
was spotted over each of the experimental samples. Mixtures of 
the standards were applied as spots to the rest of the plates 
before being developed in the following solvent mixture; diethyl 
ether/formic acid/water (7:2:1, by vol.). Once the plates had dried, 
l em sections were scraped from the length of the experimental lanes, 
placed into scintillation vials and radioactivity determined as 
described previously. The positions of standards were identified 
by spraying the scraped plates with bromocresol green indicator 
(Myers & Huang, 1969). 
The results of a typical thin-layer chromatographic analysis of the 
acid-stable products of the reaction are presented in Figure 4.2. 
Of the radioactivity applied to the plate, 96% was recovered in the 
scrapings of the developed plate, 61% being located in a spot which 
co-chromatographed with malonyl-CoA and 34.8% of the applied 
radioactivity being located in a spot which co-chromatographed with 
malonate. 
The RF values of the standards were as follows:-
Standard 
Malonate 
Malate 
Citrate 
Aspartate 
Malonyl-CoA 
RFValue 
0. 77 
0.55 
0.39 
0.27 
0.07 
'14 l It is assumed that the L ~~ malonate is a degradation product, 
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Figure 4.2 
Thin-layer chromatographic analysis of the acid-stable products 
of the assay procedure for acetyl-CoA carboxylase. 
Assay of chick liver acetyl-CoA carboxylase was performed using 
the incubation procedure and conditions described in the Methods 
section, with the exception that a 3.5 min. incubation period 
was adopted and the sodium [14c] bicarbonate specific radio-
activity was 1.2 ~Ci/~mole. 
After the reaction had been stopped by the addition of HCl (6 M), 
the acid-stable products were subjected tot. l.c. analysis on 
MN300 cellulose plates, as described in the text, using a solvent 
mixture of diethyl ether/formic acid/water (7:2:1, by vol.). 
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derived from [ 14~ malonyl-CoA as a result of the prolonged (over-
night) incubation at 50nC under acidic conditions. It appears, 
therefore, that [14~ malonyl-CoA is the only major acid-stable 
radioactive product formed under the present assay conditions, 
allowing the amount of acid-stable radioactivity to be used as a 
measure of the activity of acetyl-CoA carboxylase. 
(c) Establishment of optimum conditions for the assay of acetyl-CoA 
carboxylase 
Optimum conditions for the assay of enzyme activity were determined 
for enzyme preparations of untreated, control and oestrogen-treated 
birds. Initially the conditions of Gregolin et al. (1968b) for the 
assay of acetyl-CoA carboxylase activity from chicken liver were 
adopted with slight modifications. The assay system contained loo~M­
Tris/HCl (pH7.5 at 25°C), 8 mM magnesium chloride, 2 mM-ATP, 20 mM-
potassium citrate, 0.2 mM-acetyl-CoA, 0.6 mg/ml-BSA, 20 mM-sodium 
~ 4~ bicarbonate (0.2 ~Ci per pmole), and 3 mM-dithiothreitol in a 
final volume 0.4 ml at 37°C. Each factor was varied in turn keeping 
all other parameters constant. As each factor was optimised, this 
value was inserted into the conditions used for subsequent 
determinations. Unless stated otherwise, oestrogen-treated and 
control birds were used 48 hours after receiving an injection. 
When acetyl-CoA carboxylase activity was measured in liver extracts 
from an untreated bird, the incorporation of 1~ 4 c] bicarbonate into 
acid-stable radioactive products was found to be linear with respect 
to time only up to 1.5 minutes (Fig. 4.3). Time-course studies on 
control and oestrogen-treated birds killed at 48 hours after 
injection also showed linear incorporation up to 1,5 minutes 
incubation time (Fig. 4.4). Similar results were obtained during 
time-course studies on control and oestrogen-treated birds killed 
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Figure 4.3 
The effect of assay incubation time on the activity of acetyl-CoA 
carboxylase from the liver of an untreated male chick. 
Enzyme assays were performed at 37°C as described in the text. 
The enzyme was pre-incubated for 5 minutes at 37°C, in the 
presence of citrate (27 mM), and then assayed using varying 
incubation times in the presence of 100 mM-Tris/HCl (pH7.5 at 
25°C), 8 mM-magnesium chloride, 20 mM-potassium citrate, 
0.2 mM-acetyl-CoA, 3 mM-dithiothreitol, 0.6 mg/ml BSA, 2 mM-ATP, 
and 10 mM sod i urn [14cJ bicarbonate. 
Assays were performed in duplicate. 
Bird aged 27 days. 
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Figure 4.4 
The effect of assay incubation time on the activity of acetyl-CoA 
carboxylase from the livers of oestrogen-treated and control male 
chicks. 
Enzyme assays were performed at 37°C as described in the text. 
The enzyme was pre-incubated for 15 minutes at 37°C, in the 
presence of citrate (14.7 mM), and then assayed using varying 
incubation times in the presence of 100 mM-Tris/HCl (pH7.4 at 
25°C), 8 mM-magnesium chloride, 11 mM-potassium citrate, 0.25 mM-
acetyl-CoA, 3mM-dithiothreitol, 0.6 mg/m1 BSA, 1 mM-ATP and 
25 mM-sodium r4c} bicarbonate. 
Assays were performed in duplicate. 
Birds aged 25 days. 
(a) Activity of acetyl-CoA carboxylase from liver pf an 
oestrogen-treated chick killed 48 hours after injection. 
(b) Activity of acetyl-CoA carboxylase from liver of a control 
chick killed 48 hours after injection. 
The oestrogen-treated bird received a single intramuscular 
injection of 17~-oestradiol (0.75 mg/100 g body wt.) in 
propane-1,2-diol. The control bird received an equivalent 
volume of propane-1,2-diol. 
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at 6 hours and 24 hours after injection. Consequently, a11 
subsequent assays were performed for 1.5 minutes. 
The measured activity of the enzyme was linear with respect to 
soluble protein up to 0.25 mg protein for untreated birds (Fig. 4.5). 
Assays performed on control and oestrogen-treated birds killed at 
48 hours after injection demonstrated linearity up to 0.18 mg 
soluble protein per assay and 0.13 mg soluble protein per assay, 
respectively. (Fig.4.6). Similar studies on control and oestrogen-
treated birds killed at 5 hours, 16 hours; 24 hours, 36 hours and 
72 hours after injection also demonstrated linearity up to those 
levels of soluble protein per assay reported for birds killed 48 
hours after injection. Consequently, all subsequent assays were 
performed using less than 0.20 mg protein for untreated birds, less 
than 0.15 mg protein for control birds and less than 0.12 mg protein 
for oestrogen-treated birds. 
The optimum citrate concentration for the assay of the enzyme 
extracted from untreated birds, as well as control and oestrogen-
treated birds killed 48 hours after injection, was found to be in 
the range of 9 mM- 13 mM (Fig. 4.7). Furthermore, the results of 
an experiment where the activity of the enzyme extracted from the 
liver of an untreated bird was measured following pre-incubation of 
the enzyme with citrate (14.7 mM) at 37°C for varying times 
indicated that a pre-incubation time of 15 minutes was optimal 
(Fig. 4.8) and this pre-incubation period was used in all subsequent 
assays of the enzyme. 
Figure 4.9a shows that acetyl-CoA concentrations of 0.22 mM -
0.38 mM produced optimum activity for the enzyme extracted from 
untreated birds. Assays performed using enzyme derived from control 
and oestrogen-treated birds, killed 48 hours after injection, 
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Figure 4.5 
The effect of varying soluble protein content in the liver extract 
on the activity of acetyl-CoA carboxylase from the liver of an 
untreated male chick. 
Enzyme assays were performed at 37°C as described in the text. 
At each level of soluble protein, the enzyme extract was 
pre-incubated for 5 minutes at 37°C in the presence of citrate 
(27 mM), and then assayed in the presence of 100 mM-Tris/HCl 
(pH7.5 at 25°C), 8 mM-magnesium chloride, 20 mM-potassium 
citrate, 0.2 mM-acetyl-CoA, 3mM-dithiothreitol, 0.6 mg/ml BSA, 
2 mM-ATP and 10 mM sodium [14c] bicarbonate. 
Assays were performed in duplicate. 
Bird aged 29 days. 
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Figure 4.6 
The effect of varying soluble protein content in the liver 
extract on the activity of acetyl-CoA carboxylase from the 
livers of oestrogen-treated and control male chicks. 
Enzyme assays were performed at 37°C as described in the text. 
At each level of soluble protein, the enzyme extract was 
pre-incubated for 15 minutes at 37°C, in the presence of 
citrate (14.7 mM), and then assayed in the presence of 100 mM-
Tris/HCl (pH 7.4 at 25°C), 8 mM-magnesium chloride, 11 mM-
potassium citrate, 0.25 mM-acetyl-CoA, 3 mM-dithiothreitol, 
0.6 mg/ml BSA, 1 mM-ATP and 25 mM-sodium [14 c] bicarbonate. 
Assays were performed in duplicate. 
Birds aged 30 days. 
(a) Activity of acetyl-CoA carboxylase from liver of an 
oestrogen-treated chick killed 48 hours after injection. 
(b) Activity of acetyl-CoA carboxylase from liver of a 
control chick killed 48 hours after injection. 
The oestrogen-treated bird received an intramuscular injection 
of 17~-oestradiol (0.75 mg/100 g body wt.) in propane-1,2-diol. 
The control bird received an equivalent volume of propane-
1,2-diol. 
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Figure 4.7 
The effect of citrate concentration on the activity of 
acetyl-CoA carboxylase from the livers of untreated, 
oestrogen-treated and control male chicks. 
Enzyme assays were performed at 37°C as described in the text. 
The enzyme was pre-incubated for 15 minutes at 37°C in the 
presence of citrate, and then assayed in the presence of 
100 mM-Tris-HCl (pH7.4 at 25°C), 8 mM-magnesium chloride, 
0 - 19 mM-potassium citrate, 0.25 mM-acetyl-CoA, 3 mM-
dithiothreitol, 0.6 mg/ml BSA, 1 mM-ATP and 25 mM-sodium ~ 4 c] 
bicarbonate. 
Assays were performed in duplicate. 
Birds aged 25 - 30 days. 
(a) Activity of acetyl-CoA carboxylase from liver of an 
untreated chick. 
(b) Activity of acetyl-CoA carboxylase from liver of an 
oestrogen-treated chick killed 48 hours after injection. 
(c) Activity of acetyl-CoA carboxylase from liver of a 
control chick killed 48 hours after injection. 
The oestrogen-treated bird received a single intramuscular 
injection of 17~-oestradiol (0.75 mg/100 g body wt.) in 
propane-1,2-diol. The control bird received an equivalent 
volume of propane-1,2-diol. 
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Figure 4.8 
The effect of pre-incubation time, in the presence of citrate 
( 14.7 rnt<l), on the activity of acetyl-CoA carboxylase from 
the liver of an untreated male chick. 
Enzyme assays were performed at 37°C as described in the text. 
The enzyme was pre-incubated for 5 - 30 minutes at 37°C, in 
the presence of citrate (14.7 mM), and then assayed in the 
presence of 100 mM-Tris/HCl (pH7.5 at 25°C), 8 mM-magnesium 
chloride, 11 mM-potassium citrate, 0.2 mM-acetyl-CoA, 
3mfv1-dithiothreito1, 0.6 mg/m1 BSA, 2 mM-ATP and 10 mM-sodium 
[14cJ bicarbonate. 
Assays were performed in duplicate. 
Bird aged 32 days. 
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indicated optimum activity at acetyl-CoA concentrations above 
0.25 mM (Fig. 4.9b & c) and, therefore, this concentration was 
used in subsequent assays on all birds. 
Optimum ATP concentrations for the assay of enzyme derived from 
untreated, control and oestrogen-treated birds, at 48 hours after 
injection were in the range of 0.8 mM- 1.2 mM (Fig. 4. 10). 
Greater ATP concentrations resulted in an inhibition of the enzyme 
activity measured. As a result, an ATP concentration of 1 mM was 
used in subsequent assays on all birds. 
Assays performed at various bicarbonate concentrations using enzyme 
derived from untreated birds showed that maximal or near-maximal 
enzyme activity was measured at concentrations of 25 mM - 35 mM 
(Fig. 4. lla). Similar results were obtained using enzyme extracted 
from control and oestrogen-treated birds killed 48 hours after 
injection, in that maximal or near-maximal enzyme activity was 
measured at bicarbonate concentrations of 25 mM - 32 mM (Fig. 4. llb 
& c.). Consequently, a bicarbonate concentration of 25 mM was used 
in all subsequent assays. 
Assays performed at various magnesium chloride concentrations using 
enzyme extracted from an untreated bird indicated peak enzyme 
activity with magnesium concentrations of 7 mM- 9 mM (Fig. 4. 12a). 
As a result, a magnesium chloride concentration of 8 mM was used in 
all subsequent assays. 
An experiment in which the activity of enzyme, extracted from an 
untreated bird, was determined at various pH values, revealed that 
peak enzyme activity was measured over a range of pH6.7 to pH?. 1, 
measured at 37°C (Fig. 4. 12b). At greater pH values, the measured 
enzyme activity was greatly reduced. Consequently, a value of 
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Figure 4.9 
The effect of acetyl-CoA concentration on the activity of 
acetyl-CoA carboxylase from livers of untreated, oestrogen-
treated and control male chicks. 
Enzyme assays were performed at 37°C as described in the text. 
The enzyme was pre-incubated for 15 minutes at 37°C, in the 
presence of citrate (14.6 mM), and then assayed in the 
presence of 100 mM-Tris/HCl (pH 7.5 at 25°C), 8 mM-magnesium 
chloride, 11 mM-potassium citrate, 0 - 0.38 mM-acetyl-CoA, 
3 ITW1-dithiothreitol, 0.6 mg/ml BSA, 1 mM-ATP and 25 mM-sodium 
"14 l [ C bicarbonate. 
Assays were performed in duplicate. 
Birds aged 25 - 31 days. 
(a) Activity of acetyl-CoA carboxylase from liver of an 
untreated chick. 
(b) Activity of acetyl-CoA carboxylase from liver of an 
oestrogen-treated chick killed 48 hours after injection. 
(c) Activity of acetyl-CoA carboxylase from liver of a 
control chick killed 48 hours after injection. 
The oestrogen-treated chick received a single intramuscular 
injection of 17~-oestradiol (0.75 mg/100 g body wt.) in 
propane-1,2-diol. The control bird received an equivalent 
volume of propane-1,2-diol. 
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Figure 4.10 
The effect of ATP concentration on the activity of acetyl-CoA 
carboxylase from the livers of untreated, oestrogen-treated 
and control chicks. 
Enzyme assays were performed at 37°C as described in the text. 
The enzyme was pre-incubated for 15 minutes at 37°C in the 
presence of citrate (14.7 mM), and then assayed in the 
presence of 100 mM-Tris/HCl (pH7.5 at 25°C), 8 mM-magnesium 
chloride, 11 mM-potassium citrate, 0.25 mM-acetyl-CoA, 
3 mM-dithiothreitol, 0.6 mg/ml BSA, 0- 2.0 mM-ATP and 25 mM-
sodium [14c] bicarbonate. 
Assays were performed in duplicate. 
Birds aged 24 - 29 days. 
(a) Activity of acetyl-CoA carboxylase from liver of an 
untreated chick. 
(b) Activity of acetyl-CoA carboxylase from liver of an 
oestrogen-treated chick killed 48 hours after injection. 
(c) Activity of acetyl-CoA carboxylase from liver of a 
control chick killed 48 hours after injection. 
The oestrogen-treated bird received a single intramuscular 
injection of 17~-oestradiol (0.75 mg/100 g body wt.) in 
propane-1,2-diol. The control bird received an equivalent 
volume of propane-1,2-diol. 
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Figure 4.11 
The effect of bicarbonate concentration on the activity of 
acetyl-CoA carboxylase from the livers of untreated, 
oestrogen-treated and control male chicks. 
Enzyme assays were performed at 37°C as described in the text. 
The enzyme was pre-incubated for 15 minutes at 37°C, in the 
presence of citrate (14.7 mM), and then assayed in the 
presence of 100 mM-Tris/HCl (pH7.4 at 25°C), 8 mM-magnesium 
chloride, 11 mM-potassium citrate, 0.25 mM-acetyl-CoA, 3 mM-
dithiothreitol, 0.6 mg/ml BSA, 1 mM-ATP and 0- 35 mM-sodium 
[14 -cj bicarbonate. 
Assays were performed in duplicate. 
Birds aged 26 - 28 days. 
(a) Activity of acetyl-CoA carboxylase from liver of an 
untreated chick. 
(b) Activity of acetyl-CoA carboxylase from liver of an 
oestrogen-treated chick killed 48 hours after injection. 
(c) Activity of acetyl-CoA carboxylase from liver of a 
control chick killed 48 hours after injection. 
The oestrogen-treated bird received a single intramuscular 
injection of 17~-oestradiol (0.75 mg/100 g body wt.) in 
propane-1,2-diol. The control bird received an equivalent 
volume of propane-1,2-diol. 
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Figure 4.12 
The effect of magnesium chloride concentration and of pH on 
the activity of acetyl-CoA carboxylase from livers of 
untreated birds. 
(a) Effect of magnesium chloride concentration. 
Enzyme assays were performed at 37°C as described in the text. 
The enzyme was pre-incubated at 37°C in the presence of 
citrate (14.7 mM), and then assayed in the presence of 100 mM-
Tris/HCl (pH7.5 at 25°C), 0- 18 mM-magnesium chloride, 11 mM-
potassium citrate, 0.25 mM-acetyl-CoA, 3 mM-dithiothreitol, 
~14 J 0.6 mg/ml BSA, 1 mM-ATP and 25 mM-sodium L C bicarbonate. 
Assays were performed in duplicate. 
Bird aged 31 days. 
(b) Effect of pH. 
Enzyme assays were performed at 37°C as described in the text. 
After pre-incubation at 37°C in the presence of citrate 
(14.7 mM), the enzyme was assayed at varying pH values in the 
presence of 100 mM-Tris/HCl (pH 6.4 - 8.2 at 25°C), 8 mM-
magnesium chloride, 11 mM-potassium citrate, 0.25 mM-acetyl-
CoA, 3 mM-dithiothreitol, 0.6 mg/ml BSA, 1 mM-ATP and 25 mM-
sodium r4c] bicarbonate. 
Assays were performed in duplicate. 
Bird aged 32 days. 
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pH7.05 was adopted for subsequent assays, such a pH value being 
produced when a Tris/HCI buffer of pH7.4 at 25°C was used in the 
assay system. 
In view of the results obtained in these preliminary experiments, 
all subsequent assays of acetyl-CoA carboxylase extracted from the 
livers of untreated, control and oestrogen-treated birds were 
performed at pH7.05 at 37°( with final concentrations of 100 mM-
Tris/HCl, 8 mM-magnesium chloride, 11 mM-Rotassium citrate, 0.25 mM-
acetyl-CoA, lmM-ATP and 25 mM-sodium [ 14 ~1 bicarbonate in a fina1 
volume of 0.4 ml. The enzyme preparations were pre-incubated in 
the presence of citrate for 15 minutes at 37°C, before the addition 
of 'start cocktail', and assay incubations were of 1.5 minutes 
duration. 
2. The effect of varying doses of 17~-oestradiol on the activity of 
hepatic acetyl-CoA carboxylase 
To study the effect of 17~-oestradiol on hepatic acetyl-CoA 
carboxylase activity it was necessary to establish an optimum dose 
of hormone. Each bird received a single intramuscular injection of 
17~-oestradiol in propane-1,2-diol equiva1ent to one of the 
following doses; 0.25, 0.50, 0.75, 1.00, 1.25 mg 17~-oestradiol/ 
100 g body weight. Control chicks received an equivalent volume 
of propane-1,2-diol only (0. 1 ml/100 g body wt.). Chicks were 
killed 48 hours after injection and the enzyme activities in the 
high-speed supernatants prepared from the livers were measured. 
The results of this experiment are presented in Table 4.1 and 
Figure 4. 13, indicating an increase in the mean specific activity 
of acetyl-CoA carboxylase as a result of oestrogen treatment, 
reaching a peak at a dose of 0.75 mg hormone/100 g. body weight 
(Fig. 4. 13a). At this dose the mean specific activity was 1.99-fold 
greater than the value for the control group of birds. Higher doses 
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Table 4.1 
The effect of varying doses of 17~-oestradiol on liver weight, the soluble protein content of liver and the 
activity of hepatic acetyl-CoA carboxylase (ACC) 48 hours after injection. 
Each oestrogen-treated bird received an intramuscular injection of 17~-oestradiol in propane-1,2-diol, 
equivalent to one of the following doses:-
0.25, 0.5, 0.75, 1.0, 1.25 mg 17~-oestradiol /100 g body weight. 
Control birds received an equivalent volume of propane-1,2-diol, alone. Birds were sacrificed 48 hours 
after injection and liver enzyme preparations were obtained and assayed, in triplicate, for acetyl-CoA 
carboxylase as described in the Methods section. The protein content of the particle-free supernatant was 
assayed as described in the Methods section. 
Values are the means(± S.E.M.) of 5-8 birds. 
One unit of acetyl-CoA carboxylase activity is defined as that amount of enzyme which catalyses the 
incorporation of 1.0 ~mole [14c] bicarbonate into acid-stable products per min. under the assay conditions 
described. 
Data were analysed statistically by Student's 't' test. Levels of significance presented with oestrogen-
treated values are with respect to control values. 
* significant at p <0.05 
# significant at p <0.01 
¥ significant at p < 0 . 00 1 
The enzyme activity results are presented graphically in Figure 4. 13. 
Birds were aged 28 - 34 days. 
Data for those parameters labelled 't' have been presented in Chapter 2, Table 2. 1. 
178-oestradiol administered (mg/100 g body wt.) 
0 0 0.25 0.50 0. 75 1.00 I. 25 
Control Untreated 
Specific activity of acetyl-
-----1 
CoA carboxylase (m units/mg 
* ¥ ¥ # ¥ 
soluble protein) 11.87 ~ l.ll 12.84 !: 1.23 15.17 ! 0.93 20.84 ~ 1.07 23.65 ~ 2.36 20.85 !: l. 79 20.22 !: 1.52 
Acetyi-CoA carboxylase # ¥ * * 
activity (units/g liver) 0. 98 ~ 0. ll 1.04 ~ 0.10 I. 21 !: 0.07 l. 47 ~ 0.09 1.68 ~ 0.06 l. 42 !: 0.15 l. 35 !: 0.12 
Acetyl-CoA carboxylase ¥ ¥ ¥ ¥ 
activity (units/whole liver) 8.16 ~ 1.09 9.75 ! 1.27 10.86 !: 0.83 19.72!: 2.35 28.60 ~ 4.78 25.05 ~ 2.61 29.54!: 4.0) 
t Body weight (g). 303 !: 20 324 !: 17 294 !: 6 343 ! 18 345 !: 27 387 !: 25 425 !: 10 
t Soluble protein content # * # ¥ (mg/g liver) 81.9 !: l. 7 81.0 !1.3 79.9 ! 1.0 70.2 !: 2.6 72.9 !: 3.0 70.4 ! 2.2 66.8 !: 2. l 
t Solu~le protein content # ¥ ¥ ¥ 
mg/l iver) 677 !: 48 747 ~ 47 720 !: 43 936 !: 73 lll3 !: 87 1270 !: 69 1433 ! 83 
+Liver wt. (as% of body ¥ ¥ ¥ ¥ 
wt.) 2.75 !: 0.09 2.88 !: 0.18 3.06 !: 0.12 3.91 !: 0.22 4.50 !: 0.29 4.69 !: 0. 14 5.05 !: 0.2l! 
No. of birds 8 8 6 6 5 6 6 
-------- -
of hormone (~ l mg/100 g body wt.) caused a slight decrease in the 
mean specific activity of the enzyme. However. at all hormone doses 
the mean specific activity was higher than the values for the 
control and untreated groups. Statistical analysis of these results, 
using Student's 't' test, indicated significant differences in 
specific activity between control and oestrogen-treated birds at 
all doses of hormone (Table 4. 1). There was no significant difference 
between control and untreated birds, with respect to the specific 
activity of the enzyme. The mean specific activity of the enzyme 
from birds treated with 0.75 mg hormone/100 g body weight did not 
differ significantly from the specific activities of the enzyme from 
those birds treated with 0.50, 1.00 and 1.25 mg hormone/lOG g body 
weight. 
Expression of the data as mean enzyme activity per gram liver gave 
a similar result (Fig. 4. 13b). Maximum mean activity occurred with 
a dose of 0.75 mg hormone/100 g body weight, being 1.71-fold 
greater than the mean activity/g liver for the control group. All 
doses, except that of 0.25 mg hormone/100 g body weight, produced 
activities significantly different from the control value (Table 
4. 1). The mean activity/g liver at the dose of 0.75 mg hormone/ 
100 g body weight was significantly greater than the values obtained 
for birds treated with 0.25 mg and 1.25 mg hormone/100 g body 
weight, no significant difference being apparent with the other 
dose levels (0.50 and 1.00 mg hormone/100 g body wt.) 
Expression of enzyme activity as total organ activity revealed a 
slightly different result (Fig. 4. 13c). Maximum mean activity was 
produced with a dose of 1.25 mg hormone/100 g body weight, being 
3.62-fold greater than the mean control value, although it was only 
slightly higher than the activity produced by the 0.75 mg hormone/ 
100 g body weight dose which was 3.5-fold greater than the control 
value. All dose levels produced total organ activities significantly 
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Figure 4.13 
The effect of varying doses of 17~-oestradiol on the activity 
of hepatic acetyl-CoA carboxylase, 48 hours after injection. 
Consult the legend of Table 4.1 for details of experimental 
procedure. 
A values for untreated chicks. 
• values for control chicks, injected 
with propane-1,2-diol. 
0 values for oestrogen-treated chicks. 
(a) Specific activity (nmol [14c] bicarbonate incorporated/ 
min./mg protein). 
(b) Activity/g liver (~mo1[ 14 c] bicarbonate incorporated/ 
min./g 1iver). 
(c) Total hepatic activity (~mol [14c] bicarbonate 
incorporated/min./liver. 
The results are expressed as means (~ S.E.M.) of 5-8 
birds. 
-"0 
~ 
.... 
1'0 
a. 5 
c.. c: 
b. 
s... ·-0 ~ u .... 
c e 
·- c. 
2 ~ 
1'0 -1: .0 
0 ::l 
.0 -
s... ~ 
1'0 u C'l 
:0 E 
...---, -... 
=r-u .E 
~E 
0 
E 
1: 
-
"0 s... ~ ~ 
1U .~ 
~ -
0 C'l e--o 1: g E 
·-2 0.7 
1'0 
c. 1: 
.8 
s... 
1'0 
u 
:0 
...---, s... 
::f'u ~ 
- ·-1..--...J -... 
22 
-~ 
0.25 0 
17 {3- • 50 0. 75 oestradiol ( 1. 00 1 2 mg/100g bod • 5 Y wt.) 
greater than the control value. On the basis of these results, a 
dose of 0.75 mg 17~-oestradiol/100 g body weight was selected for 
future use. 
Oestrogen treatment also caused a decrease in the mean soluble 
protein content of a unit weight of liver (Table 4. 1). Significant 
differences between control and oestrogen-treated values were 
observed at all doses except that of 0.25 mg hormone/100 g body 
weight. The lowest soluble protein value, obtained with a dose of 
1.25 mg hormone/100 g body weight, represented an 18% decrease in 
in the value obtained for control chicks. 
Liver weights, expressed as a percentage of body weight, increased 
over the 17~-oestradiol dose range, a maximum mean value being 
obtained with a dose of 1.25 mg hormone/100 g body weight (Table 4. 1). 
Despite a dose-dependent decrease in soluble protein/g liver, the 
increase in liver weight after oestrogen treatment was accompanied 
by a dose-dependent increase in total soluble protein in the liver 
(Table 4. 1) such that maximum total soluble protein content was 
observed with a dose of 1.25 mg hormone/100 g body weight. 
The variations in liver weight and soluble protein content of male 
chicks treated with varying doses of 17~-oestradiol have been 
reported and discussed in Chapter 2. 
3. The effect of a single intramuscular injection of 17~-oestradiol 
(0.75 mg/100 g body wt.) on the activity of hepatic acetyl-CoA 
carboxylase. 
The results of an experiment designed to investigate the effect of 
an intramuscular injection of 17~-oestradiol (0.75 mg/100 g body wt.) 
on the activity of hepatic acetyl-CoA carboxylase at various times 
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after injection, are presented in Table 4.2 and Figure 4.14. 
Hepatic enzyme activities were expressed as specific activities with 
respect to soluble protein (Fig. 4. 14a) and specific activities with 
respect to DNA (Fig. 4.14b). 
During the first 19 hours after injection the mean specific 
activities, with respect to protein, of oestrogen-treated and 
control birds were not significantly different (Fig. 4. 14a). 
However, during the 24 hour - 48 hour post-injection period the 
specific activity, with respect to protein, of oestrogen-treated 
birds increased in a time-dependent manner while the specific 
activity of control birds remained at a level similar to the value 
for untreated birds. Maximum specific activity, with respect to 
protein, was observed at 48 hours after oestrogen-treatment, the 
value being 1.53-fold greater than the corresponding value for 
control birds and 1.32-fold greater than the value for untreated 
birds. At 61 hours post-injection, the mean specific activities, 
with respect to protein, of control and oestrogen-treated birds were 
not significantly different. 
The trends in mean specific activities, with respect to DNA, in 
control and oestrogen-treated birds during the 61 hour post-
injection period (Fig. 4. 14b) were similar to those for specific 
activities with respect to protein. During the first 19 hours 
after injection the mean specific activities with respect to DNA, 
of oestrogen-treated and control birds were not significantly 
different. However, the mean specific activities, with respect to 
DNA, of oestrogen-treated birds at the 24-hour, 37-hour and 48-hour 
post injection points were significantly greater than the 
corresponding values for control birds which remained at a level 
similar to the value for untreated birds. Maximum mean specific 
activity, with respect to DNA, was observed at 37 hours after 
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Table 4.2 
The effect of a single dose of l~B-oestradiol (0.75 mg in propane-1,2-diol/lOOg body wt.), or of propane-
1,2-diol alone, on the activity of hepatic acetyl-CoA carboxylase (ACC) and the hepatic soluble protein and 
DNA content, at varying times after injection. 
Each oestrogen-treated bird received an intramuscular injection of 17~-oestradiol (0.75 mg/100 g body wt.) in 
propane-1,2-diol. Control birds received an equivalent volume of propane-1,2-diol alone. At the indicated times 
after injection birds were sacrificed, liver enzyme extracts prepared and assayed in triplicate for acetyl-CoA 
carboxylase as described in the Methods section. The protein content of the particle-free supernatant and the 
DNA content of liver samples were determined as described in the Methods section. 
OE = values for oestrogen-treated birds. C = values for control birds. 
Values are means (~ S.E.M.) of 6- 19 birds. 
One unit of acetyl-CoA carboxylase activity is defined as that amount of enzyme which catalyses the incorporation 
of 1.0 ~mole l14c] bicarbonate into acid-stable products per min. under the assay conditions described. 
Data were analysed statistically by Student's 't' test. Levels of statistical significance presented with values 
for oestrogen-treated birds are with respect to the corresponding control values. 
* significant at p <0.05 
# significant at p <0.01 
¥ significant at p <0.001 
The enzyme activity results are presented graphically in Figure 4. 14. 
Birds were aged 25 - 32 days. 
Data for those parameters labelled ':f' have been presented in Chapter 2, Table 2.2. 
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oestrogen treatment when the oestrogen-treated value was 1.59-fold 
greater than the untreated value and the corresponding control value. 
It should be noted, however, that at 48 hours after injection, the 
mean specific activity, with respect to DNA, of oestrogen-treated 
birds was 1.55-fold greater than the value for untreated birds, but 
1.74-fold greater than the value for the corresponding control birds. 
At 61 hours post-injection, while the mean specific activity, with 
respect to DNA, of oestrogen-treated birds was greater than the 
corresponding value for control birds, the two values were not 
significantly different. 
When the results were expressed as activity per gram of liver, a 
slightly different picture emerged (Table 4.2). At 13 hours post-
injection, the mean activity/g liver of control birds was 
significantly greater than the corresponding value for oestrogen-
treated birds (p<0.05). Subsequently the activity/g liver values 
for both oestrogen-treated and control birds were not significantly 
different until 48 hours after injection when the activity/g liver 
of oestrogen-treated birds reached a maximum and was 1.45-fold 
greater than the corresponding value for control birds. At 61 hours 
post-injection, the activity/g liver of control and oestrogen-
treated birds were not significantly different. 
Hepatic acetyl-CoA carboxylase activity was also expressed as total 
activity per whole liver (Fig. 4. 14c). During the first 19-hour 
post-injection period, there was no significant difference between 
values for oestrogen-treated and control birds. However, from 24 
hours to 61 hours after injection the mean total activities per 
liver for oestrogen-treated birds were significantly greater than 
the corresponding values for control birds. Peaks in total hepatic 
activity were observed at 37 hours post-injection when the value for 
oestrogen-treated birds was 2. 10-fold greater than the control value 
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Figure 4. 14 
Hepatic acetyl-CoA carboxylase activity at varying times 
after a single injection of 178-oestradiol (0.75 mg/100 g 
body wt.). 
Consult the legend of Table 4.2 for details of experimental 
procedure. 
A. values for untreated birds. 
• values for control birds, injected 
with propane-1,2-diol. 
0 values for oestrogen-treated birds. 
(a) Specific activity, with respect to soluble protein 
(nmol [14c} bicarbonate incorporated/min./mg protein). 
(b) Specific activity, with respect to DNA (nmol [14c] 
bicarbonate incorporated/min./mg DNA). 
(c) Total hepatic activity ()Jmol [14c] bicarbonate 
incorporated/min./liver. 
The results are expressed as the means (~ S.E.M.) of 6- 19 
birds. 
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and 2.04-fold greater than the untreated value, and at 48 hours 
post-injection, when the oestrogen-treated value was 2.43-fold 
greater than the corresponding control value and 1.97-fold greater 
than the untreated value. 
Throughout the time-course of the experiment (Oh - 6lh) the mean 
soluble protein content/g liver was lower for the oestrogen-treated 
group of birds than the corresponding control group (Table 4.2). 
However, only at 13 hours, 19 hours, 24 hours and 37 hours after 
treatment were statistically significant differences observed and a 
minimum value for oestrogen-treated birds was observed at 37 hours 
post-injection, the value being 82% of the untreated value. 
Oestrogen-treatment also caused a time-related increase in liver 
weight, expressed as a percentage of body weight (Table 4.2). A 
peak in liver weight was observed at 37 hours after oestrogen 
treatment. The oestrogen-dependent increase in liver weight was 
accompanied by an increase in total soluble protein content per 
liver and total DNA content per liver, both parameters reaching a 
peak at 37 hours post-injection (Table 4.2). Measurements of the 
amount of hepatic soluble protein/mg DNA, a parameter which is 
indicative of the cellular soluble protein content, showed an 
increase over corresponding control values at 19 hours - 61 hours 
after oestrogen treatment, although significant differences were 
only observed at 24 hours and 48 hours after injection. 
The variations in liver weight, soluble protein content and DNA 
content of male chicks treated with a single injection of 17~­
oestradiol (0.75 mg/100 g body wt.) have been fully reported and 
discussed in Chapter 2. 
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DISCUSSION 
1. Characterisation of the procedure for the assay of acetyl-CoA 
carboxylase 
Assay of acetyl-CoA carboxylase involved the incubation of the 
enzyme with r4c1 bicarbonate, followed by the addition of HCl 
and drying overnight at 50°C. Analysis, by thin-layer chroma-
tography, of the acidified dried reaction mixtures showed that the 
radioactivity was incorporated into [14c] malonyl-CoA and r4c] 
malonate, the latter being assumed to be a degradation product of 
the former. Less than 0.5% of the radioactivity detected on the 
thin-layer plate was found to co-migrate with standards other than 
these two. It can, therefore, be concluded that the assay employed 
was specific for acetyl-CoA carboxylase and was not suspect to 
interference from other enzymes present in the liver preparation. 
It is important to establish this fact in the light of work presented 
by Davies et al. (1982} which questioned the specificity of the 
[14c] bicarbonate fixation assay for acetyl-CoA carboxylase. These 
workers showed that, under certain assay conditions, the assay is 
prone to interference by pyruvate carboxylase, a mitochondrial 
enzyme with a requirement for acetyl-CoA which is an allosteric 
effector of the enzyme. Davies et al. (1982) observed an acetyl-
CoA-dependent incorporation of C4c] bicarbonate into an acid-stable 
product b~ a crude liver extract, from a fed rat. The extract was 
prepared by homogenisation of the liver followed by centrifugation 
at 27,000 1 for 10 minutes and it was pre-incubated in the absence 
of citrate at 37°C. Thin-layer chromatographic analysis of the end-
products of the assay showed the main reaction products to be 
oxaloacetate, the product of the reaction cataly.sed by pyruvate 
carboxylase, and malate, aspartate and citrate which may be produced 
from oxaloacetate in crude enzyme preparations. However, under the 
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experimental conditions used in the present study, pyruvate 
carboxylase did not interfere with the assay of acetyl-CoA 
carboxylase for the following two reasons: 
(a) Oxaloacetate did not survive the drying process at 55oc since 
Hohorst & Reim (1965) showed that recovery was less than 5% when 
oxaloacetate (up to 4 mM) was subjected to these conditions. For 
this reason, oxaloacetate was not included as one of the standards 
during the thin-layer chromatographic analysis in the present study. 
(b) Radioactivity was not incorporated into malate, citrate or 
aspartate, which are conversion-products of oxaloacetate. 
Reasons for the different assay end-products in the present study 
and that of Davies et al. (1982) could include (a) the use of a 
more careful homogenisation procedure in the present study, which 
minimised mitochondrial disruption, (b) the use of a less crude 
enzyme extract in the present study, the preparation of which 
involved a prolonged centrifugation step for 60 minutes at 100,000 ~ 
and the dilution of the particle-free supernatant, (c) the inclusion 
of a drying down process at 50°C overnight in the present study 
which destroyed any oxaloacetate and (d) the use of a citrate-
activation assay procedure which 1 fully 1 activated the acetyl-CoA 
carboxylase so reducing the effect of any possible interfering 
enzymes. 
The particular assay conditions used by Davies et al. (1982), 
involving assay of a crude liver extract after pre-incubation at 
37°C in the absence of citrate, have become widely used in recent 
years (Allred & Roehrig, 1978; Geelen et al., 1978; Witters et al., 
1979) and have been believed to restore or preserve the in vivo 
activity of acetyl-CoA carboxylase, by a mechanism which is not fully 
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understood. While the results of Davies et al. (1982) have cast 
some doubt on the specificity of the assay, under those particular 
conditions, for acetyl-CoA carboxylase, it is interesting to note 
that Allred & Goodson (1982) showed that assays performed on crude 
rat liver extracts, pre-incubated at 37°C for 40 minutes in the 
absence of citrate, incorporated radioactivity into malonyl-CoA 
and malonic acid only. 
Acetyl-CoA carboxylase from c~ickliver gave optimum activity when 
assayed at pH7.05 at 37°C, with final concentrations of 100 mM-Tris/ 
HCl, 8 mM-magnesium chloride, 11 mM-potassium citrate, 0.25 mM-
acetyl-CoA, 1 mM-ATP, 3 mM-dithiothreitol, 0.6 mg/ml BSA and 25 mM-
sodium [14c] bicarbonate. It was found that oestrogen treatment of 
chicks in vivo did not affect the optimum assay conditions of the 
enzyme in vitro and all subsequent assays of the enzyme could be 
performed under the same conditions, irrespective of the source of 
the liver extract used. When arriving at an optimum bicarbonate 
concentration of 25 mM it was necessary to use a value high enough 
so that even allowing for unavoidable losses of 14co2 and 
12co2 
from the assay system, the bicarbonate concentration would still 
allow the near-optimal assay of acetyl-CoA carboxylase. On the 
other hand, the high cost of sodium r4c] bicarbonate precluded the 
use of high concentrations of bicarbonate in the assay. The assay 
procedure involved the addition of 100 pl of 1 Start cocktai1 1 , 
containing sodium [14~ bicarbonate and ATP, to a pre-incubated 
1 assay cocktail 1 that contained the enzyme. Initial experiments 
showed that freshly-prepared 1 Start cocktail 1 , stored on ice for 5 
minutes and then incubated at 37°C for 20 minutes, had lost 16% of 
its radioactivity at the end of the 25 minutes period (Fig 4. la). 
Another source of loss of radioactivity, in the form of 14co2, was 
from the assay itself during the 1.5 minute incubation period at 
37°C after the addition of 1 Start cocktai1 1 • Initial experiments 
indicated that the radioactivity of the assay system diminished 
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by 5% during the 1.5 minute incubation. In summary, therefore, the 
maximum loss of radioactivity for 'early' assays may be approximately 
5% whereas the maximum loss for 'late' assays may be approximately 
16% + 5% (21%). Therefore, using a bicarbonate concentration of 
25 mM, the minimum bicarbonate concentration of 'early' assays, 
allowing for co2 loss, would be approximately 23.75 mM whereas the 
minimum bicarbonate concentration of 'late' assays would be 
approximately 19.75 mM. The effect of such reduction in bicarbonate 
concentration on the observed activity of acetyl-CoA carboxylase in 
liver extracts can be gauged by reference to Figure 4. lla, which is 
a plot of enzyme specific activity against bicarbonate concentration. 
A reduction of bicarbonate concentration in the early assays, from 
25 mM to 23.75 mM would not substantially affect the measured 
enzyme activity. The possible reduction in bicarbonate concentration 
in the late assays, from 25 mM to 19.75 mM, however, could reduce 
the measured enzyme activities by up to approximately 8%. 
Consideration of these figures would suggest that, in the light of 
the predicted loss of 14co2 and 
12 co2, it would have been better to 
use a higher concentration of bicarbonate (30 mM, for example) to 
abolish the apparent reduction in enzyme activity in the 'late' 
assays. However, the bicarbonate concentration of 25 mM was adopted 
as being the most suitable compromise between the need for a high 
bicarbonate concentration and the high cost of sodium [14c] 
bicarbonate. 
The results of the experiment designed to monitor the loss of 
radioactivity in the form of co2 from the assay system cast some 
doubt upon the reliability of the acetyl-CoA carboxylase assay 
procedure adopted by some previous workers. For instance, Gregolin 
et al. (1968b) used an assay procedure which involved an 
incubation period of 10 minutes, as opposed to the 1.5 minute 
period adopted in the present study. Figure 4. lb, in the present 
study, indicates that an assay incubation period of 10 minutes at 
37°C would lead to a 26% reduction in radioactivity and bicarbonate 
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concentration. Assuming that similar losses were evident in the 10 
minute assay incubation of Gregolin et al. (1968b), the possibility 
exists that, without evidence to the contrary, substantial 
reductions in the measured enzyme activities could have been 
incurred. 
All assay incubations, in the present study were performed for 1.5 
minutes since assays on untreated, control and oestrogen-treated 
birds were all linear up to this point. When deciding how much 
soluble protein to use in a particular assay it was found that 
assays performed on liver extracts from oestrogen-treated birds 
showed a linear relationship between enzyme activity and the amount 
of soluble protein only up to 0.12 mg protein. This value was 
lower than the corresponding values for control and untreated birds 
and was indicative of a possible greater specific activity of the 
enzyme at certain times after oestrogen treatment. 
The assay conditions adopted in the present study differ somewhat 
from those used by other workers to assay acetyl-CoA carboxylase 
from avian liver. Gregolin et al. (1968b) incubated the chicken 
liver enzyme for 10 minutes at 37°C in the presence of 60 mM-Tris/ 
HCl (pH7.5 at 25°C), 10 mM-potassium [14c] bicarbonate, 20mM-
potassium DL-isocitrate, 3 mM-glutathione and 0.6 mg/ml BSA. 
Goodridge (1972) used essentially the same conditions as Gregolin 
et al. (1968b), dithiothreitol being used instead of glutathione. 
It has previously been reported that, unlike acetyl-CoA carboxylase 
from other sources, the chicken liver enzyme does not require 
preliminary incubation with citrate before assay (Gregolin et al., 
1968b). However, in the present study, it was shown that pre-
incubation of a liver extract with citrate at 37°C caused an 
increase in the acetyl-CoA carboxylase activity determined and, 
therefore, in subsequent assays a 15-minute pre-incubation 
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procedure was adopted. This citrate pre-incubation procedure has 
been shown to cause the conversion of the enzyme from the 
disaggregated protomeric form to the more catalytically active 
polymeric form (Gregolin et al., 1966a and 1966b; Numa et al., 1966). 
The assay conditions adopted in the present study also involved 
the pre-incubation of the enzyme with Mg 2+ in the absence of ATP. 
These conditions have been shown by a number of workers to lead to 
the activation of acetyl-CoA carboxylase in rat mammary gland 
extracts (McNeillie et al., 1981; McNeillie & Zammit, 1982) and 
rat adipose tissue extracts (Brownsey et al.; 1979) by the 
activation of an endogenous phosphatase which leads to dephos-
phorylation of the enzyme. Therefore, the in vitro assay used in 
the present study was designed to give an estimate of the total 
activity potential in the tissue since, in every assay, conditions 
were used to activate the enzyme as fully as possible. It is 
important to be aware of this fact when attempting to draw 
conclusions from the activity changes of the enzyme measured in 
vitro, since the optimum assay conditions may not exist in vivo. 
Goodridge (1975) assayed acetyl-CoA carboxylase activity under 
optimum conditions and considered alterations in the activity 
measured to be indicative of alterations in the amount of enzyme 
protein present. This assumption can only hold if the optimum 
conditions fully activate all the enzyme protein, and the 
relationship should be established unequivocally with immunological 
techniques as performed by Silpananta & Goodridge (1971). 
2. The effect of varying doses of 17a-oestradiol on the activity of 
hepatic acetyl-CoA carboxylase 
When assaying the effect of an exogenous agent on enzyme activity 
it is necessary to establish a suitable time of exposure to the 
agent and a suitable dose of the agent. 
-190-
Previous investigations into the effect of exogenous oestrogen on 
the activities of certain hepatic lipogenic enzymes in immature 
birds have demonstrated th~t substantial changes in enzyme activity 
occurred within 48 hours after oestrogen administration. For 
example, Pearce & Balnave (1975) reported marked changes in the 
activities of ATP citrate lyase and 'malic' enzyme in liver extracts 
from immature pullets within 48 hours after oestrogen treatment. 
Furthermore, these workers suggested that measurements during this 
period would be more indicative of physiological effects, and that 
pharmacological effects might predominate after 1onger periods of 
exposure to high levels of oestrogen. Similarly, Courtney & 
Manning (1984) observed increased activity of hepatic fatty acid 
synthetase in liver extracts from immature male chicks within 48 
hours after oestrogen treatment. In the present study, there was 
an indication that there may be an increase i~hepatic acetyl-CoA 
carboxylase activity at 48 hours after oestrogen treatment (Fig. 4.6). 
In the light of these observations it was decided to carry out a 
dose-response experiment, involving the assay of acetyl-CoA 
carboxylase in liver extracts from male chicks at 48 hours after 
the administration of varying doses of oestrogen. Statistically 
significant increases in the mean specific activity of acetyl-CoA 
carboxylase in liver cell extracts prepared from oestrogen-treated 
birds were observed at each dose, within the range used, when 
compared with control and untreated birds. Maximum mean specific 
activity was obtained using a dose of 0.75 mg hormone/100 g body 
weight when the oestrogen-treated value was 1.99-fold greater than 
the value for control birds. Therefore, at this dose, a greater 
proportion of soluble cell protein exhibited acetyl-CoA carboxylase 
activity. This could be explained by a reduction in the amount 
of protein other than acetyl-CoA carboxylase. However, oestrogen 
has been reported to stimulate lipogenic enzyme activities 
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selectively (Pearce, 1971; Pearce & Balnave, 1976) and so a more 
likely explanation is that the specific increase in acetyl-CoA 
carboxylase activity was caused by changes in the catalytic 
efficiency of the enzyme and/or changes in the amount of the enzyme. 
Although maximum mean specific activity occurred at a dose of 
0.75 mg hormone/100 g body weight, the value was not significantly 
different from the slightly lower specific activities obtained with 
doses of 0.50, 1.00 and 1.25 mg hormone/100 g body weight. 
When the results were expressed as enzyme activity/g liver, all 
doses of oestrogen caused an increase in activity with respect to 
controls. With the exception of the 0.25 mg hormone/100 g body 
weight dose, these increases were significantly different from the 
control value. The maximum activity/g liver was obtained, once 
again, with the 0.75 mg hormone/100 g body weight dose. Although 
the changes in activity/g liver and specific activity were 
qualitatively similar over the range of doses, there was an obvious 
quantitative difference which can be illustrated by a comparison 
of the two activities at the 0.75 mg hormone/100 g body weight dose. 
The mean activity/g liver at this dose was 1.71-fold greater than 
the corresponding control value* .For each dose level the 
A 
percentage increase over controls was greater when the results were 
expressed as specific activities. This difference is a result of 
the changes which were observed to occur in the amount of soluble 
protein/g liver after oestrogen treatment (see Table 4. 1). There 
was a dose-dependent decrease in the amount of soluble protein/ 
g liver such that, at the 0.75 mg hormone/100 g body weight dose, 
the oestrogen-treated value was 10% lower than the control value, 
the two values being significantly different. These decreases, 
which are thought to be caused by uptake of water by the liver 
leading to cell hypertrophy (see Chapter 2), mean that the extent 
of any increase in specific activity caused by oestrogen treatment 
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* ..... whereas the mean specific activity was 1.99-fold greater 
than the corresponding control value. 
would be somewhat masked when the same results were expressed in 
terms of activity/g liver. 
When the results were expressed as the total hepatic activity of 
a'etyl-CoA carboxylase it was found that the oestrogen-dependent 
increase in enzyme activity was increased further. For example, 
at a dose of 0.75 mg hormone/100 g body weight, the mean total 
hepatic activity was 3.5-fold greater than the control value 
(Fig. 4. 13c) while the mean specific activity was 1.99-fold greater 
than the control value (Fig. 4. 13a). Consequently; it is clear 
that the dose-dependent stimulation of total hepatic activity in 
liver weight (Table 4. 1), is accompanied by a more moderate increase 
in total soluble protein, leading to a less dramatic increase in 
the specific activity of the enzyme with respect to protein. The 
increase in liver weight may be due partially to an uptake of water 
but it also represents increased cell growth with concomitant 
protein synthesis and increased cell division (see Chapter 2). 
An interesting feature of the total hepatic activity changes was 
that the maximum value was obtained with a dose of 1.25 mg hormone/ 
100 g body weight, although it was not significantly different from 
the value obtained with 0.75 mg hormone/100 g body weight 
(Fig. 4. 13c). On the other hand, the mean specific activity of the 
enzyme decreased at high doses of oestrogen (Fig. 4. 13a). This 
suggests that high doses of 17~- oestradiol, within the range 
0.75 mg to 1.25 mg/100 g body weight, maintain the total hepatic 
activity of acetyl-CoA carboxylase at a relatively constant level, 
but this is accompanied by a dose-dependent increase in other types 
of soluble protein, causing a corresponding dose-dependent decrease 
in the mean specific activity of the enzyme. 
Previous workers have found some variation in the optimum dose of 
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oestrogen required to elevate the specific activity of different 
lipogenic enzymes in chick liver. Courtney ( 1984) reported that 
maximum specific activity of fatty acid synthetase, assayed in 
liver extracts from immature male chicks at 48 hours after oestrogen 
treatment, was obtained using a dose of 0.75 mg 17~-oestradiol/ 
100 g body weight. This is in excellent agreement with the optimum 
dose reported in the present study on acetyl-CoA carboxylase. In 
contrast, Pearce & Balnave (1975) reported lower optimum doses of 
oestrogen when they measured the effect of oestrogen on the specific 
activity of ATP citrate lyase and 'malic' enzyme in liver extracts 
from immature pullets. These workers used oestradiol dipropionate 
and measured enzyme activities 48 hours after treatment. After 
correcting their reported doses for body weight and quantity of 
oestradiol, the maximum specific activities were obtained with 
approximate doses of 0.57 mg oestradiol/100 g body weight for ATP 
citrate lyase and 0.28 mg oestradiol/100 g body weight for 'malic' 
enzyme. These differences suggest that different lipogenic enzymes 
may have different susceptibilities to oestrogen treatment. 
Another possible explanation of the lower optimum oestrogen doses 
reported by Pearce & Balnave (1975) may be that the immature 
pullets (4 weeks old) used by these workers could have possessed 
low levels of endogenous oestrogen and/or an enhanced ability to 
respond to oestrogen treatment through differences in hepatic 
oestrogen receptors. 
3. The effect of a single intramuscular injection of 17~-oestradiol 
(0.75 mg/100 g body wt.) on the activity of hepatic acetyl-CoA 
carboxylase 
In an attempt to clarify the role of acetyl-CoA carboxylase in the 
initial stages of the oestrogen-dependent stimulation of lipogenesis 
in avian liver (see Chapter 3), it was decided to assay the activity 
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of this enzyme 1n liver extracts from immature male chicks at 
various times after oestrogen treatment. It was shown that, during 
the first 19 hours after injection, there was no significant 
variation in the specific activity in oestrogen-treated birds, and 
no significant difference between the specific activity in 
oestrogen-treated and corresponding control birds. These 
observations, however, do not preclude possible changes of specific 
activity in vivo, over this initial 19-hour period, brought about 
by modulation of the catalytic efficiency of the enzyme and this 
possibility will be discussed later, 
From 24 hours - 48 hours after oestrogen treatment there was a 
significant increase in the specific activity of acetyl-CoA 
carboxylase in liver extracts from oestrogen-treated birds, with 
respect to control birds, such that, at 48 hours after injection, 
the oestrogen-treated value was 1.53-fold greater than the 
corresponding control value. This elevation could be brought about 
by one or more of the following events: (a) a decrease in soluble 
cell protein other than acetyl-CoA carboxylase, (b) an increase in 
the amount of acetyl-CoA carboxylase protein, (c) an increase in 
the catalytic efficiency of acetyl-CoA carboxylase protein. Over 
the same period of time, 24 hours - 48 hours after injection, there 
was a significant increase in the amount of protein/mg DNA 
(Table 4.2) in oestrogen-treated birds with respect to controls. 
Therefore, the possibility exists that the increase in specific 
activity may have been brought about, at least in part, by an 
increase in the amount of acetyl-CoA carboxylase through alterations 
in the rates of synthesis and/or degradation of enzyme protein, 
although such a statement cannot be asserted without direct 
measurement of acetyl-CoA carboxylase protein. 
After 61 hours post injection, the specific activities of oestrogen 
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treated and control birds were not significantly different, 
implying that a decreasing proportion of soluble protein exhibited 
acetyl-CoA carboxylase activity in oestrogen-treated birds after 
61 hours, when compared with similar birds at 48 hours after 
injection. Therefore, a decrease in the synthesis and/or an 
increase in the degradation of acetyl-CoA carboxylase could play a 
part in the reduction in specific activity of oestrogen-treated 
birds after 48 hours. A reduction in the catalytic efficiency of 
acetyl-CoA carboxylase protein and an accumulation of proteins 
other than acetyl-CoA carboxylase are factors which could also be 
involved. 
The results were also expressed as activity of acetyl-CoA carboxylase 
per mg DNA (Fig. 4. 14b). This specific activity, with respect to 
DNA, can be used as an indication of the enzyme activity per cell 
and variations in this parameter, over the 61 hour period following 
oestrogen treatment were qualitatively similar to the corresponding 
variations in specific activity, with respect to soluble protein, 
discussed above. Maximum specific activity, with respect to· ONA, 
was observed at 37 hours - 48 hours after oestrogen treatment 
(Fig. 4. 14b). Furthermore, the extent of the increase in specific 
activity, with respect to DNA, from 24 hours - 48 hours after 
oestrogen treatment was greater than the corresponding increase in 
specific activity with respect to soluble protein. This implies 
that, over this time period, not only was there an increase in the 
amount of soluble protein exhibiting acetyl-CoA carboxylase 
activity but there was also a concomitant increase in the amount of 
soluble protein per cell. Analysis of the variation in the amount 
of soluble protein/mg DNA shows that a significant increase was 
observed 24 hours - 48 hours after oestrogen treatment compared to 
controls (Table 4.2). 
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From Table 4.2 it can be seen that the amount of soluble protein/g 
liver decreased upon oestrogen treatment such that from 13 hours -
37 hours after injection, the oestrogen-treated values were 
significantly lower than corresponding control values. This 
observation represents an oestrogen-dependent cellular hypertrophy 
in which water and lipid uptake by cells may play a part (see 
Chapter 2). Therefore, expression of acetyl-CoA carboxylase 
activity in terms of enzyme activity/g liver results in a slightly 
different variation in activity, over the 61-hour period following 
oestrogen injection, compared to that of specific activity; only at 
the 48 hour post-injection point was the enzyme activity/g liver for 
oestrogen-treated birds significantly greater than the corresponding 
value for control birds. 
Following oestrogen treatment significant increases in liver weight 
(as% of body wt.) were observed at all times from 13 hours- 61 
hours after injection. The greatest increase in liver size was 
apparent at 37 hours - 48 hours after injection, the oestrogen-
treated values at these two time-points being 1.60-fold greater and 
1.57-fold greater than the corresponding control values, respectively. 
Initially, the increase in liver weight is due to uptake of water 
leading to cellular hypertrophy but, later, there is also a 
significant increase in total soluble protein (at 19 hours) and 
total DNA (at 37 hours) which suggests that cellular hyperplasia 
contributes to organ growth in the later stages of this response. 
Expression of acetyl-CoA carboxylase activity in terms of total 
hepatic activity revealed maximum activities after 37 hours and 48 
hours, when the oestrogen-treated values were 2. 11-fold greater and 
2.44-fold greater than the corresponding control values, respectively. 
Comparison of the data presented in Table 4.3 suggests that the 
hormonal stimulation of the total hepatic activity of acetyl-CoA 
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Table 4.3 
The stimulation of hepatic acetyl-CoA carboxylase, liver weight 
and hepatic DNA content in birds treated with 17a-oestradiol 
(0.75 mg/100 g body wt.) with respect to control birds. 
Consult the legend of Table 4.2 for experimental details. Data 
presented in this Table were obtained by direct comparison of 
the mean values of each parameter for corresponding oestrogen-
treated and control birds, at each of the indicated post-
injection times. 
Parameter Oestrogen-dependent stimulation 
relative to control. (%) 
24h 37h 48h 61h 
- - - -
Tota1 hepatic activity 
of ACC 153 210 243 169 
Specific activity of 
ACC with respect to DNA 139 159 174 145 
Liver weight (as % body 
wt.) 148 160 157 154 
Total DNA content of 
liver 106 138 136 119 
carboxylase is due to an increase in the enzyme activity per cell, 
as represented by the increase in specific activity with respect 
to DNA, accompanied by an increase in the number of cells in the 
liver, as represented by the increase in the total DNA content of 
liver. 
At the 61 hour post-injection point, the oestrogen-treated mean 
total hepatic activity of acetyl-CoA carboxylase was significantly 
greater than the corresponding control value. At the same time, 
specific activities, both with respect to DNA and protein, of 
oestrogen-treated and control birds were not significantly different. 
In recent years several other workers have reported changes in the 
activity of lipogenic enzymes in avian liver after oestrogen 
treatment. Courtney (1984) found that oestrogen administration 
(0.75 mg 17~-oestradiol/100 g body wt.) to immature male chicks 
caused an increase in specific activity and total hepatic activity 
of fatty acid synthetase, when compared to control birds, between 
26 hours and 48 hours after hormone treatment. However, the 
increases observed were 1.29-fold and 1.76-fold, respectively, 
which are smaller than the corresponding increases in acetyl-CoA 
carboxylase activity reported in the present study. Furthermore, 
Courtney (1984) detected an increase in fatty acid synthetase 
activity within the first 26 hours following oestrogen treatment 
and this increase was also found to occur in the corresponding 
control birds. A similar increase in acetyl-CoA carboxylase evoked 
by the handling/injection procedure was not observed in the present 
study. 
Pageaux et al. (1981) reported a rapid increase in hepatic acetyl-
CoA carboxylase activity after treating 16-day old female quail with 
a single injection of oestradiol benzoate (0.2 mg/kg body wt.). A 
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peak in the specific activity of acetyl-CoA carboxylase was observed 
3 hours after injection, and the oestrogen-treated values at 3 hours 
and 6 hours after injection were significantly higher than the 
'control' value. No difference between the specific activity of 
acetyl-CoA carboxylase in oestrogen treated birds and 'control' 
birds was observed at 24 hours after injection. The results of the 
present study, in which an increase in acetyl-CoA carboxylase 
specific activity, with respect to controls, was only observed after 
24 hours following oestrogen injection, are in sharp contrast to the 
results of Pageaux et al. (1981). Such a difference might be 
explained by the fact that these workers used female birds whereas 
male birds were used in the present study. Pageaux et al. (1981) 
also used birds of a different species, Japanese quail, and the 
hormone dose level of 0.2 mg oestradiol benzoate/kg body weight 
was very low compared to the dose level used in the present study 
and with the dose levels used by other workers (Pearce & Balnave, 
1975; Aprahamian et al., 1979). Furthermore, it seems that the 
'control' birds used by Pageaux et al. (1981) were injected with 
the olive oil vehicle just before death and, therefore, adequate 
controls were not provided for each post-injection time-point. It 
is possible, therefore, that the early peak in acetyl-CoA carboxylase 
activity observed by these workers could have been a stress response. 
Philipp & Shapiro (1981) administered 17~-oestradiol to male 
xenopus laevis (0.4 mg/100 g body wt.) at 0 hour and 24 hours, and 
measured acetyl-CoA carboxylase,fatty acid synthetase and HMG-CoA 
reductase activities in liver extracts from animals killed up to 14 
days post-injection. Oestrogen treatment resulted in increased 
hepatic fatty acid synthesis, monitored by the incorporation of 
[1 - 14~ acetate into fatty acids in liver cubes, and an increase 
in acetyl-CoA carboxylase activity per unit weight of liver. 
These increases were correlated and reached maxima on the sixth 
day after hormone administration. A later increase in the rate of 
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fatty acid synthesis (8 - 13 days) occurred without a concomitant 
increase in acetyl-CoA carboxylase activity. No change in fatty 
acid synthetase activity was observed during the study although 
HMG-CoA reductase, the major regulatory enzyme in cholesterol and 
isoprenoid synthesis, greatly increased in activity and reached a 
peak 5 days after hormone treatment. However, once again, firm 
conclusions cannot be drawn from the published data about the action 
of oestrogen on these enzyme activities since no control values 
were presented for comparison. 
Aprahamian et al. (1979) examined hepatic fatty acid synthetase 
activity after treating 1-month old pullets with oestrogen. A 
prolonged oestrogen treatment regime was adopted involving injections 
of 4 mg p-oestradiol-3-benzoate/bird/day for 6 consecutive days. 
Hepatic fatty acid synthetase activity increased as a result, such 
that a 3-fold increase in total hepatic activity and a 2-fold 
increase in specific activity was observed. However, these changes 
in fatty acid synthetase activity occurred after prolonged exposure 
to high levels of oestrogen and may represent a pharmacological 
rather than a physiological response to the hormone. Furthermore, 
short-term changes in enzyme activity were not monitored, so this 
study does not help to resolve the initial sequence of events after 
hormone administration. 
A number of investigators have examined the effect of oestrogen 
treatment on the lipogenic capacity of avian liver, in vivo, and 
in vitro, and on the level of lipids in avian liver and/or blood. 
Dashti et al. (1983) administered single injections of diethyl-
stilboestrol (40 mg/kg body wt.) to 19-day old male turkeys. 
Oestrogen treatment resulted in a 55-fold increase in plasma 
triacylglycerol concentration and a 3-fold increase in plasma 
phospholipid concentration at 48 hours after injection. Increases 
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were also observed in the hepatic triglyceride content at the same 
time after injection. The elevation of plasma and liver lipids 
over control values was maximal at 48 hours post-injection, although 
elevation was apparent and significant after 24 hours. Tritiated 
water incorporation studies revealed that increased hepatic fatty 
' 
acid synthesis was a primary and major causative factor in the 
development of the oestrogen-induced hyperglyceridaemia. However, 
this study did not report any early changes (< 24 hours) in 
lipogenesis and so throws little light on the sequence of events in 
the initial response to oestrogen administration. 
Kudzma et al. (1975), after administering 8 daily doses of diethyl-
stilboestrol (0.5 mg/bird/day) to 1-week old chicks (sex undetermined) 
observed an 86-fold increase in the incorporation of [14c] acetate 
into triacylglycerols associated with VLDL. This increase in 
lipogenesis, in vivo, was in agreement with earlier work by Kudzma 
et al. (1973)·, who reported increased lipogenesis from [14c] acetate 
by liver slices from chicks (sex undetermined) which had received 
0.1 mg diethylstilboestrol/day for 18 days. However, since both 
of these studies involved prolonged exposure to high levels of 
hormone, the results may represent a pharmacological rather than a 
physiological response to oestrogen. 
In an effort to examine the early events in oestrogen-stimulated 
lipogenesis in avian liver, Courtney (1984) measured the incorporation 
of 3H20 into lipids in liver slices taken from male chicks at 
various times after injection of 17~-oestradiol (1 mg/100 g body wt.). 
A significant increase in hepatic lipogenesis was reported 14 hours 
after oestrogen treatment, and the maximum stimulation was observed 
40 - 43 hours after injection of hormone. 
In the present study, it has been demonstrated that oestrogen 
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treatment caused a significant increase in lipid levels in the 
liver and plasma of male chicks within 7 hours (Chapter 3), but 
that significant increases in hepatic acetyl-CoA carboxylase activity 
did not occur until 24 hours after injection. This suggests that 
the initial phase (0 - 24 h) of the oestrogen-dependent stimulation 
of hepatic lipogenesis is not due to an increase in the activity of 
this enzyme in avian liver. In the later phase (> 24h) of the 
response, however, it is likely that the increase in hepatic acetyl-
CoA carboxylase activity contributes to the enhanced rate of hepatic 
lipogenesis. It is important to realise that this interpretation is 
based on the assay of this enzyme under optimum conditions in vitro, 
and that these optimum conditions may not exist in vivo. In the 
cell, therefore, it is possible that changes in the activity of 
acetyl-CoA carboxylase may occur during the initial phase of the 
response as a result of allosteric modulation, covalent modification 
of the enzyme and/or changes in substrate availability. In 
consequence, acetyl-CoA carboxylase is not precluded from involvement 
in the changes in levels of de novo lipogenesis and hepatic and 
plasma lipids which occur within 24 hours after oestrogen treatment. 
Recent work in which the activity of hepatic acetyl-CoA carboxylase 
in chicks has varied rapidly in response to sudden nutritional 
alterations has shown that the enzyme undergoes polymer/protomer 
inter-conversion (Ashcraft et al., 1980) and changes in 
phosphorylation state (Clarke, 1983) during the short term, in vivo, 
which affects the catalytic efficiency. Clarke & Salati (1985) 
suggest that during periods of food deprivation, increases in the 
concentration of long-chain fatty acyl-CoA esters in the liver favour 
depolymerisation of the enzyme. This is accompanied by elevations 
in plasma glucagon levels, inducing phosphorylation of the enzyme, 
which facilitates acyl-CoA binding and promotes depolymerisation. 
In this state, cellular c.AMP levels will be raised and this has 
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been shown by Watkins et a1. (1977) to reduce the level of citrate 
1n cultured chicken hepatocytes, thus reducing the level of a 
positive allosteric effector of the enzyme. 
It is feasible that oestrogen treatment may either directly or 
indirectly, cause similar short-term variations in the regulatory 
metabolites affecting acetyl-CoA carboxylase. In this light; it is 
interesting to note that there are reports of steroid hormones 
affecting the activity of adenylate cyclase, and so altering c.AMP 
levels in human endometrium cells (Bergamini, 1985), in Xenopus 
oocytes (Finidori-lepicard et al., 1981), in the uterine cervix of 
neonatal and immature mice (Kvinnsland, 1980) and in rat uterus 
(Szego & Davis, 1969; Francavilla et al., 1979). 
The present study clearly demonstrates an oestrogen-induced increase 
in hepatic acetyl-CoA carboxylase activity from 24 - 48 hours after 
hormone treatment and it is likely that this increased enzyme 
activity contributes to the enhanced liver and plasma lipid levels 
in similarly treated birds. However, while the present study 
provides no evidence for the involvement of enhanced acetyl-CoA 
carboxylase activity in the changes in lipid levels occurring 
within 24 hours of hormone treatment, further work needs to be 
carried out to study the changes in activity of the enzyme, in vivo, 
during this initial phase of the response to oestrogen. 
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CHAPTER 5 
GENERAL DISCUSSION 
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1. The use of oestrogen-treated birds as a model for studying 
vitellogenesis in the domestic fowl 
As the sexually-mature female domestic fowl approaches lay 
significant increases in the plasma vitellogenin and lipids, 
associated particularly with VLDL, are observed which are thought 
to be due principally to an oestrogen-dependent stimulation of 
lipid and protein biosynthesis in the liver. A similar situation 
can be evoked in male or sexually-immature female birds by treatment 
with exogenous oestrogen in vivo. Such hormone~treated birds 
provide a convenient model system for the investigation of the 
molecular events involved in these changes. Male birds have proved 
particularly useful since they lack endogenous oestrogen and they 
have been widely used in the study of the oestrogen-induced 
stimulation of hepatic VLDL biosynthesis (Kudzma et al., 1973, 1975, 
1979; Luskey et al., 1974; Chan et al., 1976, 1977a, 1978, 1980) 
and hepatic vitellogenin biosynthesis (Bergink et al., 1973, 1974; 
Beuving & Gruber, 1971). 
The administration of oestrogen to male and immature female birds, 
however, cannot be expected to completely reproduce the state of 
lipid metabolism existing in the laying hen since, undoubtedly, the 
physiological state of the latter is under the influence of a number 
of internal secretions as well as oestrogen. A number of 
differences in lipid metabolism between oestrogen-treated and laying 
birds have been reported, although such differences may be 
attributed to the high pharmacological doses of exogenous oestrogen 
applied. For example, Balnave (1971) observed heavier livers and 
higher liver and plasma levels of fatty acids for immature pullets 
treated with oestrogen than for mature laying hens. Significant 
increases in the percentage of 16:0 in plasma and liver fatty acids 
have been observed in oestrogen-treated pullets but not for laying 
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hens, suggesting that oestrogen treatment alone may result in an 
abnormal metabo1ism of 16:0 (Balnave, 1971; Paddon et al., 1982). 
The retention of dietary linoleic acid is increased at the onset 
of sexual maturity in the hen (Balnave, 1971) whereas the 
administration of exogenous oestrogen to immature pullets has no 
effect on dietary linoleic acid retention (Jackson et al., 1971). 
Some of these differences between observations in oestrogen-treated 
immature birds andlaying hens are probably a result of the egg-
laying process. In the mature hen, lipid is continually removed 
from the body in the egg-laying process. In oestrogen-treated male 
and immature female birds, the accumulation of lipid and egg-yolk 
proteins in the liver and plasma might be expected to exert feed-
back inhibition on their hepatic syntheses. Therefore, the events 
that occur at short intervals after oestrogen treatment of birds 
are probably more indicative of the situation in the laying hen. 
However, the differences between oestrogen-treated birds and laying 
hens mentioned above are considered to be relatively minor, and the 
administration of eestrogen to immature male and female birds and 
cockerels remains a useful model for the study of the molecular 
events involved in avian vitellogenesis. The investigations carried 
out in the course of the present study were designed to establish 
changes in various parameters of lipid metabolism in the male chick 
during the 48-hour period immediately after oestrogen treatment. 
2. Summary of results obtained in the present study 
The main features of the response of male chicks to single intra-
muscular injections of oestrogen (0.75 mg 17~-oestradiol/100 g body 
wt.), observed in the present study, are summarised below. 
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{a) Quantitative changes in piasma. 
Total triacylglycerol concentration in the plasma of the oestrogen-
treated male chick became significantly greater than the control 
value at 7 hours post-injection (p< 0.001), and increased 
progressively up to 44 hours after injection. The highest 
elevation of total plasma triacylglycerol represented a 27-fold 
increase in concentration compared with control levels. 
VLOL-triacylglycerol concentration in the plasma of oestrogen-
treated birds became significantly greater than the control value 
at 13 hours post-injection (p <0.01) and increased progressively 
thereafter. Maximum plasma VLDL-triacylglycerol concentration was 
observed at 37 hours after oestrogen treatment and represented a 
30-fold increase compared to control levels. 
The total phospholipid concentration in the plasma of oestrogen-
treated male chicks became significantly greater than the control 
value at 7 hours post-injection (p<0.05) and increased 
progressively up to 44 hours after injection when the value in 
oestrogen-treated birds was 4.8-fold greater than the corresponding 
control value. 
VLDL-phospholipid levels in the plasma became significantly greater 
than the control value at 6 hours after oestrogen treatment (p< 0.01) 
and increased substantially and progressively thereafter such that, 
at 48 hours post-injection, the oestrogen-treated value was 97-fold 
greater than the corresponding control value. 
Total free fatty acid (FFA) concentration in the plasma of control 
chicks, treated with propane-1,2-diol alone, was significantly 
greater than the value in oestrogen-treated birds at 2 hours after 
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injection (p< 0.01). Subsequently, up to 44 hours post-injection, 
there was no significant difference between the totai FFA 
concentration in the plasma of oestrogen-treated birds and control 
birds. 
Following oestrogen treatment of male chicks, the concentration of 
albumin-bound FFA in the plasma was lower than the corresponding 
control value from 6 - 48 hours post-injection, although only at 
24 hours post-injection was the difference significant (p <0.001), 
the control value being 2.00-fold greater than the value in 
oestrogen-treated birds. 
(b) Quantitative changes in liver 
(i) Weight, DNA content and soluble protein content 
Liver weight increased with time after oestrogen treatment and 
maximum liver weight was observed at 37 hours post-injection when 
the mean liver weight of oestrogen-treated birds was 1.61-fold 
greater than the value for corresponding control chicks injected 
with propane-1,2-diol alone. Similarly, a dose-related increase in 
liver weight was observed 48 hours after a single injection of 
17~-oestradiol over a dose range of 0 - 1.25 mg/100 g body weight. 
An increase in the total hepatic DNA content accompanied the 
oestrogen-induced increase in liver weight during the 37- to 61-hour 
post-injection period,. and reached a maximum value at 37 hours 
post-injection, representing a 1.38-fold stimulation over control 
birds. However, following oestrogen treatment a significant 
decrease in the amount of DNA/g liver was observed reaching a 
minimum value at 24 - 37 hours post injection. 
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Coincident with the increase in liver weight after oestrogen 
treatment was an increase in the total hepatic soluble protein 
content, reaching a maximum at 37 hours post-injection. Expression 
of the hepatic soluble protein content in terms of amount of 
soluble protein/mg DNA also revealed an increase after oestrogen 
treatment reaching a maximum at 37 hours post-injection, indicating 
an increase in the amount of soluble protein per cell. However, 
the increase in liver weight was accompanied by a decrease in the 
amount of soluble protein/g liver reaching a minimum value at 37 
hours post-injection. 
(ii) Triacylglycerol, phospholipid and free fatty acid content 
Total triacylglycerol content of the livers of oestrogen-treated 
male chicks became significantly greater than the control value at 
7 hours post-injection (p<O.OS). Subsequently, there was a 
progressive increase in the total hepatic triacylglycerol content 
of oestrogen-treated birds such that, at 34 hours post-injection, 
the value was 23-fold greater than the control value. 
The 'cellular' triacylglycerol content of the liver, expressed as 
mg triacylglycerol/mg DNA became significantly elevated in 
oestrogen-treated birds, compared to controls, at 11 hours post-
injection (p<0.01), and increased subsequently such that, at 34 
hours post-injection, the value was 15-fold greater than the 
corresponding control value. 
Total phospholipid content of the livers of oestrogen-treated male 
chicks became significantly greater than the control value at 7 
hours post-injection (p<O.OS), and increased subsequently such 
that, at 34 hours post-injection, the total hepatic phospholipid 
content in oestrogen-treated birds was maximal, representing a 
1.8-fold increase over control birds. 
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The 'cellular' phospholipid content of the liver, expressed as 
umol phospholipid/mg DNA, became significantly 
I 
oestrogen-treated birds, compared to controls, at 7 hours post~ 
injection (p< 0.01} and increased subsequently such that, at 20 
hours post-injection, the value in oestrogen-treated birds was 
maximal, representing a 1.3-fold increase over control birds. 
Total FFA content of the livers of oestrogen-treated male chicks 
became significantly greater than the control value at 26 hours 
post-injection (p< 0.01} and increased gradually up to 44 hours 
after injection. The highest elevation in total hepatic FFA 
content represented a 1.6-fold increase compared with control 
levels. 
The 'cellular' FFA content of the liver, expressed as umol FFA/mg DNA, 
was significantly elevated in oestrogen-treated birds, compared to 
contr.ols, at 26 hours and 44 hours post-injection (p<0.05), the 
value at the latter time being 1.3-fold greater than the 
corresponding control value. 
(iii} Acety1-CoA carboxylase activity 
Treatment of chicks with 0.75 mg 17~-oestradiol/100 g body weight 
caused an increase in the hepatic specific activity (with respect 
to protein) of hepatic acetyl-CoA carboxylase from 24 - 48 hours 
after injection. Maximum specific activity, with respect to protein, 
was observed 48 hours after oestrogen treatment, representing a 
a 1.53-fo1d increase over controls. 
Oestrogen treatment also caused an increase in the hepatic specific 
activity, with respect to DNA, of the enzyme from 24 - 48 hours 
post-injection and maximum activity was observed after 37 - 48 hours, 
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representing a 1.59-fold and a 1.74-fold increase over controls, 
at the two individual times, respectively. 
Expression of acetyl-CoA carboxylase activity in terms of total 
hepatic activity revealed a similar increase in enzyme activity 
from 24 - 61 hours after injection. Maximum total hepatic enzyme 
activity was observed after 37 - 48 hours, representing a 2. 10-fold 
and a 2.43-fold increase over controls, at the two individual 
times. 
During the first 19 hours after injection, no significant differences 
were observed between the hepatic acetyl-CoA carboxylase activity 
of oestrogen-treated and of control birds, irrespective of the 
manner of expression of enzyme activity. 
(c) Qualitative changes in liver and plasma lipids 
(i) Liver triacylglycerols 
In untreated birds, the predominant fatty acids in liver 
triacylglycerols were 18:1 and 16:0, while 18:0, 18:2 and 16:1 
contributed to a lesser extent. The major effect of oestrogen 
treatment on the fatty acid composition of liver triacylglycerol 
was to promote a substantial elevation in the molar ratio of 
unsaturated:saturated fatty acids from 13 - 48 hours after 
injection. This was caused largely by an elevation of the levels 
of 18:1 and 18:2 accompanied by a decline in the levels of 16:0 
and 18:0. 
(ii) VLDL-triacylglycerols 
In untreated birds, the predominant fatty acids were 16:0, 18:1, 
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18:2 and 18:0 in decreasing order of percentage contribution. The 
major effect of oestroger1 treatment on the fatty acid composition 
of VLDL-triacylglycerol was to cause an elevation in the level of 
18:1 from 13- 48 hours after injection accompanied by a decrease 
in the levels of 18:2. 
(iii) VLDL-phospholipids 
In untreated birds, the predominant fatty acids, in decreasing order 
of percentage contribution, were 16:0, 20:4, 18.0, 18:2 and 18:1. 
The major effects of oestrogen treatment on the fatty acid 
composition of VLDL-phospholipid was to cause an elevation in the 
level of 16:0 from 13 - 37 hours after injection, accompanied by 
an elevation in the level of 18:1 from 13- 48 hours after 
injection. 
3. Sequence and correlation of oestrogen-induced changes in the lipid 
metabolism of avian liver 
A number of workers have studied the effects of oestrogen treatment 
on the lipid metabolism of the domestic fowl. However, this work 
has been somewhat fragmentary and no clear understanding of the 
sequence of events in the initial stages of the response to 
exogenous oestrogen has been forthcoming. An understanding of the 
sequence of the changes in lipid metabolism that occur after 
oestrogen treatment of the male chick is important if the 
significance of these events is to be more fully appreciated. 
The present study, therefore, was designed to produce detailed 
time-courses of the oestrogen-induced changes in various parameters 
of lipid metabolism. Since all the results were obtained from male 
birds, of similar age, which had been reared in identical 
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conditions and treated with the same dose of oestrogen, the present 
study affords an opportunity for a greater understanding of the 
sequence of events. Furthermore, the results of the present study 
can be correlated with the results of Courtney (1984) and Courtney 
& Manning (1984) who treated 3- to 5-week old male chicks with 
doses of oestrogen similar to those employed in the present study, 
and produced time-courses of other parameters of lipid metabolism. 
For the purposes of clarity and ease of comparison, Figure 5.1 and 
Tables 5.1 and 5.2 present the time-courses of changes in various 
parameters, in oestrogen-treated birds, observed in the present 
study and in the studies of Courtney (1984) and Courtney & Manning 
(1984). 
In Chapter 1 of the present study, evidence was presented which 
suggested that both cellular hypertrophy and cellular hyperplasia 
may be involved in oestrogen-induced liver growth. The fact that 
there was no significant difference in the total hepatic DNA 
content of oestrogen-treated and control birds during the first 
24 hours after treatment, at a time when the liver weight of 
oestrogen-treated birds had increased substantially, suggests that 
the initial increase in liver weight was due to cellular hypertrophy. 
Subsequently, an increase in the total hepatic DNA content 
accompanied the oestrogen-induced increase in liver weight from 
37 - 61 hours after injection, reaching a maximu01value at 37 hours 
when the total hepatic DNA content was 1.38-fold greater than that 
in control chicks. This suggests that the increase in liver weight 
in the later stages of the response ( ~37h) was accompanied by 
cellular hyperplasia. Examination of the time-courses of the 
changes in liver weight (Fig. 5. la) and total hepatic triacyl-
glycerol content (Fig. 5. ld) suggest that the liver growth response 
is, in part, due to an increase in the lipid content of liver. 
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Figure 5. 1 (Over 1 eaf) 
Compilation of various time-courses of physiological changes in male 
chicks treated with oestrogen. 
Each time course has previously been presented in the present study or 
in the studies of Courtney (1984) and/or Courtney & Manning (1984). In 
all cases, 3- to 5-week old male chicks were treated with 0.75 mg 
178-oestradiol/100 g body wt. 
• = values for untreated birds. 
0 = values for oestrogen-treated birds. 
• = values for control birds. 
Values are means ( ~ S.E.M.) of 2 - 19 birds. 
(a) Effect of oestrogen on liver weight (as% body wt.) 
Consult the legend of Fig. 2. l, in the present study, for details of 
experimental procedure. 
(b) Effect of oestrogen on the total hepatic activity of acetyl-CoA 
carboxylase. 
Consult the legend of Fig. 4. 14c, in the present study, for details 
of experimental procedure. 
(c) Effect of oestrogen on the total hepatic activity of fatty acid 
synthetase (F.A.S.) 
Consult the legend of Fig. l, in the study of Courtney & Manning (1984) 
for details of experimental procedure. 
(d) Effect of oestrogen on total hepatic triacylglycerol content. 
Consult the legend of Fig. 3.4a, in the present study, for details of 
experimental procedure. 
(e) Effect of oestrogen on total plasma triacylglycerol level. 
Consult the legend of Fig. 3.2a, in the present study, for details 
of experimental procedure. 
a. 6 
/2"" . ~ Y--~ .... .... .r:. 31: 5 C'l 
aJ >-
31: "0 / 0 L. .0 aJ dP > 4 
..J Cll 6/ IU 
3 
0 10 20 30 40 50 60 70 
Time after injection (h) 
b. 34 
aJ L. 
.... aJ 30 IU > 
c: 
0 
-
.0 c: 26 L. E IU 
u 
-:E "0 22 aJ 
,...--, .... 
u IU L. ::;r 0 
&!:.....J c. 18 
L. 
0 0 
E u 
::1 c: 
I I I I I I 
1 0 20 30 40 50 60 70 
Time after injection (h) 
c. 
d. 
e. 
>-
130 l 
*' 
> 
~ 11 0 
u 
n::l 
-~ ~ 
E ~ 
>- > 
N 
-
90 c:: ttl ~ .... 
n::l c:: 
~ ::;, 
0 
-1- 70 
M)( 
I 
0 
.... 
50 
2000 
~ 
~ 
> 
-
.... 
0 
..... 
c:: 
~ 
..... 
c:: 
0 
u 
<.J 
.... 
1600 
-~ 
~ 1200 
-
-<.J 
.... 
C'l 
E 
-
n::l 
e-
BOO 
400 
0 
3000 
~ e 2000 
-0 
a.o 
... 
c::-
·- C'll ooo 
<.JE 
.... -
L._6 ih 
¥~ 
)--t,£ 
o ..... 2 
~· ~. • • 
I I I 
10 20 30 40 
Time after injection {h) 
i 
50 
Increases in total hepatic phospholipid content accompanied the 
inc1ease in total hepatic triacylglycerol (see Chapter 3). It 
therefore seems likely that the cellular hypertrophy involved 
increases in the cellular lipid content following oestrogen 
treatment. This suggestion is further supported by the time-
courses of the oestrogen-induced elevation of hepatic triacyl-
glycerol/mg DNA (Fig. 3.4b) and hepatic phospholipid/mg DNA 
(Fig. 3.5b) which revealed increases after 11 hours and 7 hours 
post-injection, respectively. 
An oestrogen-induced hyperlipaemia was evident from 7 hours after 
oestrogen treatment of male chicks and involved an increase in the 
total concentration of triacylglycerol in the plasma (Fig. 5. le) 
together with an increase in plasma phospholipid levels (Fig. 3.2b). 
A number of workers had previously reported that much of the 
increase in plasma lipids in oestrogen-treated domestic fowl are 
associated with VLDL (Chan et al., 1977, 1978. 1980; Kudzma et al., 
--
1979). In the present study, oestrogen-induced increases in VLDL-
triacylglycerol and VLDL-phospholipid were observed in the plasma 
of male chicks from 13 hours and 6 hours post-injection, respectively, 
and both lipid levels increased progressively with time (Fig. 3.3). 
A closer analysis of these two time-courses, however, revealed that 
at all times after oestrogen treatment, the extent of the increase 
was greater for VLDL-phospholipid than it was for VLOL-triacyl-
glycerol. Calculations of the ratio of VLDL-triacylglycerol:VLOL-
phospholipid showed that, at zero-time, this ratio was 425 whereas 
at 37 hours post-injection, the oestrogen-treated value was 186 
compared to the control value of 397. Therefore, this comparison 
suggests that the hormone promotes (a) an increase in the number of 
VLDL particles in the plasma accounting for large increases in VLDL-
lipids and (b) an early and consistent alteration in the composition 
of VLDL representing a specific enrichment of the phospholipid 
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component with respect to triacylglycerol. Furthermore, the 
observed decrease in the proportion of total plasma free fatty 
acids which are albumin-bound, from 6 - 48 hours post injection, is 
presumably a reflection of an increased proportion of the total 
plasma free fatty acid pool binding to the increasing number of 
triacylglycerol-rich lipoproptein particles. 
The results of the present study also clearly show that oestrogen 
treatment of male chicks, as well as causing a time-related 
increase in liver and plasma lipids, also caused significant 
changes in the fatty acid composition of these lipids (Chapter 3). 
In liver triacylglycerol (Fig.3.8), VLDL-triacylglycerol (Fig. 3.9) 
and VLDL-phospholipid (Fig. 3. 10) the predominant change was that 
of an elevation in the percentage contribution of 18:1 from 13- 48 
hours after oestrogen treatment. Lipie11o et al. (1979) reported 
increased stearyl-CoA desaturase activity in crude microsomal 
extracts from the liver of male chickens treated with oestrogen 
(3.5 mg 17~-oestradio1/100 g body wt.). A 7-fo1d increase in the 
specific activity of the enzyme was observed in the 24-hour period 
following injection and the activity remained high through 48 hours 
before declining. Therefore, the increases in 18:1 in the plasma 
and liver lipids of oestrogen-treated birds in the present study 
may be due to an increase in hepatic stearyl-CoA desaturase activity 
within 13 hours of injection. 
As mentioned previously, an accumulation of lipid in the liver and 
plasma of male chicks occurs in response to oestrogen treatment 
(Fig. 5. ld & e). The accumulation of these glycerolipids might be 
caused by an increased rate of hepatic de novo fatty acid synthesis 
and/or an increase in the rate of hepatic complex lipid formation 
from pre-formed fatty acids arriving from extra-hepatic sources. 
Courtney (1984) attempted to evaluate the importance of de novo 
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lipogenesis and lipogenesis from pre-formed fatty acids in the liver 
of 3- to 5-week oid male chicks which had been injected with a 
single dose of 17~-oestradiol (1.0 mg/100 g body wt.). Hepatic 
de novo fatty acid synthesis was monitored by measurement of the 
incorporation of 3H20 into lipids in liver slices taken from male 
chicks at various times after hormone injection, while complex lipid 
formation from pre-formed fatty acid was monitored by measurement of 
the incorporation of [9, 10 - 3H] palmitate into triacylglycerol in 
liver slices from similar birds. The results of these studies are 
presented in Table 5.1 and Table 5.2 respectively. This study showed 
total hepatic capacity for de novo fatty acid synthesis and for the 
synthesis of triacylglycerol from pre-formed fatty acid were 
stimulated in a roughly parallel manner during the first 44 hours 
after oestrogen treatment. For example, at 14 - 17 hours after 
hormone treatment, the total hepatic capacity for de novo fatty acid 
synthesis was stimulated by 1.75-fold and this increased to 2.40-
fold stimulation at 40! - 43! hours post-injection (Table 5. 1). 
Similarly, at 14~ - 18~ hours after hormone treatment, the total 
hepatic capacity for triacylglycerol synthesis from exogenous [3M} 
palmitate was stimulated by 1.61-fold, and this increased to 2.47-
fold stimulation at 40~- 44 hours after injection (Table 5.2). No 
significant stimulation in either process was evident at approximately 
3~ - 7~ hours after oestrogen treatment. 
These results suggest that oestrogen treatment has a general 
stimulatory effect on lipogenesis in chick liver, causing a sustained 
and roughly parallel increase in both de novo fatty acid synthesis 
and complex lipid synthesis from pre-formed fatty acid, and that 
this stimulation first becomes apparent within the 8 - 14 hour post-
injection period. 
It should be noted that this study of Courtney (1984) employed a 
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Table 5.1 
The incorporation of tritium from 3H2D into total lipid by liver slices f;·om control and oestrogen-treated male chicks at varying times after injection. 
Incorporation of tritium Time after injection (h) 
from 3H2D into total lipid. Untreated 3 ~ .. 7 * 14 .. 17 19 - zu 253 - 28t 4Da - 43a 
# # It # 
~g atoms H/liver/min. DE 28.3 :!: 1.5 (6) 46. 5 :!: 5. l ( 6) 4D. D :!: 3. 9 ( 6) 48.4 :!: 3. 7 (7) 53.5 :!: 9.D (6) 
16.5 :!: 2.2 (8) 
c 26.8 :!: 4.2 (6) 26.6 :!: 2.9 2D.3 :!: 2.6 (6) 25.5 :!: 5. 7 (7) 22.3 :!: 2.1 (6) 
Fold stimulation l.D6 1. 75 1. 97 1. 9D 2.4D 
These data are taken, with permission, from the study of Courtney (1984). Male chicks aged 3 to 5 weeks were treated wiLh a single injection of l.D mg 
17~-oestradiol/lDD g body weight. 
DE = values for oestrogen-treated chicks; C= values for control chicks. 
Consult the legend of Table 1D in the study of Courtney (1984) for details of experimental procedure. 
Values are means (t S.E.M.) of 6- 8 birds. The number of birds in each group is given in parentheses. 
Data were analysed statistically by Student's 't' test, and levels of statistical significance are presented with respect to corresponding control birds. 
#significant at p<O.Dl 
I 
N 
N 
0 
I 
Table 5.2 
The incorporation of 0.65 mM-~, 10- 3H] palmitate into triacylglycerol by liver slices from control and oestrogen-treated male chicks at varying times 
after injection. 
Incorporation of Time after injection (h) 
~, 10 - 3H] palmitate Untreated Ja - 8 14~ - 18~ 19 - 22a 28 - 3n 40 ~ - 44 
# ¥ ¥ ¥ 
nmol palmitate/ OE 198 :!: 16 (6) 230 :!: 20 (6) 278 :!: 16 (6) 382 ~ 40 (6) 390 :!: 46 (6) 
liver/min. 190 ! 19 (6) 
c 202 ~ 12 (6) 143 :!: 15 (6) 171 :!: 15 (6) 169 ~ 20 ( 5) 158 ! 13 (6) 
Fold stimulation 0.98 1.61 1.63 2.26 2.47 
These data are taken, with permission, from the study of Courtney (1984). Male chicks aged 3 to 5 weeks were treated with a single injection of 1.0 mg 
17~-oestradio/100 g body weight. 
OE = values for oestrogen-treated chicks; C = values for control ch·icks. 
Consult the legend of Table 11 in the study of Courtney (1984) for details of experimental procedure. 
Values are means (! S.E.M.) of 5 or 6 birds, the number of birds in each group is given in parentheses. 
Data were analysed statistically by Student's 't' test, and levels of statistical significance are presented w·ith respect to corresponding control birds. 
# significant at p< 0.01 
¥ significant at p< 0.001 
hormone dose of 1.0 mg 17p-oestradiol/100 body weight whereas in the 
present study a dose of 0.75 mg 17~-oestradiol/100 g body weight was 
used. Therefore, the temporal changes in liver and plasma lipid 
(Fig. 5. ld & e), in the present study, and the temporal changes in 
hepatic lipogenic capacity (Tables 5.1 & 5.2) are not directly 
comparable. Nevertheless, a tentative comparison of these parameters 
suggests that, from 14 hours post-injection onwards, the oestrogen-
induced increases in hepatic de novo fatty acid synthesis and hepatic 
1 lipogenesis from pre~formed fatty acids may account for the served 
increase in liver and plasma lipids. However, significant increases 
in plasma and liver lipids were apparent as early as 7 hours post-
injection whereas significant increases in hepatic lipogenic 
capacity were not evident until 14 hours post-injection. It should 
be noted that the rate of de novo lipogenesis, as monitored by the 
incorporation of 3H2o into lipids, might be slightly increased 
during the 3~- to 7!-hour period following oestrogen treatment 
(Table 5. 1) and, hence, could contribute to the early increases in 
plasma triacylglycerol. Unfortunately, in this study of Courtney 
(1984), no measurements were taken of hepatic de novo lipogenesis 
or lipogenesis from pre-formed fatty acids during the 7- to 14-hour 
period after hormone treatment. 
In the present study, the hepatic activity of acetyl-CoA carboxylase 
in oestrogen-treated birds was determined in vitro (Chapter 4) and 
the temporal change in total hepatic enzyme activity is presented in 
Fig. 5. lb. This enzyme is the first committed step in de novo fatty 
acid synthesis and is considered to be the rate-limiting step in 
animal cells. Oestrogen treatment led to a significant increase in 
total hepatic acetyl-CoA carboxylase activity from 24 - 61 hours 
post-injection with maximum activity being observed after 37 - 48 
hours (Fig. 5. 1b). This oestrogen-induced increase in total organ 
activity was, in part, due to significant increases in the hepatic 
-221-
specific activity of the enzyme, both with respect to DNA and to 
protein, subsequent to 24 hours post-injection. Since a significant 
oestrogen-induced increase in hepatic acetyl-CoA carboxylase did 
not occur until 24 hours post-injection, it seems likely that the 
initial phase (0 - 24 hours) of the oestrogen-dependent stimulation 
of hepatic lipogenesis and accumulation of liver and plasma lipid 
is not due to an increase in the activity of this key lipogenic 
enzyme in the liver. In the later phase of the response(> 24h), 
however, it is likely that the increase in hepatic acetyl-CoA 
carboxylase activity contributes to the enhanced rate of hepatic 
lipogenesis and the resultant accumulation of lipid in the liver 
and plasma. 
Similarly, Courtney (1984) and Courtney & Manning (1984) determined 
the activity of hepatic fatty acid synthetase, in vitro, in 3- to 
5-week old male chicks which had previously been treated with a 
single injection of 0.75 mg 178-oestradiol/100 g body weight. The 
I 
temporal change in total hepatic fatty acid synthetase activity 
following oestrogen treatment is presented in Fig. 5. lc. No 
significant increase in total enzyme activity was observed in 
oestrogen-treated birds, compared to control birds, during the 
first 26 hours after injection. However, an early increase in 
total organ enzyme activity was observed in both oestrogen-treated 
and control birds, compared to untreated birds, and it was assumed 
that this increase was a result of the handling/injection procedure. 
Therefore, the temporal change in hepatic fatty acid synthetase 
activity after oestrogen treatment (Fig. 5. lc) is consistent with 
the results for acetyl-CoA carboxylase in similar birds (Fig. 5. lb), 
in that no increase in the activity of either enzyme was observed 
in the first 24 hours after injection. Subsequently (26- 48 h), 
a significant oestrogen-induced increase was observed in total 
hepatic fatty acid synthetase activity, and this is consistent with 
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the results for hepatic acetyl-CoA carboxylase. 
These results suggest that, during the first 24 hours after 
oestrogen treatment, there is an accumulation of lipid in the liver 
and plasma and an increase in hepatic de novo lipogenesis but there 
is apparently no concomitant increase in the activity of the two 
key lipogenic enzymes, acetyl-CoA carboxylase and fatty acid 
synthetase. It is important to realise, however, that this 
interpretation is based on the assay of these two enzymes under 
optimum conditions in vitro, and that these optimum conditions may 
not exist in vivo. In the cell, therefore, it is possible that 
changes in the activity of acetyl-CoA carboxylase may occur during 
the inttial phase of the response to oestrogen as a result of 
allosteric modulation, covalent modification of the enzyme and/or 
changes in substrate availability. Similarly, fatty acid synthetase 
may be susceptible to in vivo activity changes, in the first 24 
hours after oestrogen treatment, as a result of changes in the levels 
of regulatory metabolites and/or changes in substrate availability. 
In consequence, acetyl-CoA carboxylase and fatty acid synthetase are 
not precluded absolutely from involvement in the changes in levels 
of de novo lipogenesis and hepatic and plasma lipids which occur 
within 24 hours after oestrogen treatment. It should also be borne 
in mind that the possibility exists, until shown otherwise, that 
the initial phase of the oestrogen-induced increase in hepatic de 
novo lipogenesis may involve an increase in the activity of other 
lipogenic enzymes, such as 'malic' enzyme and ATP citrate lyase. 
Therefore, in the 48 hours following oestrogen treatment of male 
chicks, the changes in the lipid metabolism can be summarised 
as follows:-
(a) An accumulation of triacylglycerol and phospholipid in liver and 
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plasma from 7 hours post injection. 
(b) The majority of accumulating glycerolipids in plasma are associated 
with VLDL. VLDL particles become progressively enriched with 
phospholipid and become more numerous. 
(c) A lesser proportion of plasma free fatty acids are albumin-bound, 
presumably as a result of an increased proportion of the total 
plasma free fatty acid pool binding to the increasing number of 
triacylglycerol-rich lipoprotein particles. 
(d) The increase in liver lipid content is accompanied by an increase 
in liver weight involving both cellular hypertrophy and cellular 
hyperplasia, the initial stages of the response (0 - 24 h) 
principally involving hypertrophy. 
(e) The accumulating plasma and liver lipids exhibit altered fatty acid 
compositions, the major change being an increase in the proportion 
of 18: 1. 
(f) An early increase ( <18 h) in de novo hepatic lipogenesis and 
hepatic lipogenesis from pre-formed fatty acids. However, increases 
in hepatic acetyl-CoA carboxylase and hepatic fatty acid synthetase 
activities, as determined in vitro under optimal conditions, were 
only observed during the later stages (~ 24 h) of the response. 
4. Suggestions for further work. 
(a) In vivo measurement of hepatic lipogenesis 
Greater understanding of the state of lipogenesis in the oestrogen-
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treated male chick could be achieved by in vivo studies, involving 
the simultaneous determination of the initiai rates of incorporation 
of injected 3H2o and 
14c-labelled palmitate into liver lipids at 
various times after oestrogen treatment. This would give more 
information about the relative importance of de novo lipogenesis 
and of lipogenesis from pre-formed fatty acids in vivo. 
(b) Further studies on lipogenic enzyme activities. 
One of the most striking features of the present study is the lack 
of an increase in the hepatic activity of the key lipogenic enzyme, 
acetyl-CoA carboxylase, within the first 24 hours immediately 
following oestrogen treatment of male chicks, even though an 
increase in hepatic and plasma lipid was evident during the same 
period. The enzyme activity was assayed in vitro under optimum 
conditions and it is generally accepted that this gives an 
indication of the total catalytic activity of the enzyme rather than 
the activity that actually exists in vivo. As described in 
Chapter 4, the activity of acetyl-CoA carboxylase is regulated both 
by allosteric modulation and by covalent modification involving 
phosphorylation and dephosphorylation. An obvious field of study, 
therefore, would be to determine the hepatic level of the positive 
allosteric effector, citrate, at various times after oestrogen 
treatment, but particularly during the first 24 hours post-injection. 
Furthermore, since acetyl-CoA carboxylase is a cytosolic enzyme, 
determinations of the citrate concentration in sub-cellular 
compartments could be extremely useful. Such sub-cellular 
determinations would necessarily involve the rapid separation of 
cytoplasm and mitochondria from liver cells followed by rapid 
quenching with perchloric acid and subsequent measurement of citrate 
in both fractions. Watkins et al. (1977) have attempted such 
determinations of cytoplasmic citrate concentration in cultured 
chicken hepatocytes, using a 'digitonin-rapid-stop' technique. This 
-225-
process involved the incubation of the cells at an optimal digitonin 
concentration which resuited in a rapid disruption of the plasma 
membrane whilst the mitochondrial membranes were left intact. A 
similar 1 digitonin-rapid-stop 1 procedure could be adopted in an 
attempt to study any possible changes in cytoplasmic citrate 
concentration of liver cells from male chicks, shortly after (~24h) 
oestrogen treatment. However, the adoption of this procedure would 
also require the prior isolation of hepatocytes from the oestrogen-
treated and control birds at varying times after injection. 
In recent years, it has become accepted practice in investigations 
of hormonal or nutritional effects on acetyl-CoA carboxylase, to 
measure enzyme activity in crude liver preparations which have been 
pre-incubated at 37°C in the absence of citrate (Allred & Roehrig, 
1978; Geelen et al., 1978; Witters et al., 1979). This form of 
assay involving the process of 1 heat activation~ is believed to 
restore or preserve the in vivo activity of acetyl-CoA carboxylase 
by a mechanism which, although not fully understood, is believed 
to involve restoration or preservation of the dephosphorylation/ 
phosphorylation state of the enzyme in vivo (Allred & Roehrig, 1978). 
Therefore, the results of the present study could be supplemented 
by the measurement of activity of hepatic acetyl-CoA carboxylase, 
particularly during the first 24 hours after oestrogen treatment, 
using the 1 heat-activation 1 procedure. 
The possibility exists that the oestrogen-induced increase in de 
novo hepatic lipogenesis and liver and plasma lipid levels during 
the first 24 hours after oestrogen treatment, in particular, may 
involve an increase in the activity of lipogenic enzymes other 
than acetyl-CoA carboxylase and fatty acid synthetase. Therefore, 
the results of the present study, and of the studies of Courtney 
(1984) and Courtney & Manning (1984) could be augmented by the 
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determination of the hepatic activity of 'malic' enzyme and ATP 
citrate lyase during the 48-hour period immediately following the 
treatment of male 3- to 5-week old chicks with 0.75 mg 178-
oestradiol/100 g body weight. Previous studies of the activity of 
these two hepatic enzymes performed at short intervals after 
oestrogen treatment have mainly used immature female domestic fowl 
(Pearce & Balnave, 1973, 1975; Balnave & Pearce, 1974). 
The increase in acetyl-CoA carboxylase specific activity reported 
in the present study, subsequent to 24 hours after oestrogen 
treatment, and any possible similar changes in other lipogenic 
enzymes in similarly-treated birds, could be further characterised 
by the following procedure:-
(a) purification of the enzyme and preparation of a monospecific 
antiserum, 
(b) use of the monospecific antiserum to monitor changes in the amount 
of enzyme protein to distinguish between changes in the catalytic 
efficiency of a fixed amount of enzyme protein and changes in the 
quantity of enzyme protein. 
Furthermore, the turnover of lipogenic enzymes could be studies in 
primary hepatocyte cultures, maintained in the presence or absence 
of oestrogen. The rates of synthesis of specific lipogenic enzymes 
could be quantified, after the incubation of the cells with 
isotopically-labelled amino acids, by disruption of the cells and 
isolation of the specific lipogenic enzymes by immune-adsorption 
techniques. The rates of degradation of specific enzymes could also 
be quantified in a similar way. After incubation of the cells with 
an isotopically-labelled amino acid, cells could be placed into 
culture medium containing non-radioactive amino acids and, at 
various times during this 'chase' period, specific isotopically-
labelled lipogenic enzymes could be isolated by immune-adsorption 
and quantified. 
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